\r\n\tThis book chapter’s main theme will be focused on transmission dynamics, pathogenesis, mechanisms of host interaction and response, epigenetics and markers, molecular diagnosis, RNA interacting proteins, RNA binding proteins, advanced development of tools for diagnosis, possible development of concepts for vaccines and anti drugs for RNA viruses, immunological mechanisms, treatment, prevention and control. \r\n\t
",isbn:"978-1-80355-667-3",printIsbn:"978-1-80355-666-6",pdfIsbn:"978-1-80355-668-0",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,hash:"52f8a3a1486912beae40b34ac557fed3",bookSignature:"Ph.D. Yogendra Shah",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11369.jpg",keywords:"HIV, Dengue, Zika, West Nile Virus, Chikungunya, Rabies, SARS-CoV2, MERS-CoV, Hanta Virus, Influenza, Whole Genome Sequencing, DNA Sequencing",numberOfDownloads:107,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"October 4th 2021",dateEndSecondStepPublish:"November 1st 2021",dateEndThirdStepPublish:"December 31st 2021",dateEndFourthStepPublish:"March 21st 2022",dateEndFifthStepPublish:"May 20th 2022",remainingDaysToSecondStep:"7 months",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Dr. Shah obtained his Ph.D. degree in Veterinary Medicine from Hokkaido University, Japan. He was awarded the Young Science and Technology Award from the Nepal Academy of Science and Technology (NAST) in 2019. His research interests include infectious diseases, zoonotic infectious diseases, and vector-borne diseases.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",middleName:null,surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah",profilePictureURL:"https://mts.intechopen.com/storage/users/278914/images/system/278914.jpg",biography:"Dr. Yogendra Shah is a consultant microbiologist/virologist, senior research microbiologist, and lecturer at Seti Provincial Hospital, COVID-19 PCR laboratory, National Zoonoses and Food Hygiene Research Center, and Kathmandu College of Science and Technology, Nepal. He obtained a Ph.D. in Veterinary Medicine (Bacteriology) from the Graduate School of Veterinary Medicine, Hokkaido University, Japan, in 2017. His research focuses on better understanding the molecular epidemiological features/transmission dynamics of infectious diseases and zoonotic infectious diseases in Nepal by employing molecular techniques like ELISA, polymerase chain reaction (PCR), loop-mediated isothermal amplification (LAMP), and DNA sequencing. He was awarded the Young Science and Technology Award from the Nepal Academy of Science and Technology (NAST) in 2019. His research interests include infectious diseases, zoonotic infectious diseases, and vector-borne diseases. He has published more than thirty-five research articles in peer-reviewed journals and twelve books.",institutionString:"National Zoonoses and Food Hygiene Research Centre",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"National Zoonoses and Food Hygiene Research Centre",institutionURL:null,country:{name:"Nepal"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"13",title:"Immunology and Microbiology",slug:"immunology-and-microbiology"}],chapters:[{id:"80540",title:"Neurotropic Virus-Induced Meningoencephalomyelitis",slug:"neurotropic-virus-induced-meningoencephalomyelitis",totalDownloads:40,totalCrossrefCites:0,authors:[null]},{id:"81675",title:"Influenza Viruses: Targetting Conserved Viral Ha-Stem, Matrix and Nucleo-Proteins to Disarm a Resilient and Recurring Pandemic",slug:"influenza-viruses-targetting-conserved-viral-ha-stem-matrix-and-nucleo-proteins-to-disarm-a-resilien",totalDownloads:6,totalCrossrefCites:0,authors:[null]},{id:"81283",title:"COVID-19 Prevention through Vitamin C, D, and Zinc Supplementation: A Small Clinical Study in Two Parts",slug:"covid-19-prevention-through-vitamin-c-d-and-zinc-supplementation-a-small-clinical-study-in-two-parts",totalDownloads:9,totalCrossrefCites:0,authors:[{id:"232234",title:"Dr.",name:"Chanda",surname:"Siddoo-Atwal",slug:"chanda-siddoo-atwal",fullName:"Chanda Siddoo-Atwal"}]},{id:"81733",title:"Impairment of the Cardiovascular System during SARS-CoV-2 Infection",slug:"impairment-of-the-cardiovascular-system-during-sars-cov-2-infection",totalDownloads:3,totalCrossrefCites:0,authors:[null]},{id:"80052",title:"Chronic Inflammatory Bowel Disease and Demyelination of the Central Nervous System: A Report on Two Cases",slug:"chronic-inflammatory-bowel-disease-and-demyelination-of-the-central-nervous-system-a-report-on-two-c",totalDownloads:51,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"429343",firstName:"Martina",lastName:"Ivancic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/429343/images/19998_n.jpg",email:"martina@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"9018",title:"Some RNA Viruses",subtitle:null,isOpenForSubmission:!1,hash:"a5cae846dbe3692495fc4add2f60fd84",slug:"some-rna-viruses",bookSignature:"Yogendra Shah and Eltayb Abuelzein",coverURL:"https://cdn.intechopen.com/books/images_new/9018.jpg",editedByType:"Edited by",editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10542",title:"Molecular Epidemiology Study of Mycobacterium Tuberculosis Complex",subtitle:null,isOpenForSubmission:!1,hash:"29279e34f971687dc28de62534335ac4",slug:"molecular-epidemiology-study-of-mycobacterium-tuberculosis-complex",bookSignature:"Yogendra Shah",coverURL:"https://cdn.intechopen.com/books/images_new/10542.jpg",editedByType:"Edited by",editors:[{id:"278914",title:"Ph.D.",name:"Yogendra",surname:"Shah",slug:"yogendra-shah",fullName:"Yogendra Shah"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"26193",title:"Endoscopic Retrograde Cholangiopancreatography-Related Acute Pancreatitis – Identification, Prophylaxis and Treatment",doi:"10.5772/26194",slug:"endoscopic-retrograde-cholangiopancreatography-related-acute-pancreatitis-identification-prophylaxis",body:'\n\t\t
\n\t\t\t
1. Introduction
\n\t\t\t
Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP) [1–4]. The reported incidence ranges from 1.8% to 7.2% in most prospective series [5–9] but can be up to 30%, depending on the criteria used to diagnose pancreatitis, the type and duration of patient follow-up, and the type of case mix [10]. More commonly, hyperamylasemia occurs in up to 30% of patients undergoing ERCP [11].
\n\t\t\t
As the indications for ERCP have increased, a greater focus on recognizing and preventing complications has emerged. The recognized complications of ERCP include asymptomatic hyperamylasemia, cardiopulmonary depression, hypoxia, aspiration, intestinal perforation, bleeding, cholangitis, adverse medication reactions, sepsis, acute pancreatitis, and death. Post-ERCP pancreatitis (PEP) remains the leading cause of morbidity and mortality after the procedure and is the focus of studies designed to improve procedural outcomes [12,13]. Some studies have suggested that the rates of PEP can be reduced, but the incidence of pancreatitis remains high particularly in at-risk patient populations. Pancreatitis continues to be the major cause of postprocedure morbidity and mortality [14–17].
\n\t\t
\n\t\t
\n\t\t\t
2. Diagnosis of PEP
\n\t\t\t
PEP was defined initially as the presence of new pancreatic-type abdominal pain associated with at least a threefold increase in serum amylase concentration occurring 24 h after an ERCP, with pain severe enough to require admission to the hospital or to extend an admitted patient’s length of stay. This definition was developed in 1991 based upon approximately 15 000 procedures evaluated during a consensus workshop. The severity of PEP was defined according to the length of stay (mild pancreatitis 2–3 d, moderate pancreatitis 4–10 d, and severe pancreatitis >10 d, or intensive care admission or local complications secondary to pancreatitis) [18]. This consensus definition has not been adopted uniformly and many studies published after 1991 have used different criteria to define PEP and to classify its severity. Several studies have challenged the serum amylase threshold of three times the upper limit of normal, arguing that this definition is not always consistent with the clinical and morphological features of pancreatitis [19–25]. Other criteria for serum amylase elevation include twice [23–26], four times [6,27,28] and five times [20,21,28–30] the upper normal limit.
\n\t\t\t
There is also heterogeneity in the criteria used to classify the severity of PEP in published studies. Some authors have used the Atlanta criteria published in 1993 to define severity [31–33]. The Atlanta criteria incorporate systemic complications of PEP by integrating the Acute Physiologic and Chronic Health Evaluation (APACHE) II classification and Ranson’s criteria to define the severity [33–35]. An APACHE II score of >8 or a Ranson’s score of 3 of 11 criteria are defined as severe PEP. Some studies have used the APACHE II classification alone to grade the severity of PEP [36]. Other studies have used combinations of criteria to define the presence and severity of PEP or have established unique definitions [26,31,37–40]. The heterogeneity of criteria in the literature on PEP hinders direct comparison of the published clinical trials.
\n\t\t
\n\t\t
\n\t\t\t
3. Pathophysiology of PEP
\n\t\t\t
The pathophysiology of PEP is not well understood. Mechanical, hydrostatic, chemical, enzymatic, allergic, thermal, cytokine, oxidative, and microbiological factors have all been proposed as causes [32,41–46]. Many studies suggest that PEP results from mechanical trauma, causing injury to the papilla or pancreatic sphincter and subsequent swelling of the pancreatic duct and obstruction to the flow of pancreatic enzymes. This hypothesis remains controversial, and no consensus about the pathogenesis of PEP has been established.
\n\t\t\t
The cascade of events leading to acute pancreatitis is characterized by three phases. The first phase is characterized by premature activation of trypsin within the pancreatic acinar cells [47]. The second phase is characterized by intrapancreatic inflammation. The third phase is characterized by extrapancreatic inflammation [47]. Inflammation in the second and third phases has been described as a four-step process: (1) activation of inflammatory cells; (2) chemoattraction of activated inflammatory cells; (3) activation of adhesion molecules causing binding of inflammatory cells to the endothelium; and (4) migration of activated inflammatory cells into areas of inflammation [47]. Recent studies have evaluated proinflammatory markers (TNF, interleukin-1 (IL-1), IL-6, IL-8, PAF, and IL-10) in the setting of PEP [48–51]. Although three randomized controlled trials (RCTs) suggested a protective effect of low- or high-dose (4 g/kg or 20 g/kg) IL-10 given intravenously 15–30 min before ERCP [52], subsequent studies using similar IL-10 protocols did not support these findings [53,54]. Although not demonstrated at present, modulation of proinflammatory pathways might be an appealing goal for studies evaluating PEP and the systemic inflammatory response.
\n\t\t
\n\t\t
\n\t\t\t
4. Procedural-related factors associates with PEP
\n\t\t\t
Although the triggers of the inflammatory cascade are not well understood, procedural- and patient-related factors have been clearly associated with the incidence of PEP. ERCP is the most technically difficult endoscopic procedure performed by trainees and experienced endoscopists in both inpatient and outpatient settings. Whereas trauma to the duodenum or papilla during endoscopy without cannulation rarely causes pancreatitis [55], cannulation of the papilla, especially in moderate to difficult cases, is associated with high rates of PEP. Procedures involving multiple (>1–4) or failed attempts at cannulation, multiple pancreatic injections (2–5), pancreatic acinarization, and prolonged cannulation time (>10 min) are associated with PEP. The following factors have also been associated with a higher risk for developing PEP: operator experience, ampullary balloon dilation, precut access sphincterotomy, endoscopic sphincterotomy (ES), sphincter of Oddi manometry, distal common bile duct diameters of 1 cm, presence of a pancreatic stricture, papillectomy, and procedures not involving stone removal [45,56–59] (Table 1).
\n\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t
Patient related factors
\n\t\t\t\t\t\t
Young age. Female gender. Suspected sphincter of Oddi dysfunction. Recurrent pancreatitis. Prior history of post-ERCP pancreatitis. Patients with normal serum bilirubin.
Factors Increasing the Risk of Post-ERCP Pancreatitis.
\n\t\t\t\t
4.1. Operator experience
\n\t\t\t\t
Although there is no established mandate for the procedure volume to develop competence in ERCP, a prospective study published in 1996 evaluated the number of supervised ERCPs a physician must perform to achieve procedural competence and reported that at least 180 procedures are required [60]. In the United States, the American Society for Gastrointestinal Endoscopy and the American College of Gastroenterology have published quality indicators for ERCP. Competent endoscopists are expected to be able to perform sphincterotomy, clear the common bile duct of stones, provide relief of biliary obstruction, and successfully place stents for bile leaks in 85% of patients [61].
\n\t\t\t\t
Few studies have been published on operator experience in ERCP, and this issue remains controversial. A recent study in Austria showed that a case volume of >50 ERCPs per year had higher success and lower overall complication rates [62]. It is generally agreed that the case mix at high volume and in academic referral centers may include a larger proportion of difficult and high-risk cases, which may confound the relationship between experience and complication rates. Although operator experience is felt to be critical for high-quality outcomes, many large prospective and retrospective trials have not shown consistent correlations between inexperience and PEP. Higher rates of bleeding have been reported after endoscopic sphincterotomy with a mean case volume of <1 per wk [14], and trainee involvement was associated with severe or fatal complications in a recent retrospective analysis [63]. However, a large prospective trial found that case volume had no effect on the incidence of PEP [24]. A prospective study of ERCP in the United Kingdom (UK) in 2007 based on self-reported surveys demonstrated that 15% of all credentialed endoscopists performed <50 ERCPs per year compared with 61% of those in training; 11% of deaths occurred after procedures by endoscopists who performed <50 ERCPs per year. Although the rates of PEP were low at 1.5%, the success rates for bile duct stone extraction and biliary stent placement were 62% and 73%, respectively. The authors concluded that in the UK there is a need for fewer operators and greater experience in those performing therapeutic endoscopy [64]. In the same year, a study in France showed no risk associated with operator inexperience [65].
\n\t\t\t
\n\t\t\t
\n\t\t\t\t
4.2. Cannulation techniques
\n\t\t\t\t
Cannulation techniques to access the pancreatic and biliary ducts include the use of a sphincterotome or straight or curved catheter with guide wires or contrast injection. When an initial attempt at cannulation fails, access may be achieved after placement of a pancreatic guide wire or stent to help guide the endoscopist toward the common bile duct and away from the pancreatic duct. Precut access papillotomy is used frequently in referral centers when conventional approaches fail. Rare or experimental techniques such as the use of endoscopic scissors or endoscopic dissection with a cotton swab have been reported but are used rarely in clinical practice [66].
\n\t\t\t\t
Compared with a standard catheter, the use of a sphincterotome may decrease the number of failed attempts to obtain biliary access, the time required to cannulate the common bile duct, and the rate of PEP [67,68]. Selective sphincterotome cannulation with a guide wire may reduce the rate of PEP compared with cannulation with contrast injection [67–71]. In 2008, a large prospective controlled trial randomized 430 patients into sphincterotome plus guide wire versus conventional cannulation arms. The series demonstrated a significantly higher rate of cannulation with guide wires but failed to show a significant difference in the rate of PEP between the two approaches [72]. The authors reported an 8.8%–14.9% increased risk of PEP after >4 attempts at the papilla, highlighting the importance of cannulation with fewer attempts. These findings are consistent with those of previous studies [7,72].
\n\t\t\t
\n\t\t\t
\n\t\t\t\t
4.3. Pancreatic duct injection
\n\t\t\t\t
Multiple pancreatic duct injections (2–5) [6,7,15,24,58] and pancreatic acinarization [6,12,15,30] are recognized as risk factors for PEP. Differences in the osmolality and ionicity of contrast media have been studied with varying results in terms of impact on PEP [25,28,59,73–75]. A recent meta-analysis of 13 RCTs found no significant difference between high- and low-osmolality contrast media [75]. Earlier studies suggested that there is a decreased risk of PEP with the use of nonionic contrast agents [73], although this has not been demonstrated consistently [74]. One large retrospective analysis of 14 331 ERCPs suggested that less opacification of the pancreatic duct in the head than in the tail produced significantly lower rates of PEP [59]. Despite the variable findings, clinical trial data suggest that hydrostatic pressure may play a role in the development of pancreatitis.
\n\t\t\t
\n\t\t\t
\n\t\t\t\t
4.4. Pancreatic duct stenting
\n\t\t\t\t
The theory that PEP is caused by pancreatic duct obstruction is supported by most RCTs, which show a decreased incidence of pancreatitis in high-risk patients after placement of a pancreatic duct stent [76–84]. The three largest published studies to evaluate the rate of pancreatitis with pancreatic duct stent placement reported significant decreases, by 10.4%, 14.8%, and 52.3%, in the rates of PEP in patients treated with stent placement versus those without stent placement [78,79,85]. Although pancreatic duct stenting decreases the risk of PEP, it has not been shown to prevent it. Despite stent placement, pancreatitis occurs in 2.0%–14% of patients [78,79,81,83,84], and some studies have failed to demonstrate a significant protective effect [59,83,84]. Eight RCTs, multiple prospective uncontrolled studies, and five meta-analyses have compared the rates of pancreatitis after ERCP with and without prophylactic pancreatic stent placement [86–90]. Prophylactic stent placement reduces the incidence of PEP, particularly in high-risk patients, and virtually eliminates the risk of severe pancreatitis.
\n\t\t\t\t
Many studies have criticized the absence of intent-to-treat analysis (i.e., patients with attempted but unsuccessful stent placement were excluded). However, a meta-analysis showed that the four RCTs used intent-to-treat principles by assuming that PEP developed in patients in whom the attempted prophylactic pancreatic stent placement failed, even when the clinical outcome was not stated in the original study. Despite the use of this approach, the odds ratio in the stent group was 0.44 compared with the controls and differed significantly in favor of stent placement [86]. On the basis of these results, prophylactic stent placement can be considered as the single most important advance in the past 15 years for the prevention of PEP in high-risk patients. Despite these findings, questions remain about when to place a prophylactic pancreatic stent, the type of stent to place, and the optimal follow-up period to ensure adequate removal. The incidence of adverse events associated with pancreatic stent placement is around 4% and must be considered in the decision-making process for the placement of a stent [86,91].
\n\t\t\t
\n\t\t\t
\n\t\t\t\t
4.5. Biliary stone extraction
\n\t\t\t\t
In the setting of choledocholithiasis, endoscopic papillary balloon dilatation (EPBD), ES, and mechanical lithotripsy are techniques used to extract obstructing stones. Many studies have shown an increased rate of PEP with EPBD; the rates range from 4.9–20% with EPBD versus 0.42–10% with ES [92–95]. Prospective trials support this observation, although it is difficult to generalize the findings given the many factors that contribute to procedural complications [96–100]. Balloon dilation may also be required in some clinical settings. If a patient has had a prior sphincterotomy and has limited remaining tissue for incision, balloon dilation may be necessary to enlarge the bile duct insertion and enable stone extraction.
\n\t\t\t
\n\t\t
\n\t\t
\n\t\t\t
5. Patient-related risk factors associated with PEP
\n\t\t\t
Given the high risk of PEP in certain populations, identifying a clear indication is critical for reducing the complication rate. ERCP is riskiest in patients who need it the least [101,102]. Large prospective trials have demonstrated that being female, being younger than 60–70 years, and having suspected sphincter of Oddi dysfunction (SOD) or a recurrent or prior PEP are associated with a higher risk of PEP [6,9,15,24,45,87,103,104] (Table 1). However, there is some variability between studies. For example, one smaller trial suggested an age of <50 years as a significant risk factor [104]. A recent large retrospective study of 16 855 patients reported that the highest rates of PEP occurred in patients with SOD, but the rate was not significantly higher in younger patients or in women [63]. Alternatively, a meta-analysis evaluating five patient-related risk factors demonstrated relative risks of SOD of 4.09 (95% CI, 1.93–3.12; P<0.001) and of being female of 2.23 (95% CI, 1.75–2.84; P<0.001) [87]. One study demonstrated a 10-fold increase in the risk of PEP in patients with SOD [105]. Some factors may be protective as well. The absence of chronic pancreatitis [57], presence of obesity [106], older age (>80 years) [107], and a history of alcohol consumption or cigarette smoking may be associated with a lower risk of PEP [108]. Proper patient selection and identification of patients at higher risk are the most effective means for reducing the incidence of PEP.
\n\t\t
\n\t\t
\n\t\t\t
6. Pharmacological agents evaluated for the prevention or reduction of PEP
\n\t\t\t
The effects of pharmacological agents on PEP have attracted much interest. Preventing cellular injury and pancreatic tissue auto-digestion may involve blocking the premature activation of proteolytic enzymes within the acinar cells [14,45,109–116]. Although conceptually straightforward, the goal of blocking this activation has been difficult to achieve. Multiple trials have been performed with the goal of reducing the incidence or severity of PEP. About 34 pharmacological agents and procedures (e.g., topical application of pharmacological agents injected or sprayed onto the papilla) have been evaluated for their potential to prevent PEP in controlled trials. Most clinical trials have been disappointing, and only a minority of studies has demonstrated benefit (Table 2-5) [26,29,37,39,40,53,54,58,87,117–175].
\n\t\t\t
In two of five prospective trials, allopurinol was shown to decrease the incidence of PEP [119,120]. In these trials showing benefits, allopurinol was given in 300 mg or 600 mg doses 15 h and 3 h before ERCP. When reviewing other studies of allopurinol, these effects were not significant in patients dosed on different 4 h and 1 h regimens and with varying dose concentrations of allopurinol [121–123]. This suggests that both the dose and timing of allopurinol administration are important in reducing the risk of PEP.
\n\t\t\t
Three meta-analyses have been published using data obtained from four prospective, randomized, placebo-controlled studies that compared rectally administered diclofenac or indomethacin at a dose of 100 mg versus placebo [124–126]. No statistical heterogeneity was detected between the studies. Two RCTs evaluated the effect of rectal administration of 100 mg diclofenac immediately after the procedure [39,143], and the other two evaluated rectal administration of 100 mg indomethacin immediately before the procedure [144,145]. Both sets of studies showed similar results. Patients who were considered to be at high risk for PEP were included in both studies. Overall, PEP occurred in 20/456 (4.4%) patients in the treatment groups versus 57/456 (12.5%) patients in the placebo groups. The estimated pooled relative risk was 0.36 (95% CI, 0.22–0.60), and the number needed to treat to prevent one episode of PEP was 15. The administration of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a similar decrease in the incidence of PEP regardless of risk. No adverse event attributable to NSAIDs has been reported. A trial evaluating diclofenac 50
\n\t\t\t
Table 2.
Randomized controlled trails of drugs that decrease inflammation evaluated for reduction or prevention of post-ERCP pancreatitis.
\n\t\t\t
Table 3.
Randomized controlled trails of drugs that interrupt the activity of proteases evaluated for reduction or prevention of post-ERCP pancreatitis.
\n\t\t\t
Table 4.
Randomized controlled trails of inhibitors of pancreatic secretion evaluated for reduction or prevention of post-ERCP pancreatitis.
\n\t\t\t
Table 5.
Randomized controlled trails of drugs that decrease Sphincter of Oddi Pressure and miscellaneous drugs evaluated for reduction or prevention of post-ERCP pancreatitis.
\n\t\t\t
mg by mouth given 30–90 min before ERCP and up to 4–6 h after ERCP showed no decrease in the incidence of PEP [146]. A small clinical trial by Senol and colleagues found no significant difference in the incidence of PEP in patients given ERCP with the use of 75 mg of diclofenac by the intramuscular route plus intravenous (IV) hydration versus those given placebo and IV solutions [147]. According to the European Society of Gastrointestinal Endoscopy, no other drug prophylaxis has been proven to be effective against PEP as rectal NSAIDs [148].
\n\t\t\t
Glyceryl trinitrate [141], hydrocortisone [130], and IL-10 [52] were shown to be beneficial in one RCT. However, studies with larger numbers of patients [26,54,140] found no significant effects of these treatments. Gabexate [160,161,163], octreotide [150,151], somatostatin [171,174], and ulinastatin [167] have all been reported to reduce the incidence of PEP. However, studies evaluating each of these agents using similar designs have reported no significant reduction in the incidence of PEP. These differences might be explained by differences in the selection and number of patients, clinical presentation, and timing of administration or dosage of the agents under investigation.
\n\t\t
\n\t\t
\n\t\t\t
7. Management of PEP
\n\t\t\t
Not all patients with pain and hyperamylasemia following ERCP have acute pancreatitis, and clinicians may have difficulty establishing the diagnosis. As a result, some patients with severe post-ERCP pancreatitis may not be identified in the early stages of their illness when aggressive hydration is most important. Some endoscopists may have difficulty acknowledging that post-ERCP pancreatitis has occurred, as this requires accepting that there has been a complication. A sense of guilt on the part of the clinician performing the procedure is understandable. However, delay in either the diagnosis or treatment of post-ERCP pancreatitis may lead to adverse consequences.
\n\t\t\t
Post-ERCP pancreatitis should be managed as for other causes of acute pancreatitis. This is sometimes complicated by the difficulty distinguishing mild from severe disease in the early stages. The elevations in serum amylase and lipase levels do not always correlate with disease severity.
\n\t\t\t
Mild and moderate PEP usually resolve quickly with conservative therapy. Although there are no specific guidelines for the treatment of PEP, a recent study found that a protocol-based management strategy was associated with less severe pancreatitis, shorter length of hospital stay, the need for fewer imaging studies, and less use of antibiotics [109,177].
\n\t\t\t
Practice guidelines for acute pancreatitis treatment are available and may be applicable to PEP as well [47]. In patients with persistent or severe PEP, two important markers of severity are multisystem organ failure and pancreatic necrosis, both of which require aggressive management [18]. Early identification of organ failure, pancreatic necrosis, perforation (especially in the setting of endoscopic sphincterotomy), biliary damage/leak and pancreatic fluid collections are important clinical branch points that may require more intensive intervention. Checking the levels of serum transaminases, amylase, and lipase is not routinely recommended after ERCP, but if assessed, postprocedure elevations occur often. These elevations are likely to be secondary to intermittent biliary, pancreatic, or papillary obstruction. In a recent study, 46% of patients had elevated liver test results after ERCP, but only 5.4% had PEP [110]. Asymptomatic elevation of liver markers is not an indication for a change in management and a repeat ERCP should be performed only with a clear indication. Although the use of enteral feeding during treatment of acute pancreatitis is controversial, patients who are unlikely to resume oral nutrition within 5 days require nutritional support, which can be provided via total parenteral nutrition or enteral routes [177]. There appear to be some advantages to enteral feeding. A recent study found that initiating oral nutrition after mild acute pancreatitis with a low-fat soft diet appeared to be safe but did not shorten the length of hospitalization [111].
\n\t\t
\n\t\t
\n\t\t\t
8. Conclusion
\n\t\t\t
Acute pancreatitis is a well-recognized and frequent complication that can occur in 1%–15% of patients undergoing ERCP. Clinical research to prevent PEP using depurate endoscopic techniques and pharmacological prophylaxis is intense and so far indicates that the use of NSAIDs and pancreatic stenting, coupled with appropriate selection of eligible patients and performed by an experienced endoscopist are the most effective preventive measures to reduce the incidence and severity this complication.
\n\t\t
\n\t\n',keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/26193.pdf",chapterXML:"https://mts.intechopen.com/source/xml/26193.xml",downloadPdfUrl:"/chapter/pdf-download/26193",previewPdfUrl:"/chapter/pdf-preview/26193",totalDownloads:2586,totalViews:246,totalCrossrefCites:0,totalDimensionsCites:0,totalAltmetricsMentions:0,impactScore:0,impactScorePercentile:27,impactScoreQuartile:2,hasAltmetrics:0,dateSubmitted:"February 4th 2011",dateReviewed:"August 22nd 2011",datePrePublished:null,datePublished:"January 18th 2012",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/26193",risUrl:"/chapter/ris/26193",book:{id:"932",slug:"acute-pancreatitis"},signatures:"Alejandro González-Ojeda, Carlos Dávalos-Cobian, Elizabeth Andalón-Dueñas, Mariana Chávez-Tostado, Arturo Espinosa-Partida and Clotilde Fuentes-Orozco",authors:[{id:"65817",title:"Prof.",name:"Alejandro",middleName:null,surname:"Gonzalez-Ojeda",fullName:"Alejandro Gonzalez-Ojeda",slug:"alejandro-gonzalez-ojeda",email:"avygail5@yahoo.com.mx",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Mexican Social Security Institute",institutionURL:null,country:{name:"Mexico"}}}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Diagnosis of PEP ",level:"1"},{id:"sec_3",title:"3. Pathophysiology of PEP",level:"1"},{id:"sec_4",title:"4. Procedural-related factors associates with PEP",level:"1"},{id:"sec_4_2",title:"4.1. Operator experience",level:"2"},{id:"sec_5_2",title:"4.2. Cannulation techniques",level:"2"},{id:"sec_6_2",title:"4.3. Pancreatic duct injection ",level:"2"},{id:"sec_7_2",title:"4.4. Pancreatic duct stenting ",level:"2"},{id:"sec_8_2",title:"4.5. Biliary stone extraction ",level:"2"},{id:"sec_10",title:"5. Patient-related risk factors associated with PEP",level:"1"},{id:"sec_11",title:"6. Pharmacological agents evaluated for the prevention or reduction of PEP",level:"1"},{id:"sec_12",title:"7. Management of PEP",level:"1"},{id:"sec_13",title:"8. Conclusion",level:"1"}],chapterReferences:[{id:"B1",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDi Sario\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNelson\n\t\t\t\t\t\t\tD. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFennerty\n\t\t\t\t\t\t\tM. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tJ. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBjorkman\n\t\t\t\t\t\t\tD. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2001 Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc;54\n\t\t\t\t\t4\n\t\t\t\t\t425\n\t\t\t\t\t34 .\n\t\t\t'},{id:"B2",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRabenstein\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHahn\n\t\t\t\t\t\t\tE. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tPost-ERCP pancreatitis: New momentum.\n\t\t\t\t\tEndoscopy; 34\n\t\t\t\t\t325\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B3",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFrank\n\t\t\t\t\t\t\tC. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdler\n\t\t\t\t\t\t\tD. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006\n\t\t\t\t\tPost-ERCP Pancreatitis and its prevention. Nat Clin Pract Gastroenterol Hepatol;3\n\t\t\t\t\t680\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B4",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLa Ferla\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGordon\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArchibald\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMurray\n\t\t\t\t\t\t\tW. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1986 Hyperamylasaemia and acute pancreatitis following endoscopic retrograde cholangiopancreatography. Pancreas.;1\n\t\t\t\t\t2\n\t\t\t\t\t160\n\t\t\t\t\t63 .\n\t\t\t'},{id:"B5",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBadalov\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTenner\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaillie\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tThe Prevention, recognition and treatment of post-ERCP pancreatitis. JOP.;10\n\t\t\t\t\t2\n\t\t\t\t\t88\n\t\t\t\t\t97 .\n\t\t\t'},{id:"B6",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVandervoort\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSoetikno\n\t\t\t\t\t\t\tR. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTham\n\t\t\t\t\t\t\tT. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWong\n\t\t\t\t\t\t\tR. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFerrari\n\t\t\t\t\t\t\tA. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJr Montes\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tRisk factors for complications after performance of ERCP. Gastrointest Endosc.;56\n\t\t\t\t\t5\n\t\t\t\t\t652\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B7",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGarcía-Cano\n\t\t\t\t\t\t\tLizcano. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGonzález\n\t\t\t\t\t\t\tMartín. J. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMorillas\n\t\t\t\t\t\t\tAriño. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPérez\n\t\t\t\t\t\t\tSola. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tComplications of endoscopic retrograde cholangiopancreatography. A study in a small ERCP unit. Rev Esp Enferm Dig.;96\n\t\t\t\t\t3\n\t\t\t\t\t163\n\t\t\t\t\t73 .\n\t\t\t'},{id:"B8",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCheng\n\t\t\t\t\t\t\tC. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWatkins\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarnett\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2006\n\t\t\t\t\tRisk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol.;101\n\t\t\t\t\t1\n\t\t\t\t\t139\n\t\t\t\t\t47 .\n\t\t\t'},{id:"B9",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilliams\n\t\t\t\t\t\t\tE. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaylor\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFairclough\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHamlyn\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLogan\n\t\t\t\t\t\t\tR. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartin\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tRisk factors for complication following ERCP; results of a large-scale, prospective multicenter study.\n\t\t\t\t\tEndoscopy.;39\n\t\t\t\t\t9\n\t\t\t\t\t793\n\t\t\t\t\t801 .\n\t\t\t'},{id:"B10",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGuda\n\t\t\t\t\t\t\tN. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2004 Prevent ion of post- ERCP pancreatitis: a comprehensive review. Gastrointest Endosc.;59\n\t\t\t\t\t7\n\t\t\t\t\t845\n\t\t\t\t\t64\n\t\t\t\t\n\t\t\t'},{id:"B11",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIto\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFujita\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNoda\n\t\t\t\t\t\t\tY.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKobayashi\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHoraguchi\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTakasawa\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tObana\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tRelationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. World J Gastroenterol; 13\n\t\t\t\t\t3855\n\t\t\t\t\t60 .\n\t\t\t'},{id:"B12",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBilbao\n\t\t\t\t\t\t\tM. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDotter\n\t\t\t\t\t\t\tC. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tT. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKaton\n\t\t\t\t\t\t\tR. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1976\n\t\t\t\t\tComplications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases.\n\t\t\t\t\tGastroenterology.;70\n\t\t\t\t\t3\n\t\t\t\t\t314\n\t\t\t\t\t20 .\n\t\t\t'},{id:"B13",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSkude\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWehlin\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaruyama\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAriyama\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1976\n\t\t\t\t\tHyperamylasaemia after duodenoscopy and retrograde cholangiopancreatography.\n\t\t\t\t\tGut.;17\n\t\t\t\t\t2\n\t\t\t\t\t127\n\t\t\t\t\t32 .\n\t\t\t'},{id:"B14",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSilviera\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMJ\n\t\t\t\t\t\t\tSeamon\n\t\t\t\t\t\t\tPorshinsky. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tProsciak\n\t\t\t\t\t\t\tM. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDoraiswamy\n\t\t\t\t\t\t\tV. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWang\n\t\t\t\t\t\t\tC. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tComplications related to endoscopic retrograde cholangiopancreatography: a comprehensive clinical review. J Gastrointestin Liver Dis.;18\n\t\t\t\t\t1\n\t\t\t\t\t73\n\t\t\t\t\t82 .\n\t\t\t'},{id:"B15",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWang\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLi\n\t\t\t\t\t\t\tZ. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLiu\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRen\n\t\t\t\t\t\t\tX.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLu\n\t\t\t\t\t\t\tN. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFan\n\t\t\t\t\t\t\tZ. N.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\tRisk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 1\n\t\t\t\t\t104\n\t\t\t\t\t31\n\t\t\t\t\t40\n\t\t\t\t\t2009\n\t\t\t\t\n\t\t\t'},{id:"B16",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCohen\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBacon\n\t\t\t\t\t\t\tB. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBerlin\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFleischer\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHecht\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLoehrer\n\t\t\t\t\t\t\tP. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tNational Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc.;56\n\t\t\t\t\t6\n\t\t\t\t\t803\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B17",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBrugge\n\t\t\t\t\t\t\tW. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVan Dam\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1999\n\t\t\t\t\tPancreatic and biliary endoscopy. N Engl J Med.;341\n\t\t\t\t\t24\n\t\t\t\t\t1808\n\t\t\t\t\t16 .\n\t\t\t'},{id:"B18",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCotton\n\t\t\t\t\t\t\tP. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLehman\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVennes\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRussell\n\t\t\t\t\t\t\tR. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMeyers\n\t\t\t\t\t\t\tW. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1991\n\t\t\t\t\tEndoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc.;37\n\t\t\t\t\t3\n\t\t\t\t\t383\n\t\t\t\t\t93 .\n\t\t\t'},{id:"B19",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCaporuscio\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLella\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1999\n\t\t\t\t\tSerum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol.;94\n\t\t\t\t\t5\n\t\t\t\t\t1235\n\t\t\t\t\t41 .\n\t\t\t'},{id:"B20",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCicardi\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBergamaschini\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGuzzoni\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCugno\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBuizza\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1995\n\t\t\t\t\tInfusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy. Gastrointest Endosc.;42\n\t\t\t\t\t4\n\t\t\t\t\t301\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B21",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tPain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis. Gastrointest Endosc.;53\n\t\t\t\t\t1\n\t\t\t\t\t33\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B22",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNatale\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPrimignani\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2000\n\t\t\t\t\tIncidence of post-endoscopic retrograde-cholangiopancreatography/sphincterotomy pancreatitis depends upon definition criteria. Dig Liver Dis.;32\n\t\t\t\t\t5\n\t\t\t\t\t412\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B23",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWeiner\n\t\t\t\t\t\t\tG. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHogan\n\t\t\t\t\t\t\tW. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCatalano\n\t\t\t\t\t\t\tM. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1995 Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc.;42\n\t\t\t\t\t6\n\t\t\t\t\t579\n\t\t\t\t\t83 .\n\t\t\t'},{id:"B24",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNelson\n\t\t\t\t\t\t\tD. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHaber\n\t\t\t\t\t\t\tG. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHerman\n\t\t\t\t\t\t\tM. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDorsher\n\t\t\t\t\t\t\tP. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1996 Complications of endoscopic biliary sphincterotomy. N Engl J Med.;335\n\t\t\t\t\t13\n\t\t\t\t\t909\n\t\t\t\t\t18 .\n\t\t\t'},{id:"B25",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJohnson\n\t\t\t\t\t\t\tG. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJohanson\n\t\t\t\t\t\t\tJ. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHogan\n\t\t\t\t\t\t\tW. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCass\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1997\n\t\t\t\t\tEvaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc.;46\n\t\t\t\t\t3\n\t\t\t\t\t217\n\t\t\t\t\t22 .\n\t\t\t'},{id:"B26",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDe Palma\n\t\t\t\t\t\t\tG. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCatanzano\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1999\n\t\t\t\t\tUse of corticosteriods in the prevention of post-ERCP pancreatitis: results of a controlled prospective study. Am J Gastroenterol.;94\n\t\t\t\t\t4\n\t\t\t\t\t982\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B27",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRuffolo\n\t\t\t\t\t\t\tT. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHawes\n\t\t\t\t\t\t\tR. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLehman\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1991\n\t\t\t\t\tComplications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.\n\t\t\t\t\tGastroenterology.;101\n\t\t\t\t\t4\n\t\t\t\t\t1068\n\t\t\t\t\t75 .\n\t\t\t'},{id:"B28",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHawes\n\t\t\t\t\t\t\tR. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRathgaber\n\t\t\t\t\t\t\tS. W.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tUzer\n\t\t\t\t\t\t\tM. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSmith\n\t\t\t\t\t\t\tM. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhusro\n\t\t\t\t\t\t\tQ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1994\n\t\t\t\t\tPost-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc.;40\n\t\t\t\t\t4\n\t\t\t\t\t422\n\t\t\t\t\t427 .\n\t\t\t'},{id:"B29",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLella\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCaporuscio\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCattani\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tColombo\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1996\n\t\t\t\t\tLong-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater’s papilla.\n\t\t\t\t\tPancreas.;13\n\t\t\t\t\t1\n\t\t\t\t\t61\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B30",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMasci\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tToti\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMariani\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCurioni\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLomazzi\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDinelli\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2001 Complications of diagnostic and therapeutic ERCP: a prospective multicenter study Am J Gastroenterol.;96\n\t\t\t\t\t2\n\t\t\t\t\t417\n\t\t\t\t\t23 .\n\t\t\t'},{id:"B31",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAbid\n\t\t\t\t\t\t\tG. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSiriwardana\n\t\t\t\t\t\t\tH. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHolt\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAmmori\n\t\t\t\t\t\t\tB. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007 Mild ERCP induced and non-ERCP-related acute pancreatitis: two distinct clinical entities? J Gastroenterol.;42\n\t\t\t\t\t2\n\t\t\t\t\t146\n\t\t\t\t\t51 .\n\t\t\t'},{id:"B32",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChen\n\t\t\t\t\t\t\tC. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWang\n\t\t\t\t\t\t\tS. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLu\n\t\t\t\t\t\t\tR. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLu\n\t\t\t\t\t\t\tC. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChang\n\t\t\t\t\t\t\tF. Y.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tS. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003 Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography. Pancreas.;26\n\t\t\t\t\t4\n\t\t\t\t\t375\n\t\t\t\t\t80 .\n\t\t\t'},{id:"B33",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBradley\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t3rd\n\t\t\t\t\t\n\t\t\t\t\t1993\n\t\t\t\t\tA clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg.;128\n\t\t\t\t\t5\n\t\t\t\t\t586\n\t\t\t\t\t90 .\n\t\t\t'},{id:"B34",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKnaus\n\t\t\t\t\t\t\tW. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZimmerman\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWagner\n\t\t\t\t\t\t\tD. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDraper\n\t\t\t\t\t\t\tE. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLawrence\n\t\t\t\t\t\t\tD. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1981\n\t\t\t\t\tAPACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med.;9\n\t\t\t\t\t8\n\t\t\t\t\t591\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B35",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRanson\n\t\t\t\t\t\t\tJ. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRifkind\n\t\t\t\t\t\t\tK. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRoses\n\t\t\t\t\t\t\tD. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFink\n\t\t\t\t\t\t\tS. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEng\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSpencer\n\t\t\t\t\t\t\tF. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1974\n\t\t\t\t\tPrognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet.;139\n\t\t\t\t\t1\n\t\t\t\t\t69\n\t\t\t\t\t81 .\n\t\t\t'},{id:"B36",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBhatia\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGarg\n\t\t\t\t\t\t\tP. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTandon\n\t\t\t\t\t\t\tR. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMadan\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006\n\t\t\t\t\tEndoscopic retrograde cholangiopancreatography-induced acute pancreatitis often has a benign outcome. J Clin Gastroenterol.;40\n\t\t\t\t\t8\n\t\t\t\t\t726\n\t\t\t\t\t31 .\n\t\t\t'},{id:"B37",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarkay\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNiv\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSanto\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBruck\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHallak\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKonikoff\n\t\t\t\t\t\t\tF. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tLow-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial. Surg Endosc.;22\n\t\t\t\t\t9\n\t\t\t\t\t1971\n\t\t\t\t\t76 .\n\t\t\t'},{id:"B38",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tConwell\n\t\t\t\t\t\t\tD. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tO’Connor\n\t\t\t\t\t\t\tJ. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFerguson\n\t\t\t\t\t\t\tD. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVargo\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarnes\n\t\t\t\t\t\t\tD. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1998 Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol.;93\n\t\t\t\t\t1\n\t\t\t\t\t61\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B39",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMurray\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCarter\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tImrie\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEvans\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tO’Suilleabhain\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tDiclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.\n\t\t\t\t\tGastroenterology.;124\n\t\t\t\t\t7\n\t\t\t\t\t1786\n\t\t\t\t\t91 .\n\t\t\t'},{id:"B40",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTulassay\n\t\t\t\t\t\t\tZ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDöbrönte\n\t\t\t\t\t\t\tZ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPrónai\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZágoni\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJuhász\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1998\n\t\t\t\t\tOctreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography. Aliment Pharmacol Ther.;12\n\t\t\t\t\t11\n\t\t\t\t\t1109\n\t\t\t\t\t12 .\n\t\t\t'},{id:"B41",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLehman\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1991 ERCP and endoscopic sphincterotomy-induced pancreatitis. Pancreas.;6\n\t\t\t\t\t3\n\t\t\t\t\t350\n\t\t\t\t\t67 .\n\t\t\t'},{id:"B42",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPezzilli\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRomboli\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCampana\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCorinaldesi\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tMechanisms involved in the onset of post-ERCP pancreatitis. JOP.;3\n\t\t\t\t\t6\n\t\t\t\t\t162\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B43",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMessmann\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVogt\n\t\t\t\t\t\t\tW.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHolstege\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLock\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHeinisch\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tvon\n\t\t\t\t\t\t\tFürstenberg. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1997\n\t\t\t\t\tPost-ERP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis.\n\t\t\t\t\tGut.;40\n\t\t\t\t\t1\n\t\t\t\t\t80\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B44",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tOezcueruemez-Porsch\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKunz\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHardt\n\t\t\t\t\t\t\tP. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFadgyas\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKress\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSchulz\n\t\t\t\t\t\t\tH. U.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1998\n\t\t\t\t\tDiagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis. Dig Dis Sci.;43\n\t\t\t\t\t8\n\t\t\t\t\t1763\n\t\t\t\t\t69 .\n\t\t\t'},{id:"B45",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCooper\n\t\t\t\t\t\t\tS. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSlivka\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007 Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterol Clin North Am.;36\n\t\t\t\t\t2\n\t\t\t\t\t259\n\t\t\t\t\t76 .\n\t\t\t'},{id:"B46",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMohseni\n\t\t\t\t\t\t\tSalehi.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMonfared\n\t\t\t\t\t\t\tS. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVahidi\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAbdolghaffari\n\t\t\t\t\t\t\tA. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNikfar\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAbdollahi\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tAntioxidant therapy in the management of acute, chronic and post-ERCP pancreatitis: a systematic review. World J Gastroenterol;15\n\t\t\t\t\t4481\n\t\t\t\t\t90 .\n\t\t\t'},{id:"B47",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBanks\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006 Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol.;101\n\t\t\t\t\t10\n\t\t\t\t\t2379\n\t\t\t\t\t400 .\n\t\t\t'},{id:"B48",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKilciler\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMusabak\n\t\t\t\t\t\t\tU.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagci\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYesilova\n\t\t\t\t\t\t\tZ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTuzun\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tUygun\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tDo the changes in the serum levels of IL-2, IL-4, TNFalpha, and IL-6 reflect the inflammatory activity in the patients with post-ERCP pancreatitis? Clin Dev Immunol.;2008:481560.\n\t\t\t'},{id:"B49",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSultan\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaillie\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tWhat are the predictors of post-ERCP pancreatitis, and how useful are they? JOP.;3\n\t\t\t\t\t6\n\t\t\t\t\t188\n\t\t\t\t\t94 .\n\t\t\t'},{id:"B50",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDemols\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDeviere\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003 New frontiers in the pharmacology prevention of post-ERCP pancreatitis: the cytokines. JOP.;4\n\t\t\t\t\t1\n\t\t\t\t\t49\n\t\t\t\t\t57 .\n\t\t\t'},{id:"B51",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPande\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tThuluvath\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003 Pharmacological prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Drugs.;63\n\t\t\t\t\t17\n\t\t\t\t\t1799\n\t\t\t\t\t812 .\n\t\t\t'},{id:"B52",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDevière\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLe Moine\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVan Laethem\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEisendrath\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGhilain\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSevers\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tInterleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology.;120\n\t\t\t\t\t2\n\t\t\t\t\t498\n\t\t\t\t\t505 .\n\t\t\t'},{id:"B53",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDumot\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tConwell\n\t\t\t\t\t\t\tD. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZuccaro\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJr Vargo\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tShay\n\t\t\t\t\t\t\tS. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEasley\n\t\t\t\t\t\t\tK. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tA randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol.;96\n\t\t\t\t\t7\n\t\t\t\t\t2098\n\t\t\t\t\t102 .\n\t\t\t'},{id:"B54",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCheng\n\t\t\t\t\t\t\tC. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCostamagna\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBinmoeller\n\t\t\t\t\t\t\tK. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPuespoek\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAithal\n\t\t\t\t\t\t\tG. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tEfficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk. Pancreas.;38\n\t\t\t\t\t3\n\t\t\t\t\t267\n\t\t\t\t\t74 .\n\t\t\t'},{id:"B55",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDeschamps\n\t\t\t\t\t\t\tJ. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAllemand\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJanin\n\t\t\t\t\t\t\tMagnificat. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCamelot\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGillet\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCarayon\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\tAcute pancreatitis following gastrointestinal endoscopy without ampullary cannulation.\n\t\t\t\t\tDeschampsJ. P.AllemandH.JaninMagnificat. R.CamelotG.GilletM.CarayonP. Acute pancreatitis following gastrointestinal endoscopy without ampullary cannulation. Endoscopy. 1982; .. 3\n\t\t\t\t\t14\n\t\t\t\t\t105\n\t\t\t\t\t6\n\t\t\t\t\t1982\n\t\t\t\t\n\t\t\t'},{id:"B56",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilliams\n\t\t\t\t\t\t\tE. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaylor\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFairclough\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHamlyn\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLogan\n\t\t\t\t\t\t\tR. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartin\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tRisk factors for complication following ERCP; results of a large-scale, prospective multicenter study.\n\t\t\t\t\tEndoscopy.;39\n\t\t\t\t\t9\n\t\t\t\t\t793\n\t\t\t\t\t801 .\n\t\t\t'},{id:"B57",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDi Sario\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNelson\n\t\t\t\t\t\t\tD. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFennerty\n\t\t\t\t\t\t\tM. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tJ. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBjorkman\n\t\t\t\t\t\t\tD. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2001 Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc.;54\n\t\t\t\t\t4\n\t\t\t\t\t425\n\t\t\t\t\t34 .\n\t\t\t'},{id:"B58",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAndriulli\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSolmi\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLoperfido\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLeo\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFesta\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBelmonte\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tProphylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol.;2\n\t\t\t\t\t8\n\t\t\t\t\t713\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B59",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCheon\n\t\t\t\t\t\t\tY. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCho\n\t\t\t\t\t\t\tK. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWatkins\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMc Henry\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFogel\n\t\t\t\t\t\t\tE. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tFrequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc.;65\n\t\t\t\t\t3\n\t\t\t\t\t385\n\t\t\t\t\t93 .\n\t\t\t'},{id:"B60",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJowell\n\t\t\t\t\t\t\tP. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaillie\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMS\n\t\t\t\t\t\t\tBranch\n\t\t\t\t\t\t\tAffronti. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBrowning\n\t\t\t\t\t\t\tC. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBute\n\t\t\t\t\t\t\tB. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1996\n\t\t\t\t\tQuantitative assessment of procedural competence. A prospective study of training in endoscopic retrograde cholangiopancreatography. Ann Intern Med.;125\n\t\t\t\t\t12\n\t\t\t\t\t983\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B61",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaron\n\t\t\t\t\t\t\tBaron. T. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPetersen\n\t\t\t\t\t\t\tB. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMergener\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChak\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCohen\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDeal\n\t\t\t\t\t\t\tS. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2006 Quality indicators for endoscopic retrograde cholangiopancreatography. Am J Gastroenterol.;101\n\t\t\t\t\t4\n\t\t\t\t\t892\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B62",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKapral\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDuller\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWewalka\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKerstan\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVogel\n\t\t\t\t\t\t\tW.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSchreiber\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tCase volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy.;40\n\t\t\t\t\t8\n\t\t\t\t\t625\n\t\t\t\t\t30 .\n\t\t\t'},{id:"B63",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCotton\n\t\t\t\t\t\t\tP. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGarrow\n\t\t\t\t\t\t\tD. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGallagher\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRomagnuolo\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009 Risk factors for complications after ERCP: a multivariate analysisof 11,497 procedures over 12 years. Gastrointest Endosc.;70\n\t\t\t\t\t1\n\t\t\t\t\t80\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B64",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilliams\n\t\t\t\t\t\t\tE. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaylor\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFairclough\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHamlyn\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLogan\n\t\t\t\t\t\t\tR. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartin\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tAre we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice.\n\t\t\t\t\tGut.;56\n\t\t\t\t\t6\n\t\t\t\t\t821\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B65",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVitte\n\t\t\t\t\t\t\tR. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMorfoisse\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007 Investigator Group of Association Nationale des Gastroentérologues des Hôpitaux Généraux. Evaluation of endoscopic retrograde cholangiopancreatography procedures performed in general hospitals in France. Gastroenterol Clin Biol.;31(8-9 Pt 1):740-9.\n\t\t\t'},{id:"B66",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGuda\n\t\t\t\t\t\t\tN. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2005\n\t\t\t\t\tERCP cannulation: a review of reported techniques. Gastrointest Endosc.;61\n\t\t\t\t\t1\n\t\t\t\t\t112\n\t\t\t\t\t25 .\n\t\t\t'},{id:"B67",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCortas\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMehta\n\t\t\t\t\t\t\tS. N.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAbraham\n\t\t\t\t\t\t\tN. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarkun\n\t\t\t\t\t\t\tA. N.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1999 Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes. Gastrointest Endosc.;50\n\t\t\t\t\t6\n\t\t\t\t\t775\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B68",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLella\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tColombo\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBonassi\n\t\t\t\t\t\t\tU.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tA simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc.;59\n\t\t\t\t\t7\n\t\t\t\t\t830\n\t\t\t\t\t834 .\n\t\t\t'},{id:"B69",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArtifon\n\t\t\t\t\t\t\tE. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSakai\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCunha\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHalwan\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIshioka\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKumar\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tGuidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol.;102\n\t\t\t\t\t10\n\t\t\t\t\t2147\n\t\t\t\t\t53 .\n\t\t\t'},{id:"B70",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIto\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFujita\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNoda\n\t\t\t\t\t\t\tY.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKobayashi\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tObana\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHoraguchi\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tPancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography. World J Gastroenterol.;14\n\t\t\t\t\t36\n\t\t\t\t\t5595\n\t\t\t\t\t6000 .\n\t\t\t'},{id:"B71",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tT. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPark do\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPark\n\t\t\t\t\t\t\tJ. Y.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKim\n\t\t\t\t\t\t\tE. O.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tY. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPark\n\t\t\t\t\t\t\tJ. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2009 Can wire-guided cannulation prevent post-ERCP pancreatitis? A prospective randomized trial. Gastrointest Endosc.;69(3 Pt 1):444-9.\n\t\t\t'},{id:"B72",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBailey\n\t\t\t\t\t\t\tA. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBourke\n\t\t\t\t\t\t\tM. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilliams\n\t\t\t\t\t\t\tS. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWalsh\n\t\t\t\t\t\t\tP. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMurray\n\t\t\t\t\t\t\tM. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tE. Y.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008 A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy.;40\n\t\t\t\t\t4\n\t\t\t\t\t296\n\t\t\t\t\t301 .\n\t\t\t'},{id:"B73",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarkin\n\t\t\t\t\t\t\tJ. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCasal\n\t\t\t\t\t\t\tG. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tReiner\n\t\t\t\t\t\t\tD. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGoldberg\n\t\t\t\t\t\t\tR. I.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPhillips\n\t\t\t\t\t\t\tR. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKaplan\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1991\n\t\t\t\t\tA comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroenterol.;86\n\t\t\t\t\t10\n\t\t\t\t\t1437\n\t\t\t\t\t41 .\n\t\t\t'},{id:"B74",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJohnson\n\t\t\t\t\t\t\tG. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBedford\n\t\t\t\t\t\t\tR. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJohanson\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCass\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1995\n\t\t\t\t\tA comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc.;42\n\t\t\t\t\t4\n\t\t\t\t\t312\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B75",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeorge\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKulkarni\n\t\t\t\t\t\t\tA. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tStevens\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tForsmark\n\t\t\t\t\t\t\tC. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDraganov\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2004 Role of osmolality of contrast media in the development of post-ERCP pancreatitis: a metanalysis. Dig Dis Sci.;49\n\t\t\t\t\t3\n\t\t\t\t\t503\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B76",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTarnasky\n\t\t\t\t\t\t\tP. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPalesch\n\t\t\t\t\t\t\tY. Y.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCunningham\n\t\t\t\t\t\t\t. J. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMauldin\n\t\t\t\t\t\t\tP. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCotton\n\t\t\t\t\t\t\tP. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHawes\n\t\t\t\t\t\t\tR. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1998 Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology.;115\n\t\t\t\t\t6\n\t\t\t\t\t1518\n\t\t\t\t\t24 .\n\t\t\t'},{id:"B77",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHarewood\n\t\t\t\t\t\t\tG. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPochron\n\t\t\t\t\t\t\tN. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGostout\n\t\t\t\t\t\t\tC. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2005 Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc.;62\n\t\t\t\t\t3\n\t\t\t\t\t367\n\t\t\t\t\t370 .\n\t\t\t'},{id:"B78",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSofuni\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaguchi\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tItoi\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKatanuma\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHisai\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNiido\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tProphylaxis of postendoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol.;5\n\t\t\t\t\t11\n\t\t\t\t\t1339\n\t\t\t\t\t46 .\n\t\t\t'},{id:"B79",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tPancreatic stents for prevention of postendoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol.;5\n\t\t\t\t\t11\n\t\t\t\t\t1354\n\t\t\t\t\t65 .\n\t\t\t'},{id:"B80",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTarnasky\n\t\t\t\t\t\t\tP. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tMechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications. JOP.;4\n\t\t\t\t\t1\n\t\t\t\t\t58\n\t\t\t\t\t67 .\n\t\t\t'},{id:"B81",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFazel\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tQuadri\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCatalano\n\t\t\t\t\t\t\tM. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMeyerson\n\t\t\t\t\t\t\tS. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t (2003).Does a pancreatic duct stent prevent post-ERCP pancreatitis?. A prospective randomized study. Gastrointest Endosc.;57\n\t\t\t\t\t3\n\t\t\t\t\t291\n\t\t\t\t\t4 .\n\t\t\t'},{id:"B82",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSimmons\n\t\t\t\t\t\t\tD. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPetersen\n\t\t\t\t\t\t\tB. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGostout\n\t\t\t\t\t\t\tC. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLevy\n\t\t\t\t\t\t\tM. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTopazian\n\t\t\t\t\t\t\tM. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaron\n\t\t\t\t\t\t\tT. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008 Risk of pancreatitis following endoscopically placed large-bore plastic biliary stents with and without biliary sphincterotomy for management of postoperative bile leaks. Surg Endosc.;22\n\t\t\t\t\t6\n\t\t\t\t\t1459\n\t\t\t\t\t63 .\n\t\t\t'},{id:"B83",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSmithline\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSilverman\n\t\t\t\t\t\t\tW.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRogers\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNisi\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWiersema\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJamidar\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1993\n\t\t\t\t\tEffect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc; 39\n\t\t\t\t\t652\n\t\t\t\t\t7\n\t\t\t\t\n\t\t\t'},{id:"B84",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTsuchiya\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tItoi\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSofuni\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tItokawa\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKurihara\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIshii\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tTemporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial. J Hepatobiliary Pancreat Surg.;14\n\t\t\t\t\t3\n\t\t\t\t\t302\n\t\t\t\t\t307 .\n\t\t\t'},{id:"B85",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFogel\n\t\t\t\t\t\t\tE. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEversman\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJamidar\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLehman\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tSphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.\n\t\t\t\t\tEndoscopy.;34\n\t\t\t\t\t4\n\t\t\t\t\t280\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B86",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAndriulli\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tForlano\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNapolitano\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tConoscitore\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCaruso\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPilotto\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007 Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: a systemic analysis of benefits and associated risks. Digestion.;75(2-3):156-163.\n\t\t\t'},{id:"B87",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMasci\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMariani\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCurioni\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tRisk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.\n\t\t\t\t\tEndoscopy.;35\n\t\t\t\t\t10\n\t\t\t\t\t830\n\t\t\t\t\t4 .\n\t\t\t'},{id:"B88",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSingh\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDas\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIsenberg\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWong\n\t\t\t\t\t\t\tR. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSivak\n\t\t\t\t\t\t\tM. V.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJr Agrawal\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004 Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled studies. Gastrointest Endosc.;60\n\t\t\t\t\t4\n\t\t\t\t\t544\n\t\t\t\t\t50 .\n\t\t\t'},{id:"B89",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMazaki\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMasuda\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTakayama\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2010\n\t\t\t\t\tProphylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy.;42\n\t\t\t\t\t10\n\t\t\t\t\t842\n\t\t\t\t\t53 .\n\t\t\t'},{id:"B90",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChoudhary\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBechtold\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArif\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSzary\n\t\t\t\t\t\t\tN. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPuli\n\t\t\t\t\t\t\tS. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tOthman\n\t\t\t\t\t\t\tM. O.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPais\n\t\t\t\t\t\t\tW. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAntillon\n\t\t\t\t\t\t\tM. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2011\n\t\t\t\t\tPancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc.;73\n\t\t\t\t\t2\n\t\t\t\t\t275\n\t\t\t\t\t82 .\n\t\t\t'},{id:"B91",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDeviere\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2011\n\t\t\t\t\tPancreatic Stents. Gastrointest Endosc Clin N Am.;21\n\t\t\t\t\t3\n\t\t\t\t\t499\n\t\t\t\t\t510 .\n\t\t\t'},{id:"B92",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArnold\n\t\t\t\t\t\t\tJ. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBenz\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartin\n\t\t\t\t\t\t\tW. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdamek\n\t\t\t\t\t\t\tH. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRiemann\n\t\t\t\t\t\t\tJ. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tEndoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study.\n\t\t\t\t\tEndoscopy.;33\n\t\t\t\t\t7\n\t\t\t\t\t563\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B93",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDisario\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tEndoscopic balloon dilation for extraction of bile duct stones: the devil is in the details. Gastrointest Endosc.;57\n\t\t\t\t\t2\n\t\t\t\t\t282\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B94",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFujita\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaguchi\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKomatsu\n\t\t\t\t\t\t\tY.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYasuda\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHasebe\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIgarashi\n\t\t\t\t\t\t\tY.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tEndoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: A prospective randomized controlled multicenter trial. Gastrointest Endosc; 57\n\t\t\t\t\t151\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B95",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVlavianos\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChopra\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMandalia\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAnderson\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tThompson\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWestaby\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tEndoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial.\n\t\t\t\t\tGut.;52\n\t\t\t\t\t8\n\t\t\t\t\t1165\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B96",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSong\n\t\t\t\t\t\t\tS. Y.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tK. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNa\n\t\t\t\t\t\t\tK. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAhn\n\t\t\t\t\t\t\tB. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009 Tension pneumothorax after endoscopic retrograde pancreatocholangiogram. J Korean Med Sci.;24\n\t\t\t\t\t1\n\t\t\t\t\t173\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B97",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGarcía-Cano\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tFatal pancreatitis after endoscopic balloon dilation for extraction of common bile duct stones in an 80 -year-old woman.\n\t\t\t\t\tEndoscopy.;39 Suppl 1:E132.\n\t\t\t'},{id:"B98",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMao\n\t\t\t\t\t\t\tZ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhu\n\t\t\t\t\t\t\tQ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWu\n\t\t\t\t\t\t\tW.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWang\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLi\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLu\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tDuodenal perforations after endoscopic retrograde cholangiopancreatography: experience and management. J Laparoendosc Adv Surg Tech A.;18\n\t\t\t\t\t5\n\t\t\t\t\t691\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B99",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMargantinis\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSakorafas\n\t\t\t\t\t\t\tG. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKostopoulos\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKontou\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTsiakos\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArvanitidis\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006\n\t\t\t\t\tPost-ERCP/endoscopic sphincterotomy duodenal perforation is not always a surgical emergency. Dig Liver Dis.;38\n\t\t\t\t\t6\n\t\t\t\t\t434\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B100",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPark\n\t\t\t\t\t\t\tD. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKim\n\t\t\t\t\t\t\tM. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tS. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tS. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChoi\n\t\t\t\t\t\t\tJ. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSong\n\t\t\t\t\t\t\tM. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004 Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc.;60\n\t\t\t\t\t2\n\t\t\t\t\t180\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B101",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCotton\n\t\t\t\t\t\t\tP. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tERCP is most dangerous for people who need it least. Gastrointest Endosc.;54\n\t\t\t\t\t4\n\t\t\t\t\t535\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B102",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWoods\n\t\t\t\t\t\t\tK. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWillingham\n\t\t\t\t\t\t\tF. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2010 Endoscopic retrograde cholangiography associated pancreatitis: A 15-year review. World J Gastrointest Endosc;2\n\t\t\t\t\t165\n\t\t\t\t\t78 .\n\t\t\t'},{id:"B103",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLoperfido\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAngelini\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBenedetti\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChilovi\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCostan\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDe Berardinis\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1998\n\t\t\t\t\tMajor early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc.;48\n\t\t\t\t\t1\n\t\t\t\t\t1\n\t\t\t\t\t10 .\n\t\t\t'},{id:"B104",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChristoforidis\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGoulimaris\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKanellos\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTsalis\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDemetriades\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBetsis\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tPost-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.\n\t\t\t\t\tEndoscopy.;34\n\t\t\t\t\t4\n\t\t\t\t\t286\n\t\t\t\t\t92 .\n\t\t\t'},{id:"B105",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTarnasky\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCunningham\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCotton\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHoffman\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPalesch\n\t\t\t\t\t\t\tY.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1997\n\t\t\t\t\tPancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.\n\t\t\t\t\tEndoscopy.;29\n\t\t\t\t\t4\n\t\t\t\t\t252\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B106",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDeenadayalu\n\t\t\t\t\t\t\tV. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBlaut\n\t\t\t\t\t\t\tU.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWatkins\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarnett\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tDoes obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study. J Clin Gastroenterol.;42\n\t\t\t\t\t10\n\t\t\t\t\t1103\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B107",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLukens\n\t\t\t\t\t\t\tF. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHowell\n\t\t\t\t\t\t\tD. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tUpender\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSheth\n\t\t\t\t\t\t\tS. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJafri\n\t\t\t\t\t\t\tS. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2010\n\t\t\t\t\tERCP in the very elderly: outcomes among patients older than eighty. Dig Dis Sci.;55\n\t\t\t\t\t3\n\t\t\t\t\t847\n\t\t\t\t\t51 .\n\t\t\t'},{id:"B108",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDebenedet\n\t\t\t\t\t\t\tA. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRaghunathan\n\t\t\t\t\t\t\tT. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWing\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWamsteker\n\t\t\t\t\t\t\tE. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDi Magno\n\t\t\t\t\t\t\tM. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009 Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol.;7\n\t\t\t\t\t3\n\t\t\t\t\t353\n\t\t\t\t\t8 e4.\n\t\t\t'},{id:"B109",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tReddy\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilcox\n\t\t\t\t\t\t\tC. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTamhane\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMA\n\t\t\t\t\t\t\tEloubeidi\n\t\t\t\t\t\t\tVaradarajulu. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008 Protocol-based medical management of post-ERCP pancreatitis. J Gastroenterol Hepatol.;23\n\t\t\t\t\t3\n\t\t\t\t\t385\n\t\t\t\t\t92 .\n\t\t\t'},{id:"B110",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSilverman\n\t\t\t\t\t\t\tW. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tThompson\n\t\t\t\t\t\t\tR. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tManagement of asymptomatically/minimally symptomatic post-ERCP serum liver test elevations: first do no harm. Dig Dis Sci.;47\n\t\t\t\t\t7\n\t\t\t\t\t1498\n\t\t\t\t\t501 .\n\t\t\t'},{id:"B111",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJacobson\n\t\t\t\t\t\t\tB. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVander\n\t\t\t\t\t\t\tVliet. M. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMD\n\t\t\t\t\t\t\tHughes\n\t\t\t\t\t\t\tMaurer. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMc Manus\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBanks\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007 A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol.;5\n\t\t\t\t\t8\n\t\t\t\t\t946\n\t\t\t\t\t51 .\n\t\t\t'},{id:"B112",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDundee\n\t\t\t\t\t\t\tP. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChin-Lenn\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSyme\n\t\t\t\t\t\t\tD. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tThomas\n\t\t\t\t\t\t\tP. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tOutcomes of ERCP: prospective series from a rural centre. ANZ J Surg.;77\n\t\t\t\t\t11\n\t\t\t\t\t1013\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B113",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarthet\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLesavre\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDesjeux\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGasmi\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBerthezene\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBerdah\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tComplications of endoscopic sphincterotomy: results from a single tertiary referral center.\n\t\t\t\t\tEndoscopy.;34\n\t\t\t\t\t12\n\t\t\t\t\t991\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B114",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAndriulli\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLoperfido\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNapolitano\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNiro\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tValvano\n\t\t\t\t\t\t\tM. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSpirito\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tIncidence rates of post- ERCP complications: a systematic survey of prospective studies.Am J Gastroenterol.;102\n\t\t\t\t\t8\n\t\t\t\t\t1781\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B115",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDisario\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBjorkman\n\t\t\t\t\t\t\tD. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMacmathuna\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPetersen\n\t\t\t\t\t\t\tB. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJaffe\n\t\t\t\t\t\t\tP. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tEndoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.\n\t\t\t\t\tGastroenterology.;127\n\t\t\t\t\t5\n\t\t\t\t\t1291\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B116",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBergman\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRauws\n\t\t\t\t\t\t\tE. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFockens\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tvan Berkel\n\t\t\t\t\t\t\tA. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBossuyt\n\t\t\t\t\t\t\tP. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTijssen\n\t\t\t\t\t\t\tJ. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1997\n\t\t\t\t\tRandomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones.\n\t\t\t\t\tLancet.;349\n\t\t\t\t\t9059\n\t\t\t\t\t1124\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B117",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMatsushita\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTakakuwa\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tShimeno\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tUchida\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNishio\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tOkazaki\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tEpinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis. J Gastroenterol; 44\n\t\t\t\t\t71\n\t\t\t\t\t5\n\t\t\t\t\n\t\t\t'},{id:"B118",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDumot\n\t\t\t\t\t\t\tJ. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tConwell\n\t\t\t\t\t\t\tD. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tO’Connor\n\t\t\t\t\t\t\tJ. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFerguson\n\t\t\t\t\t\t\tD. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVargo\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarnes\n\t\t\t\t\t\t\tD. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1998 Pretreatment with methylprednisolone to prevent ERCP-induced pancreatitis: a randomized, multicenter, placebo-controlled clinical trial. Am J Gastroenterol; 93\n\t\t\t\t\t61\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B119",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMartinez-Torres\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRodriguez-Lomeli\n\t\t\t\t\t\t\tX.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDavalos-Cobian\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGarcia-Correa\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMaldonado-Martinez\n\t\t\t\t\t\t\tJ. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMedrano-Muñoz\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tOral allopurinol to prevent hyperamylasemia and acute pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol.;15\n\t\t\t\t\t13\n\t\t\t\t\t1600\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B120",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKatsinelos\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKountouras\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChatzis\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChristodoulou\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tParoutoglou\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMimidis\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2005 Highdose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc.;61\n\t\t\t\t\t3\n\t\t\t\t\t407\n\t\t\t\t\t15 .\n\t\t\t'},{id:"B121",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRomagnuolo\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHilsden\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSandha\n\t\t\t\t\t\t\tG. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCole\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBass\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMay\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tAllopurinol to prevent pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized placebo-controlled trial. Clin Gastroenterol Hepatol.;6\n\t\t\t\t\t4\n\t\t\t\t\t465\n\t\t\t\t\t71 .\n\t\t\t'},{id:"B122",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMosler\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMarks\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWatkins\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJamidar\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2005\n\t\t\t\t\tOral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis. Gastrointest Endosc.;62\n\t\t\t\t\t2\n\t\t\t\t\t245\n\t\t\t\t\t50 .\n\t\t\t'},{id:"B123",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBudzyńska\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMarek\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNowak\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKaczor\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNowakowska-Dulawa\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2001 A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy.;33\n\t\t\t\t\t9\n\t\t\t\t\t766\n\t\t\t\t\t72 .\n\t\t\t'},{id:"B124",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDai\n\t\t\t\t\t\t\tH. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWang\n\t\t\t\t\t\t\tX. W.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhao\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tRole of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int; 8\n\t\t\t\t\t11\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B125",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElmunzer\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWaljee\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElta\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTaylor\n\t\t\t\t\t\t\tJ. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFehmi\n\t\t\t\t\t\t\tS. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHiggins\n\t\t\t\t\t\t\tP. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tA meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut; 57\n\t\t\t\t\t1262\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B126",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZheng\n\t\t\t\t\t\t\tM. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tXia\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChen\n\t\t\t\t\t\t\tY. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tRectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis.\n\t\t\t\t\tGut; 57\n\t\t\t\t\t1632\n\t\t\t\t\t3 .\n\t\t\t'},{id:"B127",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLavy\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKarban\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSuissa\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYassin\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHermesh\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBen-Amotz\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tNatural beta-carotene for the prevention of post-ERCP pancreatitis.\n\t\t\t\t\tPancreas; 29(2): e45 -e50.\n\t\t\t'},{id:"B128",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGorelick\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarnett\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChey\n\t\t\t\t\t\t\tW.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAnderson\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElta\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tBotulinum toxin injection after biliary sphincterotomy.\n\t\t\t\t\tEndoscopy; 36\n\t\t\t\t\t2\n\t\t\t\t\t170\n\t\t\t\t\t3 .\n\t\t\t'},{id:"B129",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRäty\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSand\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPulkkinen\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMatikainen\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNordback\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tPost-ERCP pancreatitis: reduction by routine antibiotics. J Gastrointest Surg; 5\n\t\t\t\t\t4\n\t\t\t\t\t339\n\t\t\t\t\t45 .\n\t\t\t'},{id:"B130",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKwanngern\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTiyapattanaputi\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWanitpukdeedecha\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNavicharern\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2005\n\t\t\t\t\tCan a single dose corticosteroid reduce the incidence of post-ERCP pancreatitis? A randomized, prospective control study. J Med Assoc Thai; 88 Suppl 4:S42\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B131",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tManolakopoulos\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAvgerinos\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVlachogiannakos\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArmonis\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tViazis\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPapadimitriou\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tOctreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc; 55\n\t\t\t\t\t4\n\t\t\t\t\t470\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B132",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBlaut\n\t\t\t\t\t\t\tU.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWatkins\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBarnett\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFreeman\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tDoes prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study. Gastrointest Endosc; 58\n\t\t\t\t\t1\n\t\t\t\t\t23\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B133",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRabenstein\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFischer\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWiessner\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSchmidt\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRadespiel-Tröger\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHochberger\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tLow-molecular-weight heparin does not prevent acute post-ERCP pancreatitis. Gastrointest Endosc.;59\n\t\t\t\t\t6\n\t\t\t\t\t606\n\t\t\t\t\t13 .\n\t\t\t'},{id:"B134",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMilewski\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRydzewska\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDegowska\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKierzkiewicz\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRydzewski\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006 N-acetylcysteine does not prevent postendoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis. World J Gastroenterol.;12\n\t\t\t\t\t23\n\t\t\t\t\t3751\n\t\t\t\t\t5 .\n\t\t\t'},{id:"B135",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKatsinelos\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKountouras\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tParoutoglou\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBeltsis\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMimidis\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZavos\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2005\n\t\t\t\t\tIntravenous N-acetylcysteine does not prevent post-ERCP pancreatitis. Gastrointest Endosc.;62\n\t\t\t\t\t1\n\t\t\t\t\t105\n\t\t\t\t\t11 .\n\t\t\t'},{id:"B136",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPrat\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAmaris\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDucot\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBocquentin\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFritsch\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChoury\n\t\t\t\t\t\t\tA. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2002\n\t\t\t\t\tNifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study. Gastrointest Endosc.;56\n\t\t\t\t\t2\n\t\t\t\t\t202\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B137",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSand\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNordback\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1993\n\t\t\t\t\tProspective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography\n\t\t\t\t\tDigestion.;54\n\t\t\t\t\t2\n\t\t\t\t\t105\n\t\t\t\t\t11 .\n\t\t\t'},{id:"B138",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHao\n\t\t\t\t\t\t\tJ. Y.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWu\n\t\t\t\t\t\t\tD. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWang\n\t\t\t\t\t\t\tY. Z.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGao\n\t\t\t\t\t\t\tY. X.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLang\n\t\t\t\t\t\t\tH. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhou\n\t\t\t\t\t\t\tW. Z.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009 Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial. World J Gastroenterol.;15\n\t\t\t\t\t3\n\t\t\t\t\t366\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B139",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBeauchant\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIngrand\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFavriel\n\t\t\t\t\t\t\tJ. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDupuychaffray\n\t\t\t\t\t\t\tJ. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCapony\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMoindrot\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tIntravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial. Endoscopy.;40\n\t\t\t\t\t8\n\t\t\t\t\t631\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B140",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKaffes\n\t\t\t\t\t\t\tA. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMJ\n\t\t\t\t\t\t\tBourke\n\t\t\t\t\t\t\tDing. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAlrubaie\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKwan\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWilliams\n\t\t\t\t\t\t\tS. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006 A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis. Gastrointest Endosc.;64\n\t\t\t\t\t3\n\t\t\t\t\t351\n\t\t\t\t\t7\n\t\t\t\t\n\t\t\t'},{id:"B141",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMoretó\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZaballa\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCasado\n\t\t\t\t\t\t\tI.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMerino\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRueda\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRamírez\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2003\n\t\t\t\t\tTransdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial. Gastrointest Endosc.;57\n\t\t\t\t\t1\n\t\t\t\t\t1\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B142",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSudhindran\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBromwich\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEdwards\n\t\t\t\t\t\t\tP. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t(2001\n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t (2001).Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg.;88\n\t\t\t\t\t9\n\t\t\t\t\t1178\n\t\t\t\t\t82 .\n\t\t\t'},{id:"B143",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhoshbaten\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhorram\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMadad\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEhsani\n\t\t\t\t\t\t\tArdakani.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMJ\n\t\t\t\t\t\t\tFarzin\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZali\n\t\t\t\t\t\t\tM. R.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tRole of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol.;23(7 Pt 2):e11\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B144",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMontaño-Loza\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRodriguez-Lomeli\n\t\t\t\t\t\t\tX.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGarcia-Correa\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFuentes\n\t\t\t\t\t\t\tOrozco. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGonzález\n\t\t\t\t\t\t\tOjeda. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMedrano\n\t\t\t\t\t\t\tMunoz. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tEffect of rectal administration of indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Rev Esp Enferm Dig;99\n\t\t\t\t\t6\n\t\t\t\t\t330\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B145",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSotoudehmanesh\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKhatibian\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKolahdoozan\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAinechi\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMalboosbaf\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNouraie\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tIndomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol.;102\n\t\t\t\t\t5\n\t\t\t\t\t978\n\t\t\t\t\t83 .\n\t\t\t'},{id:"B146",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCheon\n\t\t\t\t\t\t\tY. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCho\n\t\t\t\t\t\t\tK. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWatkins\n\t\t\t\t\t\t\tJ. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMc Henry\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFogel\n\t\t\t\t\t\t\tE. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tEfficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double blind prospective trial. Gastrointest Endosc.;66\n\t\t\t\t\t6\n\t\t\t\t\t1126\n\t\t\t\t\t32 .\n\t\t\t'},{id:"B147",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSenol\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSaritas\n\t\t\t\t\t\t\tU.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDemirkan\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2009 Efficacy of intramuscular diclofenaco and fluid replacement in prevention of post-ERCP pancreatitis. World J Gastroenterol;15\n\t\t\t\t\t32\n\t\t\t\t\t3999\n\t\t\t\t\t4004 .\n\t\t\t'},{id:"B148",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDumonceau\n\t\t\t\t\t\t\tJ. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAndriulli\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDeviere\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMariani\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRigaux\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaron\n\t\t\t\t\t\t\tT. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2010 European Society of Gastrointestinal Endoscopy (ESGE) Guideline: Prophylaxis of post-ERCP pancreatitis. Prophylaxis. Endoscopy; 42\n\t\t\t\t\t503\n\t\t\t\t\t15\n\t\t\t\t\n\t\t\t'},{id:"B149",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKisli\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaser\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAydin\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGuler\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tThe role of octreotide versus placebo in the prevention of post-ERCP pancreatitis. Hepatogastroenterology.;54\n\t\t\t\t\t73\n\t\t\t\t\t250\n\t\t\t\t\t3 .\n\t\t\t'},{id:"B150",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLi\n\t\t\t\t\t\t\tZ. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPan\n\t\t\t\t\t\t\tX.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhang\n\t\t\t\t\t\t\tW. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGong\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhi\n\t\t\t\t\t\t\tF. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGuo\n\t\t\t\t\t\t\tX. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tEffect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol.;102\n\t\t\t\t\t1\n\t\t\t\t\t46\n\t\t\t\t\t51 .\n\t\t\t'},{id:"B151",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tThomopoulos\n\t\t\t\t\t\t\tK. C.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPagoni\n\t\t\t\t\t\t\tN. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVagenas\n\t\t\t\t\t\t\tK. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMargaritis\n\t\t\t\t\t\t\tV. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTheocharis\n\t\t\t\t\t\t\tG. I.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tNikolopoulou\n\t\t\t\t\t\t\tV. N.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006 Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc.;64\n\t\t\t\t\t5\n\t\t\t\t\t726\n\t\t\t\t\t31 .\n\t\t\t'},{id:"B152",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAndriulli\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBernasconi\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCrotta\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLella\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2001\n\t\t\t\t\tOctreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther.;15\n\t\t\t\t\t7\n\t\t\t\t\t965\n\t\t\t\t\t72 .\n\t\t\t'},{id:"B153",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHardt\n\t\t\t\t\t\t\tP. D.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKress\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFadgyas\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDoppl\n\t\t\t\t\t\t\tW.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSchnell-Kretschmer\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWüsten\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2000\n\t\t\t\t\tOctreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy. Eur J Med Res.;5\n\t\t\t\t\t4\n\t\t\t\t\t165\n\t\t\t\t\t70 .\n\t\t\t'},{id:"B154",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDuvnjak\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSupanc\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSimicević\n\t\t\t\t\t\t\tV. N.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHrabar\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTroskot\n\t\t\t\t\t\t\tB.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSmircić-Duvnjak\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1999 Use of octreotideacetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography. Acta Med Croatica.;53\n\t\t\t\t\t3\n\t\t\t\t\t115\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B155",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArvanitidis\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHatzipanayiotis\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKoutsounopoulos\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFrangou\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1998\n\t\t\t\t\tThe effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP. Hepatogastroenterology.;45\n\t\t\t\t\t19\n\t\t\t\t\t248\n\t\t\t\t\t52 .\n\t\t\t'},{id:"B156",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArcidiacono\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGambitta\n\t\t\t\t\t\t\tP.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRossi\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGrosso\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBini\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZanasi\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1994\n\t\t\t\t\tThe use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.\n\t\t\t\t\tEndoscopy.;26\n\t\t\t\t\t9\n\t\t\t\t\t715\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B157",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBaldazzi\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tConti\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSpotti\n\t\t\t\t\t\t\tE. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArisi\n\t\t\t\t\t\t\tG. P.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tScevola\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGobetti\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1994 Prevention of post-ERCP acute pancreatitis with octreotide. G Chir.;15(8-9):359-62.\n\t\t\t'},{id:"B158",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTestoni\n\t\t\t\t\t\t\tP. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLella\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBagnolo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBuizza\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tColombo\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1994\n\t\t\t\t\tControlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy. Ital J Gastroenterol.;26\n\t\t\t\t\t9\n\t\t\t\t\t431\n\t\t\t\t\t6 .\n\t\t\t'},{id:"B159",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tUeki\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tOtani\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKawamoto\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tShimizu\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFujimura\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSakaguchi\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tComparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial. J Gastroenterol.;42\n\t\t\t\t\t2\n\t\t\t\t\t161\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B160",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tManes\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArdizzone\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLombardi\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tUomo\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPieramico\n\t\t\t\t\t\t\tO.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPorro\n\t\t\t\t\t\t\tG. B.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tEfficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study Gastrointest Endosc.;65\n\t\t\t\t\t7\n\t\t\t\t\t982\n\t\t\t\t\t7 .\n\t\t\t'},{id:"B161",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tXiong\n\t\t\t\t\t\t\tG. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWu\n\t\t\t\t\t\t\tS. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tZhang\n\t\t\t\t\t\t\tX. W.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGe\n\t\t\t\t\t\t\tZ. Z.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2006\n\t\t\t\t\tClinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis. Braz J Med Biol Res.;39\n\t\t\t\t\t1\n\t\t\t\t\t85\n\t\t\t\t\t90\n\t\t\t\t\n\t\t\t'},{id:"B162",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFujishiro\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAdachi\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tImaoka\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHashimoto\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKohge\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMoriyama\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2006 Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study. J Gastroenterol Hepatol.;21\n\t\t\t\t\t6\n\t\t\t\t\t1065\n\t\t\t\t\t9 .\n\t\t\t'},{id:"B163",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAndriulli\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tClemente\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSolmi\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTerruzzi\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSuriani\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSigillito\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2002 Gabexate or somatostatin administration before ERCP in patients athigh risk for post-ERCP pancreatitis: a multicenter, placebo controlled, randomized clinical trial. Gastrointest Endosc.;56\n\t\t\t\t\t4\n\t\t\t\t\t488\n\t\t\t\t\t95 .\n\t\t\t'},{id:"B164",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tCavallini\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTittobello\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFrulloni\n\t\t\t\t\t\t\tL.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMasci\n\t\t\t\t\t\t\tE.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMariana\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDi Francesco\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1996\n\t\t\t\t\tGabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group. N Engl J Med.;335\n\t\t\t\t\t13\n\t\t\t\t\t919\n\t\t\t\t\t23 .\n\t\t\t'},{id:"B165",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChoi\n\t\t\t\t\t\t\tC. W.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKang\n\t\t\t\t\t\t\tD. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKim\n\t\t\t\t\t\t\tG. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tEum\n\t\t\t\t\t\t\tJ. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tS. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSong\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2009 Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. Gastrointest Endosc. Apr;69(4):e11\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B166",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYoo\n\t\t\t\t\t\t\tJ. W.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRyu\n\t\t\t\t\t\t\tJ. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tS. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tWoo\n\t\t\t\t\t\t\tS. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPark\n\t\t\t\t\t\t\tJ. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYoon\n\t\t\t\t\t\t\tW. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008 Preventive effects of ulinastatin on post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a prospective, randomized, placebo-controlled trial. Pancreas.;37\n\t\t\t\t\t4\n\t\t\t\t\t366\n\t\t\t\t\t70 .\n\t\t\t'},{id:"B167",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTsujino\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKomatsu\n\t\t\t\t\t\t\tY.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tIsayama\n\t\t\t\t\t\t\tH.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHirano\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSasahira\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYamamoto\n\t\t\t\t\t\t\tN.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2005\n\t\t\t\t\tUlinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol.;3\n\t\t\t\t\t4\n\t\t\t\t\t376\n\t\t\t\t\t83 .\n\t\t\t'},{id:"B168",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKapetanos\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKokozidis\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChristodoulou\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMistakidis\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSigounas\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tDimakopoulos\n\t\t\t\t\t\t\tK.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2007\n\t\t\t\t\tA randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. Gastrointest Endosc.;66\n\t\t\t\t\t3\n\t\t\t\t\t513\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B169",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSherman\n\t\t\t\t\t\t\tS.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAlazmi\n\t\t\t\t\t\t\tW. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLehman\n\t\t\t\t\t\t\tG. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGeenen\n\t\t\t\t\t\t\tJ. E.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tChuttani\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKozarek\n\t\t\t\t\t\t\tR. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2009\n\t\t\t\t\tEvaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis. Gastrointest Endosc.;69(3 Pt 1):462 \n\t\t\t\t\t472 -72.\n\t\t\t'},{id:"B170",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tvan Westerloo\n\t\t\t\t\t\t\tD. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tRauws\n\t\t\t\t\t\t\tE. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHommes\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tde Vos\n\t\t\t\t\t\t\tA. F.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tvan der Poll\n\t\t\t\t\t\t\tT.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPowers\n\t\t\t\t\t\t\tB. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2008 Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence. Gastrointest Endosc.;68\n\t\t\t\t\t2\n\t\t\t\t\t246\n\t\t\t\t\t54 .\n\t\t\t'},{id:"B171",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tK. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLee\n\t\t\t\t\t\t\tD. H.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYoo\n\t\t\t\t\t\t\tB. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2008\n\t\t\t\t\tThe prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Pancreas.;37\n\t\t\t\t\t4\n\t\t\t\t\t445\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B172",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tArvanitidis\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAnagnostopoulos\n\t\t\t\t\t\t\tG. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGiannopoulos\n\t\t\t\t\t\t\tD.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPantes\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAgaritsi\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMargantinis\n\t\t\t\t\t\t\tG.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004\n\t\t\t\t\tCan somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol.;19\n\t\t\t\t\t3\n\t\t\t\t\t278\n\t\t\t\t\t82 .\n\t\t\t'},{id:"B173",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPoon\n\t\t\t\t\t\t\tR. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYeung\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLiu\n\t\t\t\t\t\t\tC. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLam\n\t\t\t\t\t\t\tC. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYuen\n\t\t\t\t\t\t\tW. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLo\n\t\t\t\t\t\t\tC. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2003 Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomized controlled trial. Gut.;52\n\t\t\t\t\t12\n\t\t\t\t\t1768\n\t\t\t\t\t73 .\n\t\t\t'},{id:"B174",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPoon\n\t\t\t\t\t\t\tR. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYeung\n\t\t\t\t\t\t\tC.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLo\n\t\t\t\t\t\t\tC. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tYuen\n\t\t\t\t\t\t\tW. K.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLiu\n\t\t\t\t\t\t\tC. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tFan\n\t\t\t\t\t\t\tS. T.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t1999\n\t\t\t\t\tProphylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc.;49\n\t\t\t\t\t5\n\t\t\t\t\t593\n\t\t\t\t\t8 .\n\t\t\t'},{id:"B175",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tBordas\n\t\t\t\t\t\t\tJ. M.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tToledo-Pimentel\n\t\t\t\t\t\t\tV.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLlach\n\t\t\t\t\t\t\tJ.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tElena\n\t\t\t\t\t\t\tM.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tMondelo\n\t\t\t\t\t\t\tF.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGinès\n\t\t\t\t\t\t\tA.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t1998\n\t\t\t\t\tEffects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. Gastrointest Endosc.;47\n\t\t\t\t\t3\n\t\t\t\t\t230\n\t\t\t\t\t4 .\n\t\t\t'},{id:"B176",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tSchwartz\n\t\t\t\t\t\t\tJ. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tLew\n\t\t\t\t\t\t\tR. J.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tAhmad\n\t\t\t\t\t\t\tN. A.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tShah\n\t\t\t\t\t\t\tJ. N.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tGinsberg\n\t\t\t\t\t\t\tG. G.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tKochman\n\t\t\t\t\t\t\tM. L.\n\t\t\t\t\t\t\n\t\t\t\t\t\tet al.\n\t\t\t\t\t\n\t\t\t\t\t2004 The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis. Gastrointest Endosc.;59\n\t\t\t\t\t2\n\t\t\t\t\t179\n\t\t\t\t\t84 .\n\t\t\t'},{id:"B177",body:'\n\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tTalukdar\n\t\t\t\t\t\t\tR.\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVege\n\t\t\t\t\t\t\tS. S.\n\t\t\t\t\t\t\n\t\t\t\t\t\n\t\t\t\t\t2011\n\t\t\t\t\tEarly Management of Severe Acute Pancreatitis. Curr Gastroenterol Rep;13\n\t\t\t\t\t2\n\t\t\t\t\t123\n\t\t\t\t\t30 .\n\t\t\t'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Alejandro González-Ojeda",address:null,affiliation:'
Surgical Section of the Research Unit in Clinical Epidemiology, Specialties Hospital, Western Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco,, Mexico
Department of Gastroenterology and Gastrointestinal Endoscopy,Specialties Hospital, Western Medical Center,Mexican Institute of Social Security, Guadalajara, Jalisco,, Mexico
Surgical Section of the Research Unit in Clinical Epidemiology, Specialties Hospital, Western Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco,, Mexico
Surgical Section of the Research Unit in Clinical Epidemiology, Specialties Hospital, Western Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco,, Mexico
Surgical Section of the Research Unit in Clinical Epidemiology, Specialties Hospital, Western Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco,, Mexico
Surgical Section of the Research Unit in Clinical Epidemiology, Specialties Hospital, Western Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco,, Mexico
'}],corrections:null},book:{id:"932",type:"book",title:"Acute Pancreatitis",subtitle:null,fullTitle:"Acute Pancreatitis",slug:"acute-pancreatitis",publishedDate:"January 18th 2012",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/932.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:null,printIsbn:"978-953-307-984-4",pdfIsbn:"978-953-51-6779-2",reviewType:"peer-reviewed",numberOfWosCitations:18,isAvailableForWebshopOrdering:!0,editors:[{id:"73208",title:"Prof.",name:"Luis",middleName:null,surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"1021"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"26182",type:"chapter",title:"Acute Biliary Pancreatitis",slug:"acute-biliary-pancreatitis",totalDownloads:3862,totalCrossrefCites:0,signatures:"Mehmet Ilhan and Halil Alıs",reviewType:"peer-reviewed",authors:[{id:"66078",title:"Dr.",name:"Mehmet",middleName:null,surname:"İlhan",fullName:"Mehmet İlhan",slug:"mehmet-ilhan"}]},{id:"26183",type:"chapter",title:"Acute Pancreatitis Induced by Drugs",slug:"acute-pancreatitis-induced-by-drugs",totalDownloads:5969,totalCrossrefCites:5,signatures:"Karel Urbánek, Ilona Vinklerová, Ondřej Krystyník and Vlastimil Procházka",reviewType:"peer-reviewed",authors:[{id:"64832",title:"Dr.",name:"Karel",middleName:null,surname:"Urbánek",fullName:"Karel Urbánek",slug:"karel-urbanek"}]},{id:"26184",type:"chapter",title:"Obesity and Acute Pancreatitis",slug:"obesity-and-acute-pancreatitis",totalDownloads:2298,totalCrossrefCites:0,signatures:"Davor Štimac and Neven Franjić",reviewType:"peer-reviewed",authors:[{id:"67987",title:"Prof.",name:"Davor",middleName:null,surname:"Štimac",fullName:"Davor Štimac",slug:"davor-stimac"},{id:"69869",title:"Dr.",name:"Neven",middleName:null,surname:"Franjić",fullName:"Neven Franjić",slug:"neven-franjic"}]},{id:"26185",type:"chapter",title:"Acute Pancreatitis During Pregnancy",slug:"acute-pancreatitis-during-pregnancy",totalDownloads:8121,totalCrossrefCites:1,signatures:"Tea Štimac and Davor Štimac",reviewType:"peer-reviewed",authors:[{id:"69839",title:"Prof.",name:"Davor",middleName:null,surname:"Štimac",fullName:"Davor Štimac",slug:"davor-stimac"},{id:"69845",title:"MSc",name:"Tea",middleName:null,surname:"Štimac",fullName:"Tea Štimac",slug:"tea-stimac"}]},{id:"26186",type:"chapter",title:"Pancreatitis in Children",slug:"pancreatitis-in-children",totalDownloads:3964,totalCrossrefCites:0,signatures:"Alfredo Larrosa-Haro, Carmen A. Sánchez-Ramírez and Mariana Gómez-Nájera",reviewType:"peer-reviewed",authors:[{id:"71209",title:"Dr.",name:"Alfredo",middleName:null,surname:"Larrosa-Haro",fullName:"Alfredo Larrosa-Haro",slug:"alfredo-larrosa-haro"},{id:"71216",title:"Dr.",name:"Carmen A",middleName:null,surname:"Sánchez-Ramírez",fullName:"Carmen A Sánchez-Ramírez",slug:"carmen-a-sanchez-ramirez"},{id:"71550",title:"Dr",name:"Mariana",middleName:null,surname:"Gomez-Najera",fullName:"Mariana Gomez-Najera",slug:"mariana-gomez-najera"}]},{id:"26187",type:"chapter",title:"Pancreatitis in Cystic Fibrosis and CFTR-Related Disorder",slug:"pancreatitis-in-cystic-fibrosis-and-cftr-related-disorder",totalDownloads:4339,totalCrossrefCites:0,signatures:"Michael J. Coffey and Chee Y. Ooi",reviewType:"peer-reviewed",authors:[{id:"71852",title:"Dr.",name:"Keith C. Y.",middleName:null,surname:"Ooi",fullName:"Keith C. Y. Ooi",slug:"keith-c.-y.-ooi"}]},{id:"26188",type:"chapter",title:"Diabetes or Diabetes Drugs: A Cause for Acute Pancreatitis",slug:"diabetes-or-diabetes-drugs-a-cause-for-acute-pancreatitis",totalDownloads:3289,totalCrossrefCites:0,signatures:"Leann Olansky",reviewType:"peer-reviewed",authors:[{id:"63358",title:"Dr.",name:"Leann",middleName:null,surname:"Olansky",fullName:"Leann Olansky",slug:"leann-olansky"}]},{id:"26189",type:"chapter",title:"Role of Peritoneal Macrophages on Local and Systemic Inflammatory Response in Acute Pancreatitis",slug:"role-of-peritoneal-macrophages-on-local-and-systemic-inflammatory-response-in-acute-pancreatitis",totalDownloads:2174,totalCrossrefCites:2,signatures:"Marcel Cerqueira Cesar Machado and Ana Maria Mendonça Coelho",reviewType:"peer-reviewed",authors:[{id:"63975",title:"Prof.",name:"Ana Maria M",middleName:"Cerqueira Cesar",surname:"Coelho",fullName:"Ana Maria M Coelho",slug:"ana-maria-m-coelho"},{id:"115040",title:"Dr.",name:"Marcel",middleName:null,surname:"Machado",fullName:"Marcel Machado",slug:"marcel-machado"}]},{id:"26190",type:"chapter",title:"Molecular Biology of Acute Pancreatitis",slug:"molecular-biology-of-acute-pancreatitis",totalDownloads:2534,totalCrossrefCites:1,signatures:"Francisco Soriano and Ester C.S. Rios",reviewType:"peer-reviewed",authors:[{id:"69471",title:"Dr.",name:"Francisco",middleName:"Garcia",surname:"Soriano",fullName:"Francisco Soriano",slug:"francisco-soriano"},{id:"117418",title:"Dr.",name:"Ester",middleName:"Correia Sarmento",surname:"Rios",fullName:"Ester Rios",slug:"ester-rios"}]},{id:"26191",type:"chapter",title:"Oxidative Stress and Antioxidative Status in the Acute Pancreatitis",slug:"oxidative-stress-and-antioxidative-status-in-the-acute-pancreatitis",totalDownloads:2440,totalCrossrefCites:0,signatures:"Andrzej Lewandowski, Krystyna Markocka-Mączka, Maciej Garbień, Dorota Diakowska and Renata Taboła",reviewType:"peer-reviewed",authors:[{id:"65620",title:"Prof.",name:"Andrzej",middleName:null,surname:"Lewandowski",fullName:"Andrzej Lewandowski",slug:"andrzej-lewandowski"},{id:"66576",title:"Prof.",name:"Krystyna",middleName:null,surname:"Markocka-Maczka",fullName:"Krystyna Markocka-Maczka",slug:"krystyna-markocka-maczka"},{id:"66577",title:"Dr.",name:"Dorota",middleName:null,surname:"Diakowska",fullName:"Dorota Diakowska",slug:"dorota-diakowska"},{id:"66578",title:"Dr.",name:"Maciej",middleName:null,surname:"Garbie?",fullName:"Maciej Garbie?",slug:"maciej-garbie"},{id:"71698",title:"Dr.",name:"Renata",middleName:null,surname:"Taboła",fullName:"Renata Taboła",slug:"renata-tabola"}]},{id:"26192",type:"chapter",title:"Microcirculatory Disturbances in the Pathogenesis of Acute Pancreatitis",slug:"microcirculatory-disturbances-in-the-pathogenesis-of-acute-pancreatitis",totalDownloads:2629,totalCrossrefCites:0,signatures:"Dirk Uhlmann",reviewType:"peer-reviewed",authors:[{id:"63169",title:"Prof.",name:"Dirk",middleName:null,surname:"Uhlmann",fullName:"Dirk Uhlmann",slug:"dirk-uhlmann"}]},{id:"26193",type:"chapter",title:"Endoscopic Retrograde Cholangiopancreatography-Related Acute Pancreatitis – Identification, Prophylaxis and Treatment",slug:"endoscopic-retrograde-cholangiopancreatography-related-acute-pancreatitis-identification-prophylaxis",totalDownloads:2586,totalCrossrefCites:0,signatures:"Alejandro González-Ojeda, Carlos Dávalos-Cobian, Elizabeth Andalón-Dueñas, Mariana Chávez-Tostado, Arturo Espinosa-Partida and Clotilde Fuentes-Orozco",reviewType:"peer-reviewed",authors:[{id:"65817",title:"Prof.",name:"Alejandro",middleName:null,surname:"Gonzalez-Ojeda",fullName:"Alejandro Gonzalez-Ojeda",slug:"alejandro-gonzalez-ojeda"}]},{id:"26194",type:"chapter",title:"Endoscopic Retrograde Cholangiopancreatography (ERCP) Related Acute Pancreatitis",slug:"endoscopic-retrograde-cholangiopancreatography-ercp-related-acute-pancreatitis",totalDownloads:3252,totalCrossrefCites:0,signatures:"Zoltán Döbrönte",reviewType:"peer-reviewed",authors:[{id:"65652",title:"Prof.",name:"Zoltan",middleName:null,surname:"Dobronte",fullName:"Zoltan Dobronte",slug:"zoltan-dobronte"}]},{id:"26195",type:"chapter",title:"Nutrition Assessment and Therapy in Acute Pancreatitis",slug:"nutrition-assessment-and-therapy-in-acute-pancreatitis",totalDownloads:4069,totalCrossrefCites:0,signatures:"Vanessa Fuchs-Tarlovsky and Krishnan Sriram",reviewType:"peer-reviewed",authors:[{id:"67143",title:"Dr.",name:"Vanessa",middleName:null,surname:"Fuchs-Tarlovsky",fullName:"Vanessa Fuchs-Tarlovsky",slug:"vanessa-fuchs-tarlovsky"},{id:"118763",title:"Dr.",name:"Krishnan",middleName:null,surname:"Sriram",fullName:"Krishnan Sriram",slug:"krishnan-sriram"}]},{id:"26196",type:"chapter",title:"Changes in the Management of Treatment in Acute Pancreatitis Patients",slug:"changes-in-the-management-of-treatment-in-acute-pancreatitis-patients",totalDownloads:2780,totalCrossrefCites:0,signatures:"Juraj Bober, Jana Kaťuchová and Jozef Radoňak",reviewType:"peer-reviewed",authors:[{id:"69676",title:"Prof.",name:"Juraj",middleName:null,surname:"Bober",fullName:"Juraj Bober",slug:"juraj-bober"},{id:"69682",title:"Prof.",name:"Jana",middleName:null,surname:"Katuchova",fullName:"Jana Katuchova",slug:"jana-katuchova"},{id:"69689",title:"Prof.",name:"Jozef",middleName:null,surname:"Radonak",fullName:"Jozef Radonak",slug:"jozef-radonak"}]},{id:"26197",type:"chapter",title:"Hypertriglyceride Induced Acute Pancreatitis",slug:"hypertriglyceride-induced-acute-pancreatitis",totalDownloads:9387,totalCrossrefCites:1,signatures:"Joshua Lebenson and Thomas Oliver",reviewType:"peer-reviewed",authors:[{id:"63815",title:"Dr.",name:"Thomas",middleName:null,surname:"Oliver",fullName:"Thomas Oliver",slug:"thomas-oliver"},{id:"64128",title:"Dr",name:"Joshua",middleName:null,surname:"Lebenson",fullName:"Joshua Lebenson",slug:"joshua-lebenson"}]},{id:"26198",type:"chapter",title:"The Role of Percutaneous Drainage in the Treatment of Severe Acute Pancreatitis on the Basis of the Modified Atlanta Classification",slug:"the-role-of-percutaneous-drainage-in-the-treatment-of-severe-acute-pancreatitis-on-the-basis-of-the-",totalDownloads:4137,totalCrossrefCites:0,signatures:"Zsolt Szentkereszty, Róbert Kotán and Péter Sápy",reviewType:"peer-reviewed",authors:[{id:"72116",title:"Dr.",name:"Zsolt",middleName:null,surname:"Szentkereszty",fullName:"Zsolt Szentkereszty",slug:"zsolt-szentkereszty"}]}]},relatedBooks:[{type:"book",id:"5752",title:"Celiac Disease and Non-Celiac Gluten Sensitivity",subtitle:null,isOpenForSubmission:!1,hash:"47dfc5b8378b01d915127fa3c1169a90",slug:"celiac-disease-and-non-celiac-gluten-sensitivity",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/5752.jpg",editedByType:"Edited by",editors:[{id:"73208",title:"Prof.",name:"Luis",surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"54215",title:"Differential Hallmarks of Celiac Versus Non-Celiac Gluten Sensitivity",slug:"differential-hallmarks-of-celiac-versus-non-celiac-gluten-sensitivity",signatures:"Mahesh Mohan and Karol Sestak",authors:[{id:"77951",title:"Dr.",name:"Karol",middleName:null,surname:"Sestak",fullName:"Karol Sestak",slug:"karol-sestak"},{id:"204823",title:"Dr.",name:"Mahesh",middleName:null,surname:"Mohan",fullName:"Mahesh Mohan",slug:"mahesh-mohan"}]},{id:"54009",title:"Celiac Disease and HBV Vaccination",slug:"celiac-disease-and-hbv-vaccination",signatures:"Caterina Anania, Francesca Olivero, Eugenia Olivero and Lucia\nPacifico",authors:[{id:"181185",title:"M.D.",name:"Lucia",middleName:null,surname:"Pacifico",fullName:"Lucia Pacifico",slug:"lucia-pacifico"},{id:"185268",title:"Prof.",name:"Caterina",middleName:null,surname:"Anania",fullName:"Caterina Anania",slug:"caterina-anania"},{id:"185269",title:"Dr.",name:"Francesca",middleName:null,surname:"Olivero",fullName:"Francesca Olivero",slug:"francesca-olivero"},{id:"185270",title:"Dr.",name:"Eugenia",middleName:null,surname:"Olivero",fullName:"Eugenia Olivero",slug:"eugenia-olivero"}]},{id:"54124",title:"Measurement of Gluten in Food Products: Proficiency‐Testing Rounds as a Measure of Precision and Applicability",slug:"measurement-of-gluten-in-food-products-proficiency-testing-rounds-as-a-measure-of-precision-and-appl",signatures:"Markus Lacorn, Susanne Siebeneicher and Thomas Weiss",authors:[{id:"178279",title:"Dr.",name:"Markus",middleName:null,surname:"Lacorn",fullName:"Markus Lacorn",slug:"markus-lacorn"},{id:"204541",title:"Dr.",name:"Susanne",middleName:null,surname:"Siebeneicher",fullName:"Susanne Siebeneicher",slug:"susanne-siebeneicher"},{id:"204542",title:"Dr.",name:"Thomas",middleName:null,surname:"Weiss",fullName:"Thomas Weiss",slug:"thomas-weiss"}]},{id:"54342",title:"Determination of Gluten Peptides Associated with Celiac Disease by Mass Spectrometry",slug:"determination-of-gluten-peptides-associated-with-celiac-disease-by-mass-spectrometry",signatures:"Thais O. Alves, Carolina T. S. D'Almeida and Mariana S. L. Ferreira",authors:[{id:"195807",title:"Prof.",name:"Mariana",middleName:null,surname:"Larraz Ferreira",fullName:"Mariana Larraz Ferreira",slug:"mariana-larraz-ferreira"},{id:"196428",title:"M.Sc.",name:"Thais",middleName:null,surname:"Alves",fullName:"Thais Alves",slug:"thais-alves"},{id:"204835",title:"BSc.",name:"Carolina",middleName:null,surname:"D'Almeida",fullName:"Carolina D'Almeida",slug:"carolina-d'almeida"}]},{id:"54282",title:"Are Gluten-Free Foods Just for Patients with a Gluten-Related Disease?",slug:"are-gluten-free-foods-just-for-patients-with-a-gluten-related-disease-",signatures:"Ana María Calderón de la Barca and Maria Esther Mejía-León",authors:[{id:"197194",title:"Ph.D.",name:"Ana Maria",middleName:null,surname:"Calderon De La Barca",fullName:"Ana Maria Calderon De La Barca",slug:"ana-maria-calderon-de-la-barca"},{id:"197200",title:"Dr.",name:"Maria Esther",middleName:null,surname:"Mejia-Leon",fullName:"Maria Esther Mejia-Leon",slug:"maria-esther-mejia-leon"}]},{id:"54216",title:"Novel Endoscopic Techniques in Celiac Disease",slug:"novel-endoscopic-techniques-in-celiac-disease",signatures:"Balaban Daniel Vasile, Popp Alina and Jinga Mariana",authors:[{id:"197233",title:"Dr.",name:"Daniel Vasile",middleName:null,surname:"Balaban",fullName:"Daniel Vasile Balaban",slug:"daniel-vasile-balaban"},{id:"204532",title:"Dr.",name:"Alina",middleName:null,surname:"Popp",fullName:"Alina Popp",slug:"alina-popp"},{id:"204533",title:"Prof.",name:"Mariana",middleName:null,surname:"Jinga",fullName:"Mariana Jinga",slug:"mariana-jinga"}]},{id:"54254",title:"Examining Non‐Celiac Consumers of Gluten‐Free Products: An Empirical Evidence in Spain",slug:"examining-non-celiac-consumers-of-gluten-free-products-an-empirical-evidence-in-spain",signatures:"Tiziana de‐Magistris, Hind Belarbi and Wajdi Hellali",authors:[{id:"72484",title:"Dr.",name:"Tiziana",middleName:null,surname:"De Magistris",fullName:"Tiziana De Magistris",slug:"tiziana-de-magistris"},{id:"204903",title:"MSc.",name:"Hind",middleName:null,surname:"Belarbi",fullName:"Hind Belarbi",slug:"hind-belarbi"},{id:"204904",title:"MSc.",name:"Wajdi",middleName:null,surname:"Hellali",fullName:"Wajdi Hellali",slug:"wajdi-hellali"}]},{id:"54234",title:"I Can’t Eat That! Sticking to a Gluten-Free Diet",slug:"i-can-t-eat-that-sticking-to-a-gluten-free-diet",signatures:"Ricardo Fueyo-Díaz, Santiago Gascón-Santos and Rosa Magallón-\nBotaya",authors:[{id:"202314",title:"Dr.",name:"Ricardo",middleName:null,surname:"Fueyo-Díaz",fullName:"Ricardo Fueyo-Díaz",slug:"ricardo-fueyo-diaz"},{id:"204604",title:"Dr.",name:"Santiago",middleName:null,surname:"Gascón-Santos",fullName:"Santiago Gascón-Santos",slug:"santiago-gascon-santos"},{id:"204605",title:"Dr.",name:"Rosa",middleName:null,surname:"Magallón-Botaya",fullName:"Rosa Magallón-Botaya",slug:"rosa-magallon-botaya"}]}]}],publishedBooks:[{type:"book",id:"5102",title:"Extradigestive Manifestations of Helicobacter Pylori Infection",subtitle:"An Overview",isOpenForSubmission:!1,hash:"c8c185be3bce68ede380640a14661ac4",slug:"extradigestive-manifestations-of-helicobacter-pylori-infection-an-overview",bookSignature:"Bruna Maria Roesler",coverURL:"https://cdn.intechopen.com/books/images_new/5102.jpg",editedByType:"Edited by",editors:[{id:"54995",title:"Dr.",name:"Bruna Maria",surname:"Roesler",slug:"bruna-maria-roesler",fullName:"Bruna Maria Roesler"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5414",title:"Challenges in Pancreatic Pathology",subtitle:null,isOpenForSubmission:!1,hash:"20877be74cb655ac2c0d75ed24d40795",slug:"challenges-in-pancreatic-pathology",bookSignature:"Andrada Seicean",coverURL:"https://cdn.intechopen.com/books/images_new/5414.jpg",editedByType:"Edited by",editors:[{id:"68858",title:"Dr.",name:"Andrada",surname:"Seicean",slug:"andrada-seicean",fullName:"Andrada Seicean"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5435",title:"Irritable Bowel Syndrome",subtitle:"Novel Concepts for Research and Treatment",isOpenForSubmission:!1,hash:"809b69e057dbb5ffdf5a04ec922d659a",slug:"irritable-bowel-syndrome-novel-concepts-for-research-and-treatment",bookSignature:"Victor Chaban",coverURL:"https://cdn.intechopen.com/books/images_new/5435.jpg",editedByType:"Edited by",editors:[{id:"83427",title:"Prof.",name:"Victor",surname:"Chaban",slug:"victor-chaban",fullName:"Victor Chaban"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5714",title:"Esophageal Abnormalities",subtitle:null,isOpenForSubmission:!1,hash:"132a5e5097b78a76535fde4196596ac9",slug:"esophageal-abnormalities",bookSignature:"Jianyuan Chai",coverURL:"https://cdn.intechopen.com/books/images_new/5714.jpg",editedByType:"Edited by",editors:[{id:"28281",title:"Dr.",name:"Jianyuan",surname:"Chai",slug:"jianyuan-chai",fullName:"Jianyuan Chai"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5744",title:"Updates in Gallbladder Diseases",subtitle:null,isOpenForSubmission:!1,hash:"7b9d968408893bda6c194ebf3fea5ef6",slug:"updates-in-gallbladder-diseases",bookSignature:"Hesham Mohamed Abdeldayem",coverURL:"https://cdn.intechopen.com/books/images_new/5744.jpg",editedByType:"Edited by",editors:[{id:"72383",title:"Prof.",name:"Hesham",surname:"Abdeldayem",slug:"hesham-abdeldayem",fullName:"Hesham Abdeldayem"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[{type:"book",id:"932",title:"Acute Pancreatitis",subtitle:null,isOpenForSubmission:!1,hash:"b9e4aebaf0e8a2dd617fe38a5d3b2bff",slug:"acute-pancreatitis",bookSignature:"Luis Rodrigo",coverURL:"https://cdn.intechopen.com/books/images_new/932.jpg",editedByType:"Edited by",editors:[{id:"73208",title:"Prof.",name:"Luis",surname:"Rodrigo",slug:"luis-rodrigo",fullName:"Luis Rodrigo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},onlineFirst:{chapter:{type:"chapter",id:"80677",title:"Veneer-Based Engineered Wood Products in Construction",doi:"10.5772/intechopen.102034",slug:"veneer-based-engineered-wood-products-in-construction",body:'
1. Introduction
Due to the significant population growth and the rising housing standards, the need to use structural wood products has been increasing [1]. At the same time, the timber industry must come up with solutions for ensuring the preservation of natural resources because of the growing demand for lumber and decreasing availability of large-diameter old-growth trees [2, 3]. Previously sawn from massive logs, structural lumber is now made from reconstituted wood in various shapes and sizes, which is classified as engineered wood products (EWPs). EWPs can maximize the use of wood and utilize small-diameter logs in comparison with conventional lumber [3, 4]. There are several types of EWPs in terms of the elements used, such as veneer-, strand-, fiber- and lumber-based EWPs, among which the veneer-based group is the oldest but still widely used.
The veneer-based EWPs, or called layered wood composites, are made of veneer sheets or veneer strands bonded with an adhesive [2], mainly including plywood, laminated veneer lumber (LVL), and parallel strand lumber (PSL), Figure 1. These products are largely made from peeled logs and reconstituted wood, which can then be fabricated into large sheets known as engineered panels [7]. The significant advantage of using veneer, as opposed to sawn lumber, is that it can increase the yield of wood materials from logs, particularly from small-diameter logs [8]. Veneer-based EWPs have a more homogeneous structure and uniform mechanical properties than solid lumber, making them a good candidate for building materials in construction.
Figure 1.
Veneer-based EWPs. Top left – plywood (source: photos obtained from Indiamart [5]) top right – thick plywood. Bottom left – LVL, bottom right – PSL (source: photos obtained from think wood [6]).
Veneer-based EWPs differ by wood species, adhesive type, as well as by layup structure. Figure 2 shows the cross-sections (i.e., the width-thickness plane, or x-y plane named here) of four widely used wood products in construction, i.e., solid wood/lumber, plywood, LVL, and PSL. In the y-axis, the dimensional change is similar between solid wood, plywood, and LVL due to limited efficacy of adhesive bonds in this direction, i.e., the radial direction of the wood. However, the dimensional change of PSL in the y-axis is smaller than that of the other three products because of its irregular arrangement of veneer strands in the x-y plane and application of an adhesive. On the x-axis, the dimensional change is largest in solid wood (Note: the x-axis is the tangential direction of the wood.) and smallest in plywood and PSL, with LVL being in between. In other words, solid wood has the largest variability in both x- and y-axes; plywood and LVL have the reduced variability in x-axes, and PSL has the smallest variability in both x- and y-axis.
Figure 2.
Cross-sections of solid wood and veneer-based EWPs.
The first type of veneer-based EWPs invented is plywood [9]. Later, modifications applied to the veneer layups resulted in LVL, and afterward, the long veneer strands were used to make PSL. The veneer-based EWPs have been widely used in construction nowadays [8]. Plywood is usually used as the sheathing material for walls, floors, and roofs, and the web stock for I-joists. LVL is commonly used as beams, columns, and the flange stock of I-joists. PSL is mainly used as columns and beams.
2. Plywood
2.1 Introduction
Plywood is a glued wood panel consisting of several thin layers of veneer with wood fibers in adjacent layers at right angles in most cases. Usually, a plywood sheet consists of an odd number of veneer layers [2, 3, 10]. Each layer is called ply, so the plywood can be deemed as a wood sandwich [7]. The cross lamination of adjacent plies in plywood contributes to improved mechanical properties and dimensional stability in both length and width directions [10].
Plywood is one of the oldest veneer-based EWPs. More than 3500 years ago, a type of plywood was found in ancient Egypt, which is part of the coffin, dating back to the third Egyptian dynasty [8]. Later, around 1500 BC, some images were discovered in which workers cut plywood with an axe-like tool. These images also show that the glue, apparently of animal origin, was prepared in a pot on fire [6]. Furniture constructed from overlapping sheets of wood and inlay had been discovered in Egyptian tombs. Hardwood veneer was preferred due to its attractive texture and shades [11]. The introduction of plywood was linked to the high cost of wood. Due to the shortage of available wood than supply, Egyptians had to import, by sea, ebony and mahogany from East Africa and cedar and pine from Lebanon at a very high price [12]. Later, the ancient Greeks and Romans started producing plywood. Plywood was primarily used for the manufacturing of furniture and household items [11]. Plywood production took off in the 1850s thanks to the Swedish inventor Emmanuel Nobel, who created a model of a rotary lathe [8]. This model made it possible to remove the veneer in a certain and constant thickness from a wooden block. It gave the plywood a uniform thickness and structure [8].
Despite the fact that plywood is now widely used for sheathing in residential and commercial construction, early builders were hesitant to use the newly-born plywood panels because the blood and soybean protein-based glues used were not waterproof, and some panels delaminated when they got wet [13]. In 1934, waterproof synthetic wood adhesives were introduced, which solved the problem and eased builders’ concerns [8, 13]. During World War II, the use of plywood was exploded in many industries such as boats, aircrafts, footlockers, crates, and buildings [13]. It led to the post-war boom in plywood production [8], which was adopted for structural and exterior applications. One notable example of using plywood is the construction of the legendary bomber Mosquito [14]. This aircraft was introduced during the World War II. Spruce wood, birch plywood, and balsa wood were used in the construction of aircraft, which made it possible to achieve the necessary strength with a low weight structure [15]. Plywood and other structural panels have changed the way of constructing light wood-frame houses and buildings [11, 16]. Since the middle of the past century, usage of structural panels has expanded from a few niche applications to a popular commodity such as subflooring, roof and wall sheathing, corner bracing, and concrete forming [16]. Initially concentrated in the Pacific Northwest of the United States, where old-growth, large-diameter Douglas-fir was mostly used the plywood business therefrom expanded into the southeastern regions in the 1970s as the technological barrier of bonding southern yellow pine veneer was removed [13]. As seen from Figure 3, plywood consumption in Canada was rather stable in the last 15 years or so despite the emergence of other new types of building materials. However, Canada also imports plywood from other countries to meet its increasing demand in construction and other industries such as furniture [17].
Figure 3.
Plywood production and consumption in Canada [17].
2.2 Manufacturing
Figure 4 illustrates the key processes of manufacturing three major veneer-based EWPs, i.e., plywood, LVL, and PSL. An example of manufacturing Canadian softwood plywood is given below, which is used for structural applications. Specially chosen peeler logs are transported to a barker, where they are rotated against a steel claw, which removes the bark [18]. Then debarked logs are cut into peeler blocks. A block is placed on a massive lathe, rotating against a sharp knife. When the block turns, a continuous thin layer of wood, i.e., veneer is peeled off, similar to how paper unwinds from a roll.
Figure 4.
Processes of manufacturing veneer-based EWPs.
The whole block is tried to use with an aim to generate a high yield of good quality wood material. The leftover small spindles are used to make other wood products. The long ribbon of the veneer is then cut with clippers into desired widths and sorted. It is also possible to remove defective pieces of veneer. Subsequentially, the veneer is dried to a moisture content of 5% or so in steam- or gas-heated ovens [18]. Depending on its intended use, the veneer may range in thickness from 0.3 mm (0.01 in) to 6.3 mm (0.25 in) [11]. After drying and sorting, the veneer is fed by glue spreaders, which apply an adhesive layer of uniform thickness. Phenol-formaldehyde (PF) adhesives are usually used in the manufacturing of plywood for structural and outdoor applications when exposed to the weather in its service [3]. Veneer sandwiches are sent to the hot press, which is a key step in the production process of curing the adhesive, subjected to a temperature of 150°C (300°F), and a pressure of 1.38 MPa (200 psi). After the press panels are cut to required dimensions, sanded, and graded [18].
In the fabrication of plywood for non-structural uses, such as furniture, cabinets, and indoor decoration, water-resistant urea-formaldehyde (UF) adhesives are used. The UF adhesives can be cured at a temperature of about 120°C (250°F) during hot-pressing, which can also be cured with high-frequency heating system with an aim to reduce the hot-pressing time and increase the production efficiency [3].
Quality control, which includes incoming management of raw materials, such as wood and glue, and manufacturing parameters at all stages of the production, must be applied in order to produce good quality plywood products. Acceptance quality control is the final stage of the manufacturing process. Many plywood manufacturers in western Canada produce structural plywood under the supervision of the British Columbia Council of Forest Industries (COFI), which constantly checks glue bond strength and other properties to guarantee that the products satisfy the Canadian Standards Association (CSA) standard [18].
2.3 Typical species and sizes
Plywood can be made from various types of wood. Softwoods are commonly used to make veneer for plywood in North America, containing Douglas fir, western hemlock, spruces, pines, and firs [14]. These wood species can be divided into various categories based on their strength and use within the plywood structure. Spruce is used to make the majority of construction-grade softwood plywood in Canada [7]. More discussion on softwood plywood is given through the text in following sections.
Of hardwoods, birch, alder, linden, and lauan (“Philippine mahogany”) are most popular for veneer production [7, 10]. These species do not have distinguished earlywood and latewood zones, which are characterized by uniform density and structure, making them easy to be peeled to produce thin and durable veneer.Beautifully grained hardwoods are often combined in several ways to make a unique face pattern [7].
The first standard plywood sheet had a width of 1.22 m (4 ft) and a length of 2.44 m (8 ft), which appeared in 1928 [19]. Such a standard size for plywood sheets has, since then, almost not been changed. The common thickness of plywood varies from 3.2 mm (1/8 in) to 76 mm (3 in) [10]. It depends on the thickness of the veneer and the number of layers. The most common plywood contains 3, 5, or multiple layers. With a three-layer, the plywood is 2–3 mm (0.08–0.12 in) in thickness, which can be used as an underlayment between the subfloor and the tile. Hardwood decorative plywood is often uniformly selected for grain texture, which is widely employed for indoor uses. The universal hardwood plywood has five layers, resulting in a thickness of 4 mm (0.16 in) or so, which can be used for multiple outdoor and indoor applications. Multiple layer plywood with more than seven layers can be classified as thick plywood, which is widely used for structural purposes, requiring acceptable strength and durability under the loading condition [11]. The thick plywood needs a sub-floor or structural sheathing attached to the framing elements of a new canopy.
Hardwood can be peeled or sliced for the production of decorative veneer for making furniture, cabinets, and interior decoration. Slicing results in more loss in raw materials and more intensiveness in labor [16]. Hardwood veneer, such as birch, usually has a thickness of 1.5 mm (0.06 in), whereas softwood veneer is often cut to a thickness of 3 mm (0.12 in) for plywood and LVL production [8].
2.4 Grading
Plywood comes in a range of appearance grades, from flat natural surfaces suitable for finishing to cost-effective unsanded grades suitable for sheathing. More than a dozen typical thicknesses and over twenty different grades of plywood are available [14]. The plywood is usually graded based on the appearance quality of veneer in North America. There are commonly two classes of plywood, each of which has its own set of standards: (a) construction and industrial plywood and (b) hardwood and decorative plywood [3].
In Canada, the two most popular types of softwood plywoods are unsanded sheathing grade Douglas Fir Plywood (DFP), which conforms to CSA O121 “Douglas fir plywood”, and Canadian softwood plywood (CSP), which conforms to CSA O151 “Canadian softwood plywood”. The poplar plywood, which conforms to CSA O153 “Poplar plywood”, is also designated but less uses in construction [14]. The group of DFP can include other species in addition to Douglas fir. For example, the front and back faces are made of Douglas fir, but the inner plies can be made from any of the specified species, including Douglas fir, western hemlock, and the majority of spruce, pine, and fir species in Canada [14]. Plywood that contains other selected Canadian wood species in the face and back plies is labeled CSP. Most species that are only allowed as inner plies for DFP may also be used as the face or back plies for CSP. Three hardwood species, i.e., balsam poplar, trembling aspen, and cottonwood, are restricted to use as inner plies in DFP and CSP [14]. The sizes, grades, specialty panels, manufacturing tolerances, and glue bond quality of plywood are all stipulated in the standards CSA O121, CSA O151, and CSA O153. The structural plywood is put with a legible and durable stamp showing the manufacturer, the bond style (EXTERIOR), the species (DFP or CSP), and the grade [14]. DFP and CSP are both made in a variety of grades based on the appearance and quality of the veneer used for making the outer plies.
Many plywood mills are members of the associations, which are responsible for inspecting, testing, and certifying the products with stamps. These stamps indicate that the stamped products meet the standards accepted by the associations. One of the largest associations in North America is APA – The Engineered Wood Association (formerly American Plywood Association) [20]. There are usually two letters on a stamp, the first indicating the quality of one surface, while the second showing the quality of the opposite surface, Figure 5 [7]. This stamp ensures the customer that this product has followed the association’s stringent quality and efficiency standards [3]. In Canada, the CertiWood™ Technical Center (formerly CANPLY– the Canadian Plywood Association), a non-profit, industry-funded association, represents manufacturers of EWPs [21]. Those mills, being the members of CertiWood™ Technical Center, can put the stamp with the trademark CANPLY on their products [7, 21].
Figure 5.
A sample stamp on plywood: 1- panel grade - panel grades are generally identified in terms of the veneer grade used on the face and back of a panel (e.g., A-B, B-C); 2- bond classification - exposure ratings for APA wood structural panels may be exterior or exposure 1; 3 - decimal thickness declaration; 4 - mill number - manufacturing mill identification number; 5- species group number - classified according to strength and stiffness under manufacturing standard; 6 - product standard [20] (source: photos obtained from APA – the Engineered Wood Association [20]).
The vast majority of construction and industrial plywood is used in applications where structural performance surpasses appearance. Some construction and industrial plywood are manufactured with faces chosen mainly for appearance of either plain natural finishes or lightly pigmented finishes [3]. Structural plywood is available in two exposure durability classes: interior and exterior [13]. INTERIOR plywood is only intended for use in dry indoor applications where the panels should be protected from moisture permanently; which is even glued with a water-resistant interior-use adhesive [13]. EXTERIOR plywood is the only panels suitable for outdoor exposure. They are bonded with a waterproof exterior-use adhesive [13], including EXPOSURE 1 and EXPOSURE 2. EXPOSURE 1 panels are waterproof and designed for applications where long construction delays or exposure to high moisture in service are possible [13]. EXPOSURE 2 panels are water-resistant and designed for protected applications, where only minor construction delays are expected since they are mainly developed for interior use [13]. Sheathing grades that are not listed for appearance usually have the grading stamp on one of the faces, whereas grades such as Good Two Sides are stamped on the edge to avoid affecting the appearance. The strength values stipulated in CSA O86 “Engineering design in wood” [22] are used for Sheathing grade panels based on layups containing only C-grade veneer. Typical DFP and CSP grades include Sanded grades, primarily used in concrete formwork or non-structural applications, and Select and Select Tight Face grades, which are primarily used in floor underlayment applications requiring a smooth and solid surface [14].
Chemical treatments can be applied to plywood to increase its resistance to decay and fire. In Canada, the preservative-treated plywood must be made following CSA O80 “Wood preservation” [23]. To assess the effects of fire retardants or some other potentially strength-reducing compounds, plywood producers shall conduct tests following ASTM D5516 “Standard test method for evaluating the flexural properties of fire-retardant-treated softwood plywood exposed to elevated temperatures” [24] and ASTM D6305 “Standard practice for calculating bending strength design adjustment factors for fire-retardant-treated plywood roof sheathing” [14].
2.5 Properties
The density of plywood depends on the wood species and thickness used, which varies from 400 kg/m3 (25 lb./ft3) to 800 kg/m3 (50 lb./ft3) [3]. This is compared to the density of oven-dry wood, ranging from approximately 320 kg/m3 (20 lb./ft3) to 720 kg/m3 (45 lb./ft3) [3]. Plywood has good machining properties; thus, it is possible to work with it just like with ordinary wood, such as sawing, nailing, and gluing. However, the cross-lamination design of plywood, in contrast to wood that is broken down the grain, prevents it from splitting readily in the grain direction. As a result, screws and nails can be used in structural applications near the edges of plywood panels.
Plywood has exceptional built-in resistance to raking, twisting, or distortion, which is especially crucial when care is taken for transferring large shear stresses generated by powerful winds or earthquakes [11]. Many strength properties are equalized by changing the direction at 90 degrees to the grain with each consecutive wood layer of veneer. This provides plywood with a two-way capacity, i.e., the properties in the width direction are approximately equal to those in the length direction. For example, 6 mm (1/4 in) sheathing plywood on a typical framed construction wall with doors and windows delivers double the rigidity and strength furnished by 19 mm (3/4 in) thick boards laid diagonally. When glued to the framework, the strength values for plywood walls are raised even further [11].
Because structural plywood uses waterproof resins, a weather-resistant panel can be obtained if the edges are properly sealed [10]. Awareness of the allowable design values of a plywood panel is not required except in special engineering applications such as diaphragms and earthquake-resistant shear walls. When properly fastened to framing at the correct spacing, the span ratings alone ensure that the panels can work well under the roof and floor loadings stipulated in the building code. In North America, the design values can be found in CSA O86 “Engineering design in wood” [22], Wood Design Manual [25], and APA – Plywood Design Specification [20] or in its Design Capacities of APA Performance-rated Structural-Use Panels Technical Note N375 [26]. For engineering applications, STRUCTURAL I panels are typically the best choice. The typical values of sheathing grades are listed in Table 1. The properties of plywood vary with the quality of the constituent layers.
Through thickness (edgewise shear) ASTM D2719 [32]
Table 1.
Mechanical properties and testing standards of plywood (source: Wood Engineering Handbook [27]).
2.6 Applications
Plywood is widely employed in structural and non-structural applications [3], which can be an ideal option for use in both wet and dry environments [14]. It was reported that plywood took about 54.8% of the market share in 2017 in the construction sector in North America Figure 6 [21].
Figure 6.
North America plywood market share by segment in 2017 (source: Figure obtained from BCC research, FAO, RAUTE, IMF, National Statistics Offices [33]).
In construction, plywood is mainly used as a load-bearing element in platform-frame structures, including single-family and multi-family housing, such as sheathing and underlayment, since it has good dimensional stability and does not crack, cup, or twist [18]. Plywood panels are used as wall sheathing materials, providing high lateral resistance to shear walls and high racking strength, and assisting in achieving the overall thermal efficiency of walls [16, 18]. Roof sheathing is frequently made of plywood. The stiffness of which constitutes diaphragm action when using prescribed framing and nailing patterns [18]. Also, plywood often finds its uses in the fabrication of I-joists as web stocks, marine applications, pallets, industrial containers, and furniture, Figure 7. Extra thick plywood with special surface treatment can be used for facing concrete formwork in concrete structures [7, 10, 14].
Figure 7.
Plywood applications [20, 34, 35, 36].
3. Laminated veneer lumber (LVL)
3.1 Introduction
Laminated veneer lumber (LVL) is a type of structural composite lumber (SCL) made by gluing several layers of veneer in the longitudinal direction of the wood, which differs from plywood that has the veneer layers cross-laminated. LVL is one of the most important members in the family of veneer-based EWPs [8]. This material was initially used to produce aircraft propellers and other high-strength aircraft components during World War II [18, 37]. The research and development of LVL can be dated back to the 1940s with an aim at making high-strength parts for aircraft structures out of Sitka spruce veneer [3]. LVL was used as a building material since the mid-1970s [18, 37, 38] when the research was focused on examining the effects of manufacturing variables on LVL with a thickness being up to 12.7 mm (1/2 in) [3]. LVL is now widely used as building and packaging materials [18].
3.2 Manufacturing
The veneer manufacturing and drying processes are almost the same as those used in making plywood. Figure 4 illustrates the different processes in the manufacturing of LVL from plywood, largely including veneer orientation during layup, hot press type, and end cutting to produce the length required.
To make veneer sheets, the logs are usually peeled in a lathe. The thickness of veneer sheets in 1.5 mm (0.06 in) up to 6.4 mm (0.25 in) [16, 38], the length is 2640 mm (104 in), and the width is 1320 mm (52 in) or 660 mm (26 in) [18]. The veneer is dried to a moisture content of 6–10%, ideally 6–8% [38]. The veneer is clipped to remove any strength-reducing defects and graded. The veneer sheets are cut to the desired width for billet production [18]. The individual veneer sheets are then joined, with the grain of all veneers running in the direction of a billet’s length direction. End joints between different veneer pieces are staggered along the length of the billet to distribute any defects that could reduce strength. To effectively transmit load, the joints might be scarf joined or overlapped for some distance [18]. Then the veneer sheets are covered with a waterproof phenol-formaldehyde adhesive [18, 37, 38] or phenol-resorcinol-formaldehyde or polyurethane adhesives [39].
The veneer layup of LVL differs from that of plywood. In the production of LVL, the veneer is oriented in the same direction, i.e., the longitudinal grain direction of the wood, providing the super strength in this direction, which is similar to or larger than solid lumber, Figure 8. Thus, LVL is commonly used for beams and columns in the construction of buildings [8, 10]. Veneer sheets in plywood are cross-laminated, making it possess two-way properties, i.e., similar properties in both major and minor directions, as mentioned in Section 2, suitable for sheathing materials.
Figure 8.
Layups of LVL and plywood (source: image obtained from Gong [39]).
The pre-pressing of LVL billets could be carried out in a single-opening cold press or a short continuous cold press [38]. The completed billets are simultaneously exposed to pressure to consolidate the veneer and heat to accelerate the curing of the glue [18]. In general, the press temperature used to produce LVL is rarely higher than 175°C (350°F). For the batch type presses, it is usually 160°C (320°F). For the continuous presses, the temperature might be significantly higher since there is a pre-heating zone. As veneer sheets are relatively low in permeability, it is recommended to avoid using a high press temperature, especially when combined with a long press time [38]. This process is similar to used in manufacturing of plywood, except that instead of being formed into thin flat panels, the veneer sheets for making LVL is formed into long billets up to 25 m (80 in) in length. After curing, the billets are sawn to specific lengths and widths for the target application(s) of a LVL product [18].
During the manufacturing of LVL, the selection of veneer is, in terms of thickness and grade, of great importance. The right veneer thickness can help balance LVL properties and manufacturing costs in the production. The veneer used in the manufacture of LVL must be carefully selected in order to obtain the desired engineering properties. Ultrasonic scanning is often used to sort veneer sheets to ensure that the final product has the desired engineering properties [37]. The individual veneer is typically graded so that the strength characteristics of each LVL can be customized [10]. For esthetic reasons and superior flatwise bending properties, the best veneer sheets are usually used as surface plies, while lower-grade sheets are used for the inner plies [38]. For example, if the final use of LVL is scaffold planks, the higher grade veneer will be put on the plank’s outer sides [18].
With decreasing veneer thickness, the number of veneer sheets required increases for the same density, thickness, and layout technique of an LVL product. As a result, defects in LVL with thinner veneer will disperse more defects than in LVL with thicker veneer. Because of this, as the veneer thickness decreases, the variation diminishes, and the strength values increase. However, as veneer thickness decreases, resin content, press cycle time, and production cost increase [38].
The strength properties of veneer are more critical for LVL than those in plywood in general. As a result, it is highly desirable for LVL producers to avoid using the veneer sheets with deep lathe checks that cause a reduction in veneer strength. Deep lathe checks can decrease LVL’s shear strength and stiffness while having little effect on its MOE. Low shear rigidity can reduce LVL’s MOE rating [38].
3.3 Typical species and sizes
LVL can be made from different softwood and hardwood species; however, in North America, Douglas-fir, larch, southern yellow pine, hemlock, aspen, and yellow poplar are the most widely used wood species for producing LVL [18, 37, 40].
LVL is available in thicknesses ranging from 19 mm (3/4 in) to 89 mm (3–1/2 in) and likely to 178 mm (7 in) [18, 41]. The most typical thickness of LVL used in construction are 38 mm (1–1/2 in) [3] and 45 mm (1–3/4 in) [18], from which broader beams can be conveniently assembled on a job site by fastening several LVL plies [18]. The typical depth is from 140 mm (5–1/2 in) to 508 mm (20 in). Different manufacturers can also provide different widths and depths. At the job site, LVL can easily be cut to a length required [37]. Typical lengths of LVL are 14.6 m (48 in), 17 m (56 in), 18.3 m (60 in), 20.1 m (66 in), and 24.4 m (80 in) [10, 37, 41]. LVL is manufactured in the form of billets with widths of 610 mm (24 in) or 1220 mm (48 in). The required depth of LVL can be cut from these billets [18].
3.4 Grading
LVL is a proprietary product; therefore, its engineering properties and sizes can differ from one manufacturer to another. As a result, there is no general production standard or design values in the LVL industry [37]. However, the Canadian Construction Materials Centre (CCMC) reviews and approves the design values, which are derived from test results following CSA O86 “Engineering design in wood” and ASTM D5456 “Standard specification for evaluation of structural composite lumber products” [37]. Each manufacturer develops the characteristic properties of its LVL products by in-grade testing. The manufacturer is also responsible for checking the properties of its products by constant monitoring and quality management. Each manufacturer publishes its own list of design properties, resulting in a unique grade for a given LVL product [42]. Products that satisfy the CCMC criteria are assigned an Evaluation Number and an Evaluation Report that describes the design strengths. They are then entered into the CCMC’s Registry of Product Evaluations. The manufacturer’s name or product marking, as well as the stress grade, are stamped on the material at different intervals, although this may not be present on every piece due to end cutting [37].
Figure 9 presents a stamp of LVL from APA – The Engineered Wood Association, which shows a qualified LVL grade (e.g., 3100Fb-2.0E), product evaluation reports, the treatment facility, and standard specifications for SCL.
Figure 9.
LVL stamp: 1 – qualified LVL grade (usually represented by design values; 2 – APA mill number; 3 – product evaluation reports; 4 – standard specification for structural composite lumber (source: photo obtained from APA – the Engineered Wood Association).
3.5 Properties
The density of LVL is about 480–510 kg/m3 (30-32 lb./ft3) [43], which is similar to that of the wood made from. Compared to solid wood, LVL has more stable characteristics than solid timber. This is due to the fact that natural defects, such as knots, splits and slope of grain, are dispersed throughout the material or completely removed during the manufacturing, and dried veneer and adhesives are employed [37].
LVL can easily absorb water, resulting in the change in dimensions, in particular in the thickness direction since there are almost no adhesive restrictions. Therefore, LVL should be protected from the weather during job site storage and after installation [3, 37]. Wrapping the LVL materials for shipping to the job site is also critical for minimizing the moisture effect. End and edge sealing are the commonly used approach to avoid moisture penetration and protect LVL products in their services [37].
Both special cutting, notching, or drilling should be performed according to the manufacturer’s instruction. LVL acts similarly to solid sawn timber or glue-laminated beams of equal height, which requires the same fastening and connection requirements as solid lumber [40]. The primary sources of knowledge for design, standard installation descriptions, and performance characteristics are provided in the manufacturer catalogs and inspection reports [37].
3.6 Applications
LVL is mainly used as structural framing in residential and industrial buildings. In the building industry, LVL is widely used for beams or headers over windows and doors on the edge, for hip and valley rafters, scaffold planking, and the flange material of I-joists [3, 10]. LVL may also be used as truck bed decking and road signposts. LVL is chiefly used as a structural component, most commonly in hidden spaces where esthetics is not a concern. Certain manufacturers offer a finished or architectural grade look, but it typically comes at a cost. When using LVL in applications where esthetics is significant, standard wood finishing techniques may be used to accent the grain and preserve the surface layer. The finished wide outer layer of LVL looks like plywood [37]. Figure 10 shows such a complex curved structure constructed Burnaby, British Columbia, Canada, which was designed and built with 53 parallel CNC-cut spruce LVL sections [44]. Each curved structure was panelized into six segments, shipped to the construction site, and assembled into one piece [44].
Figure 10.
Curved LVL structures at Simon Fraser University (Canada) - Ripple Cone Canopy (source: photos obtained from StructureCraft [44]).
Veneer-based EWPs have also been used in the windmill industry, in which wood veneer sheets are used to make windmill blades [45]. Previously, the size of the wooden blade was constrained by the availability of large, consistent-quality tree trunks. Veneering, on the other hand, spreads out defects like knots, resulting in more substantial and more predictable stiffness properties. This makes it possible to make larger wooden blades. When compared to fiberglass, wood laminates provide substantial cost and reduced weight. There are examples of blades made primarily of LVL reinforced with carbon composite spars and coated with a fiberglass composite outer layer [46]. One of the largest windmill blades is 107 meters long (351 ft), which is longer than a football field, produced in Cherbourg, France. It was made from a high-tech sandwich structure consisting of thin layers of glass and carbon fibers and balsa wood veneer [47].
4. Parallel strand lumber (PSL)
4.1 Introduction
Parallel strand lumber (PSL) is known as a composite of veneer strands with wood fibers aligned primarily along the length of the member, i.e., the longitudinal direction of wood [3]. PSL is overall similar to laminated strand lumber (LSL) and oriented strand lumber (OSL) but is made up of veneer strands (sometimes called veneer strips). The length of veneer strands used in PSL is longer than the strands used in LSL and OSL, with a length-to-thickness ratio of around 300.
PSL was invented in 1975 by MacMillan Bloedel Ltd., in Vancouver, Canada, who set out to create a high-strength wood-based material [13]. The first PSL plant was opened in 1982, and its products were first commercially sold for Expo ‘86. MacMillan Bloedel, which is now called Weyerhaeuser, commercialized and patented its PSL products with the brand name Parallam®. The process has been improved over time to produce relatively giant and long beams, and the production and sales have steadily increased [48].
4.2 Manufacturing
The process of manufacturing PSL allows prominent members to be built from small trees, resulting in the more efficient use of forest resources [49]. The first stages in the production of PSL are similar to those used in the production of plywood or LVL. Figure 4 illustrates the unique processes employed in the manufacturing of PSL, differentiating from those in plywood or LVL. To make veneer, logs are turned on a lathe [18]. The thickness of veneer is from 3 mm (1/8 in) to 6.4 mm (1/4 in) [3]. The veneer sheets are then dried to a moisture content of 2–3% before being sliced into long thin veneer strands parallel to one another [9]. After that, the veneer sheets are clipped into long, narrow veneer strands with a length of 2.4 m (8 feet), a width of 13 mm (1/2 in) [18], and a thickness from 2.54 mm (1/10 in) to 3.175 mm (1/8 in) [38].
The production process is designed to use materials from the log roundup and other less than full-width veneer in the veneer cutting stage. As a result, the process uses waste materials from a plywood or LVL operation [3]. The veneer strands are oriented to the length direction of a continuous billet using special equipment (Figure 11) and mixed with a waterproof exterior structural adhesive, such as phenol-formaldehyde, prior to hot-pressing.
Figure 11.
Orientation of veneer strands in PSL (source: photos obtained from WorldPress.com [50]).
The pressing process densifies the veneer strands to some degree, and the adhesive is cured with the aid of microwave technology [18, 49]. A continuous press is employed to produce PSL, which theoretically produces an unlimited length but is constrained only by transportation restrictions [3].
4.3 Typical species and sizes
Douglas fir is used to produce PSL in Canada, and southern yellow pines are employed in the USA. In addition to this, western hemlock and yellow poplar are also used [3, 49, 51]. In general, there are no restrictions on the use of other wood species.
The available stock sizes for PSL have to be compatible with existing wood framing materials and standard dimensions [18]. PSL beams are available in thicknesses from 89 mm (3–1/2 in) to 178 mm (7 in), and in-depth from 235 mm (9–1/4 in) to 457 mm (18 in) [41]. PSL columns come in square and rectangular shapes of a dimension of 89 mm (3–1/2 in), 133 mm (5–1/4 in), or 178 mm (7 in) [41]. Smaller thicknesses can also be used, either individually as single plies or in combination for multi-ply applications [18, 49]. Steel connectors are usually required for larger dimensions [51]. PSL is available in lengths up to 20 meters (66 ft) [41].
The beam-like PSL products can be also ripped into thin boards, Figure 12, which opens a window for non-structural applications [18].
Figure 12.
Boards ripped from PSL (source: photos adopted from Goulddesigninc.com [52]).
4.4 Grading
PSL is a proprietary product, the same as LVL. Therefore, specifications and dimensions are unique to each manufacturer. In North America, both PSL and LVL are treated as the same structural composite lumber [18]. The evaluation procedure and grade determination of PSL are the same as LVL (refer to Section 3.4). Figure 13 presents a stamp of PSL (Parallam® Plus), including a description of the product and uses, the type of treatment, and the treatment facility. The treatment stamp can also reference the treating standards (such as AWPA U1/UC4A by the American Wood Protection Association) and third-party quality program monitor (SPIB - Southern Pine Inspection Bureau) [53].
Figure 13.
Stamp on PSL (Parallam® plus) (source: image obtained from Weyerhaeuser [53]).
4.5 Properties
Since natural defects such as knots, the slope of grain, and splits have been scattered across the material or eliminated during the manufacturing process. The combination of a structural adhesive used with dried wood veneer strands, heat, and pressure employed during pressing makes PSL less warping than solid timber. Therefore, PSL is a type of highly consistent, uniform EWPs [49], which exhibits much less variability and larger load-bearing capabilities than solid lumber [51]. The density of PSL is 720 kg/m3 (45 lb./ft3) [54], which is similar to that of the wood used. Other advantages of PSL are given to its high strength, stiffness, and dimensional flexibility [49]. PSL is less susceptible to shrinkage, warping, and splitting as it has a moisture content of 11% [49].
The texture of PSL is rich due to the grain of wood veneer strands and dark glue lines. PSL is a visually appealing construction material that fits well to the applications that require a high level of finished appearance [49]. The techniques applicable to sawn lumber can be used to machine, stain, and finish PSL. At the end of the manufacturing period, PSL is sanded to ensure exact dimensions and a high-quality appearance. Stain can be used to emphasize the warmth and texture of the wood [49]. It should be pointed out that the special cutting, notching, or drilling of PSL shall be performed in compliance with the manufacturer’s instruction.
As mentioned above, both PSL and LVL are treated as the same SCL in Canadian practices; therefore, their design values are the same. Table 2 lists the key strength properties of sample SCL. Some specific design values can be obtained from manufacturers [41].
Property
Value (MPa)
Modulus of elasticity, E
13,800
Allowable bending stress, fb (300 mm depth)
37.0
Allowable shear stress, fv (perpendicular to glue line or wide face of the strand)
3.7
Allowable bearing stress, fcp (parallel to glue line or wide face of the strand)
9.4
Table 2.
Major strength properties of SCL (source: Canadian Wood Council [41]).
4.6 Applications
PSL is mainly used in residential, commercial, and industrial construction as structural framing components, such as beams and columns in the post-and-beam construction, and headers, pillars, and lintels in the light-frame construction [18]. According to Part 3 of the National Building Code of Canada, CCMC has approved PSL for use as heavy timber construction [51]. Due to the excellent strength characteristics of PSL, it is possible to use it in the design of the roofs with a large span and rooms with open spaces. Figure 14(left) presents PSL beams that are used for an open floor plan at Vancouver Firehall No.15, Vancouver, Canada. Another example is presented in Figure 14(right), showing a portable Concord Pacific Display Pavilion at Vancouver, Canada, which uses a glass-enclosed superstructure made of exposed PSL columns. In addition, PSL is a visually attractive material; thus, it is well suited to applications where the finished look is essential. It can be also appropriate for hidden structural applications where appearance is unimportant [18].
Figure 14.
Floor and columns made of PSL in Vancouver Firehall No.15 (left) and Concord Pacific display pavilion (right), respectively (source: photos obtained from StructureCraft [55]).
5. Endnotes
EWPs are relatively recent structural members that have been widely incorporated in the building industry in North America and beyond. They have been invented and used for making timber buildings and furniture. The family of veneer-based EWPs mainly has three major members, i.e., plywood, LVL, and PSL. Because the majority of veneer-based EWPs are designed to handle relatively large loads, they must be manufactured in accordance with recognized standards or technical guides to ensure that the required engineering design values and applications are met. Veneer-based EWPs have been accepted and acknowledged in the building industry as premium structural materials. It is possible to make these products considerably large from small-diameter logs. The only restriction can be the length of LVL and PSL during transportation [38].
Non-traditional resources (such as under-utilized wood species) can be used to manufacture veneer-based EWPs of better physical and mechanical properties than other traditional structural products (such as solid timber products) [1]. Due to engineering design, removal of defects, drying of wood materials, application of adhesive, and layer-by-layer bonding, the veneer-based EWPs are stronger and more durable than solid wood of the same size. This is an outstanding advantage for constructing a building requiring high strength without a bulky appearance. Typically, LVL and PSL have about three times larger bending strength and 30% larger stiffness than the lumber products of comparable sizes [41].
Interest in veneer-based EWPs products will continue to grow for ecological reasons. For example, restrictions have been introduced in many countries on deforestation of large-diameter old-growth trees. Due to the needs in the construction market, alternative materials must be further developed. The rapid advancement in technology, along with the available raw materials, i.e., small-size fast-growth trees, would inevitably accelerate the development of EWPs [2]. Also, in recent years, the minimization of carbon footprints in construction has reached a consensus. Many architects and engineers have been designing and constructing buildings with 100% solid wood and EWPs. Meanwhile, research on the standardization of the veneer-based EWPs and expansion of their uses is no doubt required. Modernization of existing equipment and improvement of the gluing systems will allow the creation of innovative designs and special shapes that are currently not available for wood products. This will certainly expand the matrix of applications for veneer-based EWPs, as well as making them become more competitive in the market of building materials.
Acknowledgments
This piece of work was financially supported by the New Brunswick Innovation Research Chair Initiative Program by the New Brunswick Innovation Foundation (Canada) and the Collaborative Research and Development Grants by Natural Sciences and Engineering Research Council of Canada (CRDPJ 523922-18).
Conflict of interest
The authors declare no conflict of interest.
\n',keywords:"veneer-based engineered wood products, plywood, laminated veneer lumber, parallel strand lumber, adhesives, engineering properties, structural uses",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/80677.pdf",chapterXML:"https://mts.intechopen.com/source/xml/80677.xml",downloadPdfUrl:"/chapter/pdf-download/80677",previewPdfUrl:"/chapter/pdf-preview/80677",totalDownloads:67,totalViews:0,totalCrossrefCites:0,dateSubmitted:"June 18th 2021",dateReviewed:"December 15th 2021",datePrePublished:"March 2nd 2022",datePublished:"April 28th 2022",dateFinished:"March 2nd 2022",readingETA:"0",abstract:"Veneer-based engineered wood products (EWPs) are widely used in construction. Veneer-based EWPs are made of thin veneer sheets or veneer strands with adhesives, mainly including plywood, laminated veneer lumber (LVL), and parallel strand lumber (PSL). This chapter first discusses veneer-based EWPs in terms of their manufacturing, properties, and applications. Secondly, it introduces how veneer sheets or veneer strands intersect with each other in these products, providing additional strength and stable dimensions. Thirdly, this chapter overviews the effects of element dimensions, basic structure, veneer grade, adhesive type, and processing parameters on the properties of these products. Finally, it illustrates the uses of veneer-based EWPs through examples with a focus on their construction applications.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/80677",risUrl:"/chapter/ris/80677",signatures:"Elena Vladimirova and Meng Gong",book:{id:"10584",type:"book",title:"Engineered Wood Products for Construction",subtitle:null,fullTitle:"Engineered Wood Products for Construction",slug:"engineered-wood-products-for-construction",publishedDate:"April 28th 2022",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83962-772-9",printIsbn:"978-1-83962-771-2",pdfIsbn:"978-1-83962-790-3",isAvailableForWebshopOrdering:!0,editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",fullName:"Meng Gong",slug:"meng-gong",email:"meng.gong@unb.ca",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/274242/images/system/274242.jpg",institution:{name:"University of New Brunswick",institutionURL:null,country:{name:"Canada"}}},{id:"349598",title:"Mrs.",name:"Elena",middleName:null,surname:"Vladimirova",fullName:"Elena Vladimirova",slug:"elena-vladimirova",email:"evladimi@unb.ca",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Plywood",level:"1"},{id:"sec_2_2",title:"2.1 Introduction",level:"2"},{id:"sec_3_2",title:"2.2 Manufacturing",level:"2"},{id:"sec_4_2",title:"2.3 Typical species and sizes",level:"2"},{id:"sec_5_2",title:"2.4 Grading",level:"2"},{id:"sec_6_2",title:"2.5 Properties",level:"2"},{id:"sec_7_2",title:"2.6 Applications",level:"2"},{id:"sec_9",title:"3. Laminated veneer lumber (LVL)",level:"1"},{id:"sec_9_2",title:"3.1 Introduction",level:"2"},{id:"sec_10_2",title:"3.2 Manufacturing",level:"2"},{id:"sec_11_2",title:"3.3 Typical species and sizes",level:"2"},{id:"sec_12_2",title:"3.4 Grading",level:"2"},{id:"sec_13_2",title:"3.5 Properties",level:"2"},{id:"sec_14_2",title:"3.6 Applications",level:"2"},{id:"sec_16",title:"4. Parallel strand lumber (PSL)",level:"1"},{id:"sec_16_2",title:"4.1 Introduction",level:"2"},{id:"sec_17_2",title:"4.2 Manufacturing",level:"2"},{id:"sec_18_2",title:"4.3 Typical species and sizes",level:"2"},{id:"sec_19_2",title:"4.4 Grading",level:"2"},{id:"sec_20_2",title:"4.5 Properties",level:"2"},{id:"sec_21_2",title:"4.6 Applications",level:"2"},{id:"sec_23",title:"5. Endnotes",level:"1"},{id:"sec_24",title:"Acknowledgments",level:"1"},{id:"sec_27",title:"Conflict of interest",level:"1"}],chapterReferences:[{id:"B1",body:'Thelandersson S, Larsen HJ. Timber Engineering. New York, USA: Wiley; 2003'},{id:"B2",body:'Bodig J, Jayne BA. Mechanics of Wood and Wood Composites. Reprint edition. Malabar, FL: Krieger Pub Co; 1993'},{id:"B3",body:'Forest Products Laboratory (FPL). WoWood Handbook-Wood as an Engineering Material. General Technical Report FPL-GTR-190. Madison, WI: U.S. Department of Agriculture, Forest Service, Forest Products Laboratory; 2010'},{id:"B4",body:'Gong M. Lumber-Based Mass Timber Products in Construction. London, UK: IntechOpen; 2019. pp. 7-16. DOI: 10.5772/intechopen.85808'},{id:"B5",body:'Wooden Plywood Board. IndiamartCom 2021. https://www.indiamart.com/proddetail/wooden-plywood-board-14009756373.html [Accessed: June 16, 2021]'},{id:"B6",body:'ThinkWood CEU. Design and Construction of Taller Wood Buildings. 2021. https://www.thinkwood.com/wp-content/uploads/2019/09/ThinkWood-CEU-Design-and-Construction-of-Taller-Wood-Buildings.pdf [Accessed: June 3, 2021]'},{id:"B7",body:'Vogt F, Nauth M. Carpentry. Toronto, Canada: Nelson Education Limited; 2015'},{id:"B8",body:'Ansell MP. Wood Composites. Cambridge, United Kingdom: Elsevier Science & Technology; 2015'},{id:"B9",body:'Porteous J, Kermani A. Structural Timber Design to Eurocode 5. Hoboken, United Kingdom: John Wiley & Sons, Incorporated; 2013'},{id:"B10",body:'Canada NR. Plywood 2014. https://www.nrcan.gc.ca/our-natural-resources/forests-forestry/forest-industry-trade/forest-products-applications/taxonomy-wood-products/plywood/15855 [Accessed: March 24, 2021]'},{id:"B11",body:'Sellers T. Plywood and Adhesive Technology. Forest Products Utilization Laboratory, Mississippi State University, Mississippi, USA: CRC Press; 1985'},{id:"B12",body:'Filippovich A. Plywood history. From ancient Egypt to mid-twentieth century, part 1. Saint-Petersburg, Russia: Lesprominform. 2018;3:104-113'},{id:"B13",body:'Smulski S, editor. Engineered Wood Products: A Guide for Specifiers, Designers & Users. Madison, WI: Pfs Research Foundation; 1997'},{id:"B14",body:'Plywood - Sizes - Grades. The Canadian Wood Council - CWC 2021. https://cwc.ca/how-to-build-with-wood/wood-products/panel-products/plywood/. [Accessed: March 24, 2021]'},{id:"B15",body:'McIntyre RB. Design Features of the Mosquito. Aircraft Engineering and Aerospace Technology Emerald Insight, United Kingdom. 1944;16:64-67. DOI: 10.1108/eb031101'},{id:"B16",body:'Bowyer JL, Shmulsky R, Haygreen JG. Forest Products and Wood Science: An Introduction. 5th Ed. Oxford, UK: Wiley-Blackwell; 2007'},{id:"B17",body:'FAO. Yearbook of Forest Products 2000,2005,2010,2015,2019. Rome, Italy: FAO; 2021. DOI: 10.4060/cb3795m'},{id:"B18",body:'Canadian Wood Council. Wood Reference Handbook. Ottawa, Ontario, Canada: Canadian Wood Council; 1997'},{id:"B19",body:'Plywood. Wikipedia 2021. https://en.wikipedia.org/w/index.php?title=Plywood&oldid=1028259276 [Accessed: June 17, 2021]'},{id:"B20",body:'APA – The Engineered Wood Association. 2021. https://www.apawood.org/ [Accessed: April 14, 2021]'},{id:"B21",body:'certiWood™ Canply plywood. Plywood Design Fundamentals Canadian Plywood Association 2021. https://tolko.com/wp-content/uploads/2020/05/Plywood-Design-Fundamentals-Canadian-Plywood-Association.pdf [Accessed: May 18, 2021]'},{id:"B22",body:'CSA Group. CSA 086:19 Engineering Design in Wood. National Standard of Canada. Toronto, Canada: CSA Group; 2021'},{id:"B23",body:'CSA Group. CAN/CSA-O80 SERIES-15 (R2020) Wood Preservation. National Standard of Canada. Toronto, Canada: CSA Group; 2020'},{id:"B24",body:'ASTM International. D5516-18 Standard Test Method for Evaluating the Flexural Properties of Fire-Retardant Treated Softwood Plywood Exposed to Elevated Temperatures. West Conshohocken, PA: ASTM International; 2018. DOI: 10.1520/D5516-18'},{id:"B25",body:'Wood Design Manual 2017. Ottawa, Ontario, Canada: Canadian Wood Council Webstore; 2017'},{id:"B26",body:'APA. Design Capacities of APA Performance-Rated Structural-Use Panels Technical Note N375. Tacoma, Washington, USA: APA The Engineered Wood Association; 1995'},{id:"B27",body:'Wood Engineering Handbook. Second ed. Englewood Cliffs, NJ: Forest Products Laboratory; Prentice Hall; 1990 http://www.matweb.com/search/datasheet_print.aspx?matguid=bd6620450973496ea2578c283e9fb807 [Accessed: May 31, 2021]'},{id:"B28",body:'ASTM International. D3500-20 Standard Test Methods for Wood Structural Panels in Tension. West Conshohocken, PA: ASTM International; 2020. DOI: 10.1520/D3500-20'},{id:"B29",body:'ASTM International. D3043-17 Standard Test Methods for Structural Panels in Flexure. West Conshohocken, PA: ASTM International; 2017. DOI: 10.1520/D3043-17'},{id:"B30",body:'ASTM International. D3501-05a (2018) Standard Test Methods for Wood-Based Structural Panels in Compression. West Conshohocken, PA: ASTM International; 2018. DOI: 10.1520/D3501-05AR18'},{id:"B31",body:'ASTM International. D2718-18 Standard Test Method for Structural Panels in Planar Shear (Rolling Shear). West Conshohocken, PA: ASTM International; 2018. DOI: 10.1520/D2718-18'},{id:"B32",body:'ASTM International. D2719-19 Standard Test Methods for Structural Panels in Shear through-the-Thickness. West Conshohocken, PA: ASTM International; 2019. DOI: 10.1520/D2719-19'},{id:"B33",body:'BBC Research. MFG058A Plywood Manufacturing: Global Markets to 2022. Wellesley, Massachusetts, USA: BCC Publishing; 2018'},{id:"B34",body:'Georgia-Pacific Building Products. Plytanium Sturd-I-Floor Plywood Subfloor Panels. Atlanta, Georgia, USA: Georgia-Pacific Building Products; 2021. https://buildgp.com/product/plytanium-sturd-i-floor/ [Accessed: May 22, 2021]'},{id:"B35",body:'Georgia-Pacific Building Products. Plywood Roof Sheathing, OSB Roofing Boards. Atlanta, Georgia, USA: Georgia-Pacific Building Products; 2021. https://buildgp.com/wood/roof-sheathing/ [Accessed: May 22, 2021]'},{id:"B36",body:'American Wood Council. Visual Guide to Floor, Roof, and Wall Systems. Washington, DC, USA: American Wood Council; 2021'},{id:"B37",body:'Laminate Veneer Lumber. The Canadian Wood Council - CWC 2021. https://cwc.ca/how-to-build-with-wood/wood-products/structural-composite/laminate-veneer-lumber/ [Accessed: April 14, 2021]'},{id:"B38",body:'Hsu WE. Structural Composite Lumber Manufacturing. Scotts Valley, California, USA: CreateSpace Independent Publishing Platform; 2016'},{id:"B39",body:'Gong M. Wood Technology, Lecture on Wood Products. Fredericton, Canada: University of New Brunswick; 2021'},{id:"B40",body:'Natural Resources Canada. Laminated veneer lumber. Ottawa, ON, Canada: Natural Resources Canada; 2014. https://www.nrcan.gc.ca/our-natural-resources/forests-forestry/forest-industry-trade/forest-products-applications/taxonomy-wood-products/laminated-veneer-lumber/15795 [Accessed: April 14, 2021]'},{id:"B41",body:'Introduction to Wood Design 2018. Canadian Wood Council; 2018'},{id:"B42",body:'Structural Grading. WoodSolutions; 2021 https://www.woodsolutions.com.au/articles/structural-grading [Accessed: April 14, 2021]'},{id:"B43",body:'Stora Enso Wood Products GmbH. LVL by Stora Enso Technical brochure. Helsinki. Finland: Stora Enso; 2021. https://www.storaenso.com/-/media/documents/download-center/documents/product-brochures/wood-products/lvl-by-stora-enso-technical-brochure-en.pdf [Accessed: June 4, 2021]'},{id:"B44",body:'Laminated Veneer Lumber | Engineered Wood | StructureCraft. StructureCraft Builders. 2021. https://structurecraft.com/materials/engineered-wood/laminated-veneer-lumber [Accessed: May 21, 2021]'},{id:"B45",body:'Moretti PM, Divone LV. Modern windmills. Scientific American. 1986;254:110-119'},{id:"B46",body:'Decker KD. Reorienting the economy to the rhythms of nature: Learning to live with intermittent energy supply. American Journal of Economics and Sociology. 2020;79:877-905. DOI: 10.1111/ajes.12333'},{id:"B47",body:'Extreme Measures: At 107 Meters, The World’s Largest Wind Turbine Blade Is Longer Than A Football Field. Here’s What It Looks Like | GE News. 2019. https://www.ge.com/news/reports/extreme-measures-107-meters-worlds-largest-wind-turbine-blade-longer-football-field-heres-looks-like [Accessed: May 30, 2021]'},{id:"B48",body:'Weyerhaeuser Uses Strong Scraps. Wood Business. 2014. https://www.woodbusiness.ca/weyerhaeuser-strong-scraps-1859/ [Accessed: April 24, 2021]'},{id:"B49",body:'Parallel Strand Lumber. The Canadian Wood Council – CWC. 2021. https://cwc.ca/how-to-build-with-wood/wood-products/structural-composite/parallel-strand-lumber/ [Accessed: April 16, 2021]'},{id:"B50",body:'Waste not Cambodia: Image. 2021. https://wastenotcambodia.files.wordpress.com/2012/05/parallam1.jpg [Accessed: June 16, 2021]'},{id:"B51",body:'Canada NR. Oriented Strand Lumber. 2014. https://www.nrcan.gc.ca/our-natural-resources/forests-forestry/forest-industry-trade/forest-products-applications/taxonomy-wood-products/oriented-strand-lumber/15827 [Accessed: April 24, 2021]'},{id:"B52",body:'Gould-Design-Inc. Parallel-strand-lumber. Gould Design, Inc. 2013. https://goulddesigninc.com/2013/11/14/the-abcs-of-ewp-engineered-wood-products/parallel-strand-lumber/ [Accessed: June 16, 2021]'},{id:"B53",body:'How can I be sure that I have genuine Parallam® Plus PSL? Trus Joist Technical Support. 2021. https://www.techsupport.weyerhaeuser.com/hc/en-us/articles/205173710-How-can-I-be-sure-that-I-have-genuine-Parallam-Plus-PSL [Accessed: May 30, 2021]'},{id:"B54",body:'Parallam® PSL Deep Beam Specifier’s Guide. 2015'},{id:"B55",body:'Parallel Strand Lumber. Engineered Wood. StructureCraft. StructureCraft Builders. 2021. https://structurecraft.com/materials/engineered-wood/parallel-strand-lumber [Accessed: May 21, 2021]'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Elena Vladimirova",address:"evladimi@unb.ca",affiliation:'
'}],corrections:null},book:{id:"10584",type:"book",title:"Engineered Wood Products for Construction",subtitle:null,fullTitle:"Engineered Wood Products for Construction",slug:"engineered-wood-products-for-construction",publishedDate:"April 28th 2022",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83962-772-9",printIsbn:"978-1-83962-771-2",pdfIsbn:"978-1-83962-790-3",isAvailableForWebshopOrdering:!0,editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"189087",title:"Prof.",name:"Nelio",middleName:null,surname:"Teixeira Machado",email:"machado@ufpa.br",fullName:"Nelio Teixeira Machado",slug:"nelio-teixeira-machado",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"3",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:{name:"Federal University of Para",institutionURL:null,country:{name:"Brazil"}}},booksEdited:[],chaptersAuthored:[{id:"54676",title:"Fractional Distillation of Organic Liquid Compounds Produced by Catalytic Cracking of Fats, Oils, and Grease",slug:"fractional-distillation-of-organic-liquid-compounds-produced-by-catalytic-cracking-of-fats-oils-and-",abstract:"This work aims to investigate the fractional distillation of organic liquid products (OLP) obtained by catalytic cracking of palm oil (Elaeis guineensis Jacq.) at 450°C, 1.0 atm, with 5, 10, and 15% (wt) Na2CO3, using a stirred tank reactor of 143 L. The fractional distillations of OLP were carried out in laboratory scale with and without reflux using columns of different heights, and a pilot‐packed distillation column with internal reflux. OLP and distillation fractions (gasoline, kerosene, light diesel, and heavy diesel) were physicochemically characterized for density, kinematic viscosity, acid value, saponification value, refractive index, flash point, and copper strip corrosion. The OLP and light diesel fractions were analyzed by Fourier transform infrared spectroscopy (FT‐IR) and gas chromatography‐mass spectrometry (GC‐MS). For the experiments in laboratory scale, the yields of distillates decrease along with column height, with and without reflux, while those of bottoms products increase. The yields of distillates and gas increase with increasing Na2CO3 content, while those of bottoms products decrease. The densities of gasoline, kerosene, and light diesel produced in laboratory scale with reflux superpose exactly those of kerosene, light diesel, and heavy diesel produced in laboratory scale without reflux. The kinematic viscosity decreases with increasing column height for the experiments in laboratory scale. The acid values of distillation fractions decrease along with the column height for the experiments with and without reflux. The FT‐IR of distillation fractions in pilot and laboratory scales identified the presence of aliphatic hydrocarbons and oxygenates. The GC‐MS analysis identified OLP composition of 92.84% (area) hydrocarbons and 7.16% (area) oxygenates. The light diesel fraction contains 100% hydrocarbons with an acid value of 0.34 mg KOH/g, proving the technical feasibility of OLP de‐acidification by the fractional distillation process.",signatures:"C. C. Fereira, E. C. Costa, D. A. R. de Castro, M. S. Pereira, A. A.\nMâncio, M. C. Santos, D. E. L. Lhamas, S. A. P. da Mota, M. E. Araújo,\nLuiz E. P. Borges and N. T. Machado",authors:[{id:"189087",title:"Prof.",name:"Nelio",surname:"Teixeira Machado",fullName:"Nelio Teixeira Machado",slug:"nelio-teixeira-machado",email:"machado@ufpa.br"}],book:{id:"5452",title:"Distillation",slug:"distillation-innovative-applications-and-modeling",productType:{id:"1",title:"Edited Volume"}}},{id:"58923",title:"Carbon Dioxide Use in High-Pressure Extraction Processes",slug:"carbon-dioxide-use-in-high-pressure-extraction-processes",abstract:"This chapter describes the use of carbon dioxide at high pressures as an alternative for the extraction of bioactive compounds in a more sustainable way, addressing some of its physicochemical properties, such as pressure, temperature, density, solvation, selectivity, and its interaction with the solute when modified by other solvents such as ethanol and water. This extraction process is considered chemically “green,” when compared to conventional extraction processes using toxic organic solvents.",signatures:"Vânia Maria Borges Cunha, Marcilene Paiva da Silva, Wanessa\nAlmeida da Costa, Mozaniel Santana de Oliveira, Fernanda Wariss\nFigueiredo Bezerra, Anselmo Castro de Melo, Rafael Henrique\nHolanda Pinto, Nelio Teixeira Machado, Marilena Emmi Araujo and\nRaul Nunes de Carvalho Junior",authors:[{id:"189087",title:"Prof.",name:"Nelio",surname:"Teixeira Machado",fullName:"Nelio Teixeira Machado",slug:"nelio-teixeira-machado",email:"machado@ufpa.br"},{id:"192844",title:"Dr.",name:"Raul",surname:"Nunes de Carvalho Jr",fullName:"Raul Nunes de Carvalho Jr",slug:"raul-nunes-de-carvalho-jr",email:"raulncj@ufpa.br"},{id:"195289",title:"MSc.",name:"Wanessa",surname:"Almeida Da Costa",fullName:"Wanessa Almeida Da Costa",slug:"wanessa-almeida-da-costa",email:"wanessa.almeida712@yahoo.com.br"},{id:"195290",title:"Ph.D.",name:"Mozaniel",surname:"Santana De Oliveira",fullName:"Mozaniel Santana De Oliveira",slug:"mozaniel-santana-de-oliveira",email:"mozaniel.oliveira@yahoo.com.br"},{id:"195291",title:"MSc.",name:"Marcilene",surname:"Paiva Da Silva",fullName:"Marcilene Paiva Da Silva",slug:"marcilene-paiva-da-silva",email:"arci_paiva@hotmail.com"},{id:"195292",title:"MSc.",name:"Vânia Maria",surname:"Borges Cunha",fullName:"Vânia Maria Borges Cunha",slug:"vania-maria-borges-cunha",email:"vaniacunha21@hotmail.com"},{id:"195294",title:"Mr.",name:"Rafael Henrique",surname:"Holanda Pinto",fullName:"Rafael Henrique Holanda Pinto",slug:"rafael-henrique-holanda-pinto",email:"rafael_holanda90@hotmail.com"},{id:"195295",title:"Dr.",name:"Fernanda",surname:"Wariss Figueiredo Bezerra",fullName:"Fernanda Wariss Figueiredo Bezerra",slug:"fernanda-wariss-figueiredo-bezerra",email:"fernandawarissf@gmail.com"},{id:"222143",title:"Mr.",name:"Anselmo",surname:"Castro De Melo",fullName:"Anselmo Castro De Melo",slug:"anselmo-castro-de-melo",email:"anselmelo@yahoo.com.br"},{id:"222144",title:"Prof.",name:"Marilena",surname:"Emmi Araújo",fullName:"Marilena Emmi Araújo",slug:"marilena-emmi-araujo",email:"meaaraujo@gmail.com"}],book:{id:"6186",title:"Carbon Dioxide Chemistry, Capture and Oil Recovery",slug:"carbon-dioxide-chemistry-capture-and-oil-recovery",productType:{id:"1",title:"Edited Volume"}}},{id:"62931",title:"Fractional Distillation of Bio-Oil Produced by Pyrolysis of Açaí (Euterpe oleracea) Seeds",slug:"fractional-distillation-of-bio-oil-produced-by-pyrolysis-of-a-a-euterpe-oleracea-seeds",abstract:"In this work, the seeds of açaí (Euterpe oleracea, Mart), a rich lignin-cellulose residue, has been submitted to pyrolysis to produce a bio-oil-like fossil fuels. The pyrolysis carried out in a reactor of 143 L, 450°C, and 1.0 atm. The morphology of Açaí seeds in nature and after pyrolysis is characterized by SEM, EDX, and XRD. The experiments show that bio-oil, gas, and coke yields were 4.38, 30.56, and 35.67% (wt.), respectively. The bio-oil characterized by AOCS, ASTM, and ABNT/NBR methods for density, kinematic viscosity, and acid value. The bio-oil density, viscosity, and acid value were 1.0468 g/cm3, 68.34 mm2/s, and 70.26 KOH/g, respectively. The chemical composition and chemical functions of bio-oil are determined by GC-MS and FT-IR. The GC-MS identified in bio-oil 21.52% (wt.) hydrocarbons and 78.48% (wt.) oxygenates (4.06% esters, 8.52% carboxylic acids, 3.53% ketones, 35.16% phenols, 20.52% cresols, 5.75% furans, and 0.91% (wt.) aldehydes), making it possible to apply fractional distillation to obtain fossil fuel-like fractions rich in hydrocarbons. The distillation of bio-oil is carried out in a laboratory-scale column, according to the boiling temperature of fossil fuels. The distillation of bio-oil yielded fossil fuel-like fractions (gasoline, kerosene, and light diesel) of 4.70, 28.21, and 22.35% (wt.), respectively.",signatures:"Douglas Alberto Rocha de Castro, Haroldo Jorge da Silva Ribeiro,\nCaio Campos Ferreira, Márcio de Andrade Cordeiro, Lauro Henrique\nHamoy Guerreiro, Anderson M. Pereira, W. G. dos Santos, Marcelo\nCosta Santos, Fernanda B. de Carvalho, Jose Otavio Carrera Silva\nJunior, R. Lopes e Oliveira, Sergio Duvoisin, Luiz Eduardo Pizarro\nBorges and Nélio Teixeira Machado",authors:[{id:"189087",title:"Prof.",name:"Nelio",surname:"Teixeira Machado",fullName:"Nelio Teixeira Machado",slug:"nelio-teixeira-machado",email:"machado@ufpa.br"},{id:"38525",title:"Dr.",name:"Jose Otavio Carrera",surname:"Silva Junior",fullName:"Jose Otavio Carrera Silva Junior",slug:"jose-otavio-carrera-silva-junior",email:"carrera@ufpa.br"},{id:"144662",title:"Prof.",name:"Luiz Eduardo",surname:"Pizarro Borges",fullName:"Luiz Eduardo Pizarro Borges",slug:"luiz-eduardo-pizarro-borges",email:"luiz@ime.eb.br"},{id:"249172",title:"MSc.",name:"Douglas Alberto",surname:"Rocha De Castro",fullName:"Douglas Alberto Rocha De Castro",slug:"douglas-alberto-rocha-de-castro",email:"douglascastro87@hotmail.com"},{id:"249173",title:"MSc.",name:"Haroldo Jorge",surname:"Da Silva Ribeiro",fullName:"Haroldo Jorge Da Silva Ribeiro",slug:"haroldo-jorge-da-silva-ribeiro",email:"mineiroeq@yahoo.com.br"},{id:"249175",title:"MSc.",name:"Caio",surname:"Campos Ferreira",fullName:"Caio Campos Ferreira",slug:"caio-campos-ferreira",email:"caiocf7@hotmail.com"},{id:"249177",title:"Mr.",name:"Lauro Henrique",surname:"Hamoy Guerreiro",fullName:"Lauro Henrique Hamoy Guerreiro",slug:"lauro-henrique-hamoy-guerreiro",email:"guerreirolauro@hotmail.com"},{id:"249178",title:"Prof.",name:"Marcelo",surname:"Costa Santos",fullName:"Marcelo Costa Santos",slug:"marcelo-costa-santos",email:"marceloenqui@bol.com.br"},{id:"259444",title:"Prof.",name:"Sergio",surname:"Duvoisin",fullName:"Sergio Duvoisin",slug:"sergio-duvoisin",email:"duvoisin66@hotmail.com"},{id:"259445",title:"MSc.",name:"Anderson",surname:"Pereira",fullName:"Anderson Pereira",slug:"anderson-pereira",email:"ampereira.eng@gmail.com"},{id:"259446",title:"MSc.",name:"Wenderson",surname:"Santos",fullName:"Wenderson Santos",slug:"wenderson-santos",email:"wendersoneq@hotmail.com"},{id:"259448",title:"MSc.",name:"Márcio",surname:"Cordeiro",fullName:"Márcio Cordeiro",slug:"marcio-cordeiro",email:"mandradebio@yahoo.com.br"}],book:{id:"6720",title:"Fractionation",slug:"fractionation",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"12387",title:"Dr.",name:"Jose Antonio",surname:"Gutierrez Gnecchi",slug:"jose-antonio-gutierrez-gnecchi",fullName:"Jose Antonio Gutierrez Gnecchi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"109423",title:"Dr.",name:"José",surname:"Zavala Loría",slug:"jose-zavala-loria",fullName:"José Zavala Loría",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Autonomous University of Carmen",institutionURL:null,country:{name:"Mexico"}}},{id:"152064",title:"Prof.",name:"Edson Antonio",surname:"da Silva",slug:"edson-antonio-da-silva",fullName:"Edson Antonio da Silva",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"188933",title:"Dr.",name:"Asteria",surname:"Narvaéz García",slug:"asteria-narvaez-garcia",fullName:"Asteria Narvaéz García",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"189035",title:"Dr.",name:"Vilmar",surname:"Steffen",slug:"vilmar-steffen",fullName:"Vilmar Steffen",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/189035/images/system/189035.jpg",biography:"I have received BSc in Chemical Engineering from The Western Paraná State University – Unioeste (2007), MSc in Chemical Engineering (title of the dissertation: Modelling and Simulation of Reactive Distillation Columns) from The Western Paraná State University – Unioeste (2010) and PhD in Chemical Engineering (thesis title: Determination of Ions Sorption Isotherms Using Poisson-Boltzmann Equation) from State University of Maringá (2014). I have successfully completed one year of post-doctoral research fellowship in The Western Paraná State University – Unioeste (2015). Since February 2015, I am Assistant Professor at Academic Department of Chemical Engineering (DAENQ) of Federal University of Technology - Paraná (UTFPR) Campus Francisco Beltrão – Paraná – Brazil.\r\nMy research work focuses on process modelling and simulation.",institutionString:"Universidade Tecnológica Federal do Paraná",institution:{name:"Federal University of Technology – Paraná",institutionURL:null,country:{name:"Brazil"}}},{id:"189166",title:"Dr.",name:"Adriana",surname:"Téllez-Anguiano",slug:"adriana-tellez-anguiano",fullName:"Adriana Téllez-Anguiano",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"194844",title:"MSc.",name:"Mario",surname:"Heras-Cervantes",slug:"mario-heras-cervantes",fullName:"Mario Heras-Cervantes",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"194845",title:"Dr.",name:"Juan",surname:"Anzurez-Marín",slug:"juan-anzurez-marin",fullName:"Juan Anzurez-Marín",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"194846",title:"Dr.",name:"Gerardo",surname:"Chávez-Campos",slug:"gerardo-chavez-campos",fullName:"Gerardo Chávez-Campos",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/194846/images/14754_n.jpg",biography:"Born in Mexico, developing as a researcher and professor at Instituto Tecnologico de Morelia.",institutionString:null,institution:null},{id:"194857",title:"Dr.",name:"Alejandro",surname:"Ruiz",slug:"alejandro-ruiz",fullName:"Alejandro Ruiz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]},generic:{page:{slug:"open-access-funding",title:"Open Access Funding",intro:"
IntechOpen’s Academic Editors and Authors have received funding for their work through many well-known funders, including: the European Commission, Bill and Melinda Gates Foundation, Wellcome Trust, Chinese Academy of Sciences, Natural Science Foundation of China (NSFC), CGIAR Consortium of International Agricultural Research Centers, National Institute of Health (NIH), National Science Foundation (NSF), National Aeronautics and Space Administration (NASA), National Institute of Standards and Technology (NIST), German Research Foundation (DFG), Research Councils United Kingdom (RCUK), Oswaldo Cruz Foundation, Austrian Science Fund (FWF), Foundation for Science and Technology (FCT), Australian Research Council (ARC).
Open Access publication costs can often be designated directly in the grants or in specific budgets allocated for that purpose. Many of the most important funding organisations encourage, and even request, that the projects they fund are made available at no cost to the wider public. IntechOpen strives to maintain excellent relationships with these funders and ensures compliance with mandates.
\\n\\n
In order to help Authors identify appropriate funding agencies and institutions, we have created a list, based on extensive research on various OA resources (including ROARMAP and SHERPA/JULIET) of organizations that have funds available. Before consulting our list we encourage you to petition your own institution or organization for Open Access funds or check the specifications of your grant with your funder to ascertain if publication costs are included. Where you are in receipt of a grant you should clarify:
\\n\\n
\\n\\t
Does your institution already have a budget for covering Open Access publication costs?
\\n\\t
Does your grant list Open Access publication fees as legitimate direct/indirect costs?
\\n
\\n\\n
If you are associated with any of the institutions in our list below, you can apply to receive OA publication funds by following the instructions provided in the links. Please consult the Open Access policies or grant Terms and Conditions of any institution with which you are linked to explore ways to cover your publication costs (also accessible by clicking on the link in their title).
\\n\\n
Please note that this list is not a definitive one and is updated regularly. To suggest possible modifications or the inclusion of your institution/funder, please contact us at funders@intechopen.com
\\n\\n
Please be aware that you must be a member, or grantee, of the institutions/funders listed in order to apply for their Open Access publication funds.
Open Access publication costs can often be designated directly in the grants or in specific budgets allocated for that purpose. Many of the most important funding organisations encourage, and even request, that the projects they fund are made available at no cost to the wider public. IntechOpen strives to maintain excellent relationships with these funders and ensures compliance with mandates.
\n\n
In order to help Authors identify appropriate funding agencies and institutions, we have created a list, based on extensive research on various OA resources (including ROARMAP and SHERPA/JULIET) of organizations that have funds available. Before consulting our list we encourage you to petition your own institution or organization for Open Access funds or check the specifications of your grant with your funder to ascertain if publication costs are included. Where you are in receipt of a grant you should clarify:
\n\n
\n\t
Does your institution already have a budget for covering Open Access publication costs?
\n\t
Does your grant list Open Access publication fees as legitimate direct/indirect costs?
\n
\n\n
If you are associated with any of the institutions in our list below, you can apply to receive OA publication funds by following the instructions provided in the links. Please consult the Open Access policies or grant Terms and Conditions of any institution with which you are linked to explore ways to cover your publication costs (also accessible by clicking on the link in their title).
\n\n
Please note that this list is not a definitive one and is updated regularly. To suggest possible modifications or the inclusion of your institution/funder, please contact us at funders@intechopen.com
\n\n
Please be aware that you must be a member, or grantee, of the institutions/funders listed in order to apply for their Open Access publication funds.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"396",title:"Dr.",name:"Vedran",middleName:null,surname:"Kordic",slug:"vedran-kordic",fullName:"Vedran Kordic",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/396/images/7281_n.png",biography:"After obtaining his Master's degree in Mechanical Engineering he continued his education at the Vienna University of Technology where he obtained his PhD degree in 2004. He worked as a researcher at the Automation and Control Institute, Faculty of Electrical Engineering, Vienna University of Technology until 2008. His studies in robotics lead him not only to a PhD degree but also inspired him to co-found and build the International Journal of Advanced Robotic Systems - world's first Open Access journal in the field of robotics.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"441",title:"Ph.D.",name:"Jaekyu",middleName:null,surname:"Park",slug:"jaekyu-park",fullName:"Jaekyu Park",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/441/images/1881_n.jpg",biography:null,institutionString:null,institution:{name:"LG Corporation (South Korea)",country:{name:"Korea, South"}}},{id:"465",title:"Dr",name:"Christian",middleName:null,surname:"Martens",slug:"christian-martens",fullName:"Christian Martens",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"479",title:"Dr.",name:"Valentina",middleName:null,surname:"Colla",slug:"valentina-colla",fullName:"Valentina Colla",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/479/images/358_n.jpg",biography:null,institutionString:null,institution:{name:"Sant'Anna School of Advanced Studies",country:{name:"Italy"}}},{id:"494",title:"PhD",name:"Loris",middleName:null,surname:"Nanni",slug:"loris-nanni",fullName:"Loris Nanni",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/494/images/system/494.jpg",biography:"Loris Nanni received his Master Degree cum laude on June-2002 from the University of Bologna, and the April 26th 2006 he received his Ph.D. in Computer Engineering at DEIS, University of Bologna. On September, 29th 2006 he has won a post PhD fellowship from the university of Bologna (from October 2006 to October 2008), at the competitive examination he was ranked first in the industrial engineering area. He extensively served as referee for several international journals. He is author/coauthor of more than 100 research papers. He has been involved in some projects supported by MURST and European Community. His research interests include pattern recognition, bioinformatics, and biometric systems (fingerprint classification and recognition, signature verification, face recognition).",institutionString:null,institution:null},{id:"496",title:"Dr.",name:"Carlos",middleName:null,surname:"Leon",slug:"carlos-leon",fullName:"Carlos Leon",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Seville",country:{name:"Spain"}}},{id:"512",title:"Dr.",name:"Dayang",middleName:null,surname:"Jawawi",slug:"dayang-jawawi",fullName:"Dayang Jawawi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Technology Malaysia",country:{name:"Malaysia"}}},{id:"528",title:"Dr.",name:"Kresimir",middleName:null,surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/528/images/system/528.jpg",biography:"K. Delac received his B.Sc.E.E. degree in 2003 and is currentlypursuing a Ph.D. degree at the University of Zagreb, Faculty of Electrical Engineering andComputing. His current research interests are digital image analysis, pattern recognition andbiometrics.",institutionString:null,institution:{name:"University of Zagreb",country:{name:"Croatia"}}},{id:"557",title:"Dr.",name:"Andon",middleName:"Venelinov",surname:"Topalov",slug:"andon-topalov",fullName:"Andon Topalov",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/557/images/1927_n.jpg",biography:"Dr. Andon V. Topalov received the MSc degree in Control Engineering from the Faculty of Information Systems, Technologies, and Automation at Moscow State University of Civil Engineering (MGGU) in 1979. He then received his PhD degree in Control Engineering from the Department of Automation and Remote Control at Moscow State Mining University (MGSU), Moscow, in 1984. From 1985 to 1986, he was a Research Fellow in the Research Institute for Electronic Equipment, ZZU AD, Plovdiv, Bulgaria. In 1986, he joined the Department of Control Systems, Technical University of Sofia at the Plovdiv campus, where he is presently a Full Professor. He has held long-term visiting Professor/Scholar positions at various institutions in South Korea, Turkey, Mexico, Greece, Belgium, UK, and Germany. And he has coauthored one book and authored or coauthored more than 80 research papers in conference proceedings and journals. His current research interests are in the fields of intelligent control and robotics.",institutionString:null,institution:{name:"Technical University of Sofia",country:{name:"Bulgaria"}}},{id:"585",title:"Prof.",name:"Munir",middleName:null,surname:"Merdan",slug:"munir-merdan",fullName:"Munir Merdan",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/585/images/system/585.jpg",biography:"Munir Merdan received the M.Sc. degree in mechanical engineering from the Technical University of Sarajevo, Bosnia and Herzegovina, in 2001, and the Ph.D. degree in electrical engineering from the Vienna University of Technology, Vienna, Austria, in 2009.Since 2005, he has been at the Automation and Control Institute, Vienna University of Technology, where he is currently a Senior Researcher. His research interests include the application of agent technology for achieving agile control in the manufacturing environment.",institutionString:null,institution:null},{id:"605",title:"Prof",name:"Dil",middleName:null,surname:"Hussain",slug:"dil-hussain",fullName:"Dil Hussain",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/605/images/system/605.jpg",biography:"Dr. Dil Muhammad Akbar Hussain is a professor of Electronics Engineering & Computer Science at the Department of Energy Technology, Aalborg University Denmark. Professor Akbar has a Master degree in Digital Electronics from Govt. College University, Lahore Pakistan and a P-hD degree in Control Engineering from the School of Engineering and Applied Sciences, University of Sussex United Kingdom. Aalborg University has Two Satellite Campuses, one in Copenhagen (Aalborg University Copenhagen) and the other in Esbjerg (Aalborg University Esbjerg).\n· He is a member of prestigious IEEE (Institute of Electrical and Electronics Engineers), and IAENG (International Association of Engineers) organizations. \n· He is the chief Editor of the Journal of Software Engineering.\n· He is the member of the Editorial Board of International Journal of Computer Science and Software Technology (IJCSST) and International Journal of Computer Engineering and Information Technology. \n· He is also the Editor of Communication in Computer and Information Science CCIS-20 by Springer.\n· Reviewer For Many Conferences\nHe is the lead person in making collaboration agreements between Aalborg University and many universities of Pakistan, for which the MOU’s (Memorandum of Understanding) have been signed.\nProfessor Akbar is working in Academia since 1990, he started his career as a Lab demonstrator/TA at the University of Sussex. After finishing his P. hD degree in 1992, he served in the Industry as a Scientific Officer and continued his academic career as a visiting scholar for a number of educational institutions. In 1996 he joined National University of Science & Technology Pakistan (NUST) as an Associate Professor; NUST is one of the top few universities in Pakistan. In 1999 he joined an International Company Lineo Inc, Canada as Manager Compiler Group, where he headed the group for developing Compiler Tool Chain and Porting of Operating Systems for the BLACKfin processor. The processor development was a joint venture by Intel and Analog Devices. In 2002 Lineo Inc., was taken over by another company, so he joined Aalborg University Denmark as an Assistant Professor.\nProfessor Akbar has truly a multi-disciplined career and he continued his legacy and making progress in many areas of his interests both in teaching and research. He has contributed in stochastic estimation of control area especially, in the Multiple Target Tracking and Interactive Multiple Model (IMM) research, Ball & Beam Control Problem, Robotics, Levitation Control. He has contributed in developing Algorithms for Fingerprint Matching, Computer Vision and Face Recognition. He has been supervising Pattern Recognition, Formal Languages and Distributed Processing projects for several years. He has reviewed many books on Management, Computer Science. Currently, he is an active and permanent reviewer for many international conferences and symposia and the program committee member for many international conferences.\nIn teaching he has taught the core computer science subjects like, Digital Design, Real Time Embedded System Programming, Operating Systems, Software Engineering, Data Structures, Databases, Compiler Construction. In the Engineering side, Digital Signal Processing, Computer Architecture, Electronics Devices, Digital Filtering and Engineering Management.\nApart from his Academic Interest and activities he loves sport especially, Cricket, Football, Snooker and Squash. He plays cricket for Esbjerg city in the second division team as an opener wicket keeper batsman. He is a very good player of squash but has not played squash since his arrival in Denmark.",institutionString:null,institution:null},{id:"611",title:"Prof.",name:"T",middleName:null,surname:"Nagarajan",slug:"t-nagarajan",fullName:"T Nagarajan",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Teknologi Petronas",country:{name:"Malaysia"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6581},{group:"region",caption:"Middle and South America",value:2,count:5888},{group:"region",caption:"Africa",value:3,count:2381},{group:"region",caption:"Asia",value:4,count:12507},{group:"region",caption:"Australia and Oceania",value:5,count:1006},{group:"region",caption:"Europe",value:6,count:17528}],offset:12,limit:12,total:132501},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{sort:"dateEndThirdStepPublish/editedvolumes"},books:[],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:41},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:10},{group:"topic",caption:"Business, Management and Economics",value:7,count:6},{group:"topic",caption:"Chemistry",value:8,count:21},{group:"topic",caption:"Computer and Information Science",value:9,count:20},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:15},{group:"topic",caption:"Engineering",value:11,count:59},{group:"topic",caption:"Environmental Sciences",value:12,count:8},{group:"topic",caption:"Immunology and Microbiology",value:13,count:9},{group:"topic",caption:"Materials Science",value:14,count:27},{group:"topic",caption:"Mathematics",value:15,count:9},{group:"topic",caption:"Medicine",value:16,count:122},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:9},{group:"topic",caption:"Neuroscience",value:18,count:3},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:6},{group:"topic",caption:"Physics",value:20,count:11},{group:"topic",caption:"Psychology",value:21,count:10},{group:"topic",caption:"Robotics",value:22,count:4},{group:"topic",caption:"Social Sciences",value:23,count:9},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:4}],offset:0,limit:12,total:null},popularBooks:{featuredBooks:[{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10222",title:"Demyelination Disorders",subtitle:null,isOpenForSubmission:!1,hash:"b6c26ceccacdde70c41c587361bd5558",slug:"demyelination-disorders",bookSignature:"Stavros J. Baloyannis, Fabian H. Rossi and Welwin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/10222.jpg",editors:[{id:"156098",title:"Emeritus Prof.",name:"Stavros J.",middleName:"J.",surname:"Baloyannis",slug:"stavros-j.-baloyannis",fullName:"Stavros J. Baloyannis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9544",title:"Global Trade in the Emerging Business Environment",subtitle:null,isOpenForSubmission:!1,hash:"fb8cb09b9599246add78d508a98273d5",slug:"global-trade-in-the-emerging-business-environment",bookSignature:"Muhammad Mohiuddin, Jingbin Wang , Md. Samim Al Azad and Selim Ahmed",coverURL:"https://cdn.intechopen.com/books/images_new/9544.jpg",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10979",title:"Parenting",subtitle:"Challenges of Child Rearing in a Changing Society",isOpenForSubmission:!1,hash:"6f345ebcf4fd61e73643c69063a12c7b",slug:"parenting-challenges-of-child-rearing-in-a-changing-society",bookSignature:"Sayyed Ali Samadi",coverURL:"https://cdn.intechopen.com/books/images_new/10979.jpg",editors:[{id:"52145",title:"Dr.",name:"Sayyed Ali",middleName:null,surname:"Samadi",slug:"sayyed-ali-samadi",fullName:"Sayyed Ali Samadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9808",title:"Contemporary Topics in Patient Safety",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"fb6371607c2c6c02c6a2af8892765aba",slug:"contemporary-topics-in-patient-safety-volume-1",bookSignature:"Stanislaw P. Stawicki and Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/9808.jpg",editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10764",title:"Antenna Systems",subtitle:null,isOpenForSubmission:!1,hash:"2fbf1c7a5d92723f08198fc9b526a8ad",slug:"antenna-systems",bookSignature:"Hussain Al-Rizzo and Said Abushamleh",coverURL:"https://cdn.intechopen.com/books/images_new/10764.jpg",editors:[{id:"153384",title:"Prof.",name:"Hussain",middleName:null,surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10668",title:"Sustainability of Concrete With Synthetic and Recycled Aggregates",subtitle:null,isOpenForSubmission:!1,hash:"55856c6a8bc3a5b21dae5a1af09a56b6",slug:"sustainability-of-concrete-with-synthetic-and-recycled-aggregates",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/10668.jpg",editors:[{id:"144691",title:"Prof.",name:"Hosam",middleName:null,surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,isOpenForSubmission:!1,hash:"176adcf090fdd1f93cb8ce3146e79ca1",slug:"reactive-oxygen-species",bookSignature:"Rizwan Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10351",title:"Enhanced Liposuction",subtitle:"New Perspectives and Techniques",isOpenForSubmission:!1,hash:"f08ed6de16da357614586c5b58ed4dfa",slug:"enhanced-liposuction-new-perspectives-and-techniques",bookSignature:"Diane Irvine Duncan",coverURL:"https://cdn.intechopen.com/books/images_new/10351.jpg",editors:[{id:"279869",title:"Dr.",name:"Diane Irvine",middleName:null,surname:"Duncan",slug:"diane-irvine-duncan",fullName:"Diane Irvine Duncan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10779",title:"21st Century Nanostructured Materials",subtitle:"Physics, Chemistry, Classification, and Emerging Applications in Industry, Biomedicine, and Agriculture",isOpenForSubmission:!1,hash:"72c67f97f9bef68200df115b5fd79884",slug:"21st-century-nanostructured-materials-physics-chemistry-classification-and-emerging-applications-in-industry-biomedicine-and-agriculture",bookSignature:"Phuong V. Pham",coverURL:"https://cdn.intechopen.com/books/images_new/10779.jpg",editors:[{id:"236073",title:"Dr.",name:"Phuong",middleName:"Viet",surname:"Pham",slug:"phuong-pham",fullName:"Phuong Pham"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:4386},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"10584",title:"Engineered Wood Products for Construction",subtitle:null,isOpenForSubmission:!1,hash:"421757c56a3735986055250821275a51",slug:"engineered-wood-products-for-construction",bookSignature:"Meng Gong",coverURL:"https://cdn.intechopen.com/books/images_new/10584.jpg",publishedDate:"April 28th 2022",numberOfDownloads:3665,editors:[{id:"274242",title:"Dr.",name:"Meng",middleName:null,surname:"Gong",slug:"meng-gong",fullName:"Meng Gong"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10222",title:"Demyelination Disorders",subtitle:null,isOpenForSubmission:!1,hash:"b6c26ceccacdde70c41c587361bd5558",slug:"demyelination-disorders",bookSignature:"Stavros J. Baloyannis, Fabian H. Rossi and Welwin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/10222.jpg",publishedDate:"May 4th 2022",numberOfDownloads:1713,editors:[{id:"156098",title:"Emeritus Prof.",name:"Stavros J.",middleName:"J.",surname:"Baloyannis",slug:"stavros-j.-baloyannis",fullName:"Stavros J. Baloyannis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9544",title:"Global Trade in the Emerging Business Environment",subtitle:null,isOpenForSubmission:!1,hash:"fb8cb09b9599246add78d508a98273d5",slug:"global-trade-in-the-emerging-business-environment",bookSignature:"Muhammad Mohiuddin, Jingbin Wang , Md. Samim Al Azad and Selim Ahmed",coverURL:"https://cdn.intechopen.com/books/images_new/9544.jpg",publishedDate:"April 28th 2022",numberOfDownloads:2481,editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10979",title:"Parenting",subtitle:"Challenges of Child Rearing in a Changing Society",isOpenForSubmission:!1,hash:"6f345ebcf4fd61e73643c69063a12c7b",slug:"parenting-challenges-of-child-rearing-in-a-changing-society",bookSignature:"Sayyed Ali Samadi",coverURL:"https://cdn.intechopen.com/books/images_new/10979.jpg",publishedDate:"May 4th 2022",numberOfDownloads:1107,editors:[{id:"52145",title:"Dr.",name:"Sayyed Ali",middleName:null,surname:"Samadi",slug:"sayyed-ali-samadi",fullName:"Sayyed Ali Samadi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9808",title:"Contemporary Topics in Patient Safety",subtitle:"Volume 1",isOpenForSubmission:!1,hash:"fb6371607c2c6c02c6a2af8892765aba",slug:"contemporary-topics-in-patient-safety-volume-1",bookSignature:"Stanislaw P. Stawicki and Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/9808.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3307,editors:[{id:"181694",title:"Dr.",name:"Stanislaw P.",middleName:null,surname:"Stawicki",slug:"stanislaw-p.-stawicki",fullName:"Stanislaw P. Stawicki"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10681",title:"Biodegradation Technology of Organic and Inorganic Pollutants",subtitle:null,isOpenForSubmission:!1,hash:"9a6e10e02788092872fd249436898e97",slug:"biodegradation-technology-of-organic-and-inorganic-pollutants",bookSignature:"Kassio Ferreira Mendes, Rodrigo Nogueira de Sousa and Kamila Cabral Mielke",coverURL:"https://cdn.intechopen.com/books/images_new/10681.jpg",publishedDate:"April 20th 2022",numberOfDownloads:3266,editors:[{id:"197720",title:"Ph.D.",name:"Kassio",middleName:null,surname:"Ferreira Mendes",slug:"kassio-ferreira-mendes",fullName:"Kassio Ferreira Mendes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10764",title:"Antenna Systems",subtitle:null,isOpenForSubmission:!1,hash:"2fbf1c7a5d92723f08198fc9b526a8ad",slug:"antenna-systems",bookSignature:"Hussain Al-Rizzo and Said Abushamleh",coverURL:"https://cdn.intechopen.com/books/images_new/10764.jpg",publishedDate:"April 28th 2022",numberOfDownloads:1868,editors:[{id:"153384",title:"Prof.",name:"Hussain",middleName:null,surname:"Al-Rizzo",slug:"hussain-al-rizzo",fullName:"Hussain Al-Rizzo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10668",title:"Sustainability of Concrete With Synthetic and Recycled Aggregates",subtitle:null,isOpenForSubmission:!1,hash:"55856c6a8bc3a5b21dae5a1af09a56b6",slug:"sustainability-of-concrete-with-synthetic-and-recycled-aggregates",bookSignature:"Hosam M. Saleh",coverURL:"https://cdn.intechopen.com/books/images_new/10668.jpg",publishedDate:"May 4th 2022",numberOfDownloads:856,editors:[{id:"144691",title:"Prof.",name:"Hosam",middleName:null,surname:"Saleh",slug:"hosam-saleh",fullName:"Hosam Saleh"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"10803",title:"Reactive Oxygen Species",subtitle:null,isOpenForSubmission:!1,hash:"176adcf090fdd1f93cb8ce3146e79ca1",slug:"reactive-oxygen-species",bookSignature:"Rizwan Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10803.jpg",publishedDate:"April 28th 2022",numberOfDownloads:1704,editors:[{id:"40482",title:null,name:"Rizwan",middleName:null,surname:"Ahmad",slug:"rizwan-ahmad",fullName:"Rizwan Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9032",title:"Corporate Social Responsibility",subtitle:null,isOpenForSubmission:!1,hash:"f609bf3251d7cc7bae0099a4374adfc3",slug:"corporate-social-responsibility",bookSignature:"Beatrice Orlando",coverURL:"https://cdn.intechopen.com/books/images_new/9032.jpg",publishedDate:"March 16th 2022",numberOfDownloads:7489,editors:[{id:"232969",title:"Prof.",name:"Beatrice",middleName:null,surname:"Orlando",slug:"beatrice-orlando",fullName:"Beatrice Orlando"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"8737",title:"Rabies Virus at the Beginning of 21st Century",subtitle:null,isOpenForSubmission:!1,hash:"49cce3f548da548c718c865feb343509",slug:"rabies-virus-at-the-beginning-of-21st-century",bookSignature:"Sergey Tkachev",coverURL:"https://cdn.intechopen.com/books/images_new/8737.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"61139",title:"Dr.",name:"Sergey",middleName:null,surname:"Tkachev",slug:"sergey-tkachev",fullName:"Sergey Tkachev"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10861",title:"Furan Derivatives",subtitle:"Recent Advances and Applications",isOpenForSubmission:!1,hash:"fdfc39cecd82f91b0effac994f75c877",slug:"furan-derivatives-recent-advances-and-applications",bookSignature:"Anish Khan, Mohammed Muzibur Rahman, M. Ramesh, Salman Ahmad Khan and Abdullah Mohammed Ahmed Asiri",coverURL:"https://cdn.intechopen.com/books/images_new/10861.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"293058",title:"Dr.",name:"Anish",middleName:null,surname:"Khan",slug:"anish-khan",fullName:"Anish Khan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10356",title:"Natural Medicinal Plants",subtitle:null,isOpenForSubmission:!1,hash:"943e56ccaaf19ff696d25aa638ae37d6",slug:"natural-medicinal-plants",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/10356.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10870",title:"Ultrasound Imaging",subtitle:"Current Topics",isOpenForSubmission:!1,hash:"2f0bc3733ab226d67fa73759ef0e12ad",slug:"ultrasound-imaging-current-topics",bookSignature:"Felix Okechukwu Erondu",coverURL:"https://cdn.intechopen.com/books/images_new/10870.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"68312",title:"Prof.",name:"Felix",middleName:null,surname:"Okechukwu Erondu",slug:"felix-okechukwu-erondu",fullName:"Felix Okechukwu Erondu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11392",title:"Leadership in a Changing World",subtitle:"A Multidimensional Perspective",isOpenForSubmission:!1,hash:"86a6d33cf601587e591064ce92effc02",slug:"leadership-in-a-changing-world-a-multidimensional-perspective",bookSignature:"Muhammad Mohiuddin, Bilal Khalid, Md. Samim Al Azad and Slimane Ed-dafali",coverURL:"https://cdn.intechopen.com/books/images_new/11392.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10400",title:"The Application of Ant Colony Optimization",subtitle:null,isOpenForSubmission:!1,hash:"f4fdfd07ee1ab99fb7c740d6d0c144c6",slug:"the-application-of-ant-colony-optimization",bookSignature:"Ali Soofastaei",coverURL:"https://cdn.intechopen.com/books/images_new/10400.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"257455",title:"Dr.",name:"Ali",middleName:null,surname:"Soofastaei",slug:"ali-soofastaei",fullName:"Ali Soofastaei"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10915",title:"Leadership",subtitle:"New Insights",isOpenForSubmission:!1,hash:"0d72e79892f2a020cee66a52d09de5a4",slug:"leadership-new-insights",bookSignature:"Mário Franco",coverURL:"https://cdn.intechopen.com/books/images_new/10915.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"105529",title:"Dr.",name:"Mário",middleName:null,surname:"Franco",slug:"mario-franco",fullName:"Mário Franco"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10683",title:"Technological Innovations and Advances in Hydropower Engineering",subtitle:null,isOpenForSubmission:!1,hash:"7ce7ad8768bd2cad155470fe1fd883f4",slug:"technological-innovations-and-advances-in-hydropower-engineering",bookSignature:"Yizi Shang, Ling Shang and Xiaofei Li",coverURL:"https://cdn.intechopen.com/books/images_new/10683.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"349630",title:"Dr.",name:"Yizi",middleName:null,surname:"Shang",slug:"yizi-shang",fullName:"Yizi Shang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7102",title:"Pneumonia",subtitle:null,isOpenForSubmission:!1,hash:"9fd70142814192dcec58a176749f1b60",slug:"pneumonia",bookSignature:"Nima Rezaei",coverURL:"https://cdn.intechopen.com/books/images_new/7102.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"116250",title:"Dr.",name:"Nima",middleName:null,surname:"Rezaei",slug:"nima-rezaei",fullName:"Nima Rezaei"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9670",title:"Current Trends in Wheat Research",subtitle:null,isOpenForSubmission:!1,hash:"89d795987f1747a76eee532700d2093d",slug:"current-trends-in-wheat-research",bookSignature:"Mahmood-ur-Rahman Ansari",coverURL:"https://cdn.intechopen.com/books/images_new/9670.jpg",editedByType:"Edited by",publishedDate:"May 11th 2022",editors:[{id:"185476",title:"Dr.",name:"Mahmood-ur-Rahman",middleName:null,surname:"Ansari",slug:"mahmood-ur-rahman-ansari",fullName:"Mahmood-ur-Rahman Ansari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"54",title:"Human Genetics",slug:"human-genetics",parent:{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"},numberOfBooks:31,numberOfSeries:0,numberOfAuthorsAndEditors:1019,numberOfWosCitations:1080,numberOfCrossrefCitations:530,numberOfDimensionsCitations:1311,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"54",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"8073",title:"Chromosomal Abnormalities",subtitle:null,isOpenForSubmission:!1,hash:"6a9d3c58434edf5e65f9849a6858edfe",slug:"chromosomal-abnormalities",bookSignature:"Tülay Aşkın Çelik and Subrata Dey",coverURL:"https://cdn.intechopen.com/books/images_new/8073.jpg",editedByType:"Edited by",editors:[{id:"74041",title:"Dr.",name:"Tulay",middleName:null,surname:"Askin Celik",slug:"tulay-askin-celik",fullName:"Tulay Askin Celik"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6920",title:"Cytogenetics",subtitle:"Past, Present and Further Perspectives",isOpenForSubmission:!1,hash:"d72001eed508dfa72d9a68e1de28bb4b",slug:"cytogenetics-past-present-and-further-perspectives",bookSignature:"Marcelo Larramendy and Sonia Soloneski",coverURL:"https://cdn.intechopen.com/books/images_new/6920.jpg",editedByType:"Edited by",editors:[{id:"14764",title:"Dr.",name:"Marcelo L.",middleName:null,surname:"Larramendy",slug:"marcelo-l.-larramendy",fullName:"Marcelo L. Larramendy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6719",title:"Genetic Diversity and Disease Susceptibility",subtitle:null,isOpenForSubmission:!1,hash:"0c9919347cc7cb1dcbc245ce8684eee7",slug:"genetic-diversity-and-disease-susceptibility",bookSignature:"Yamin Liu",coverURL:"https://cdn.intechopen.com/books/images_new/6719.jpg",editedByType:"Edited by",editors:[{id:"201887",title:"Dr.",name:"Yamin",middleName:null,surname:"Liu",slug:"yamin-liu",fullName:"Yamin Liu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7204",title:"Gene Expression and Regulation in Mammalian Cells",subtitle:"Transcription Toward the Establishment of Novel Therapeutics",isOpenForSubmission:!1,hash:"10030057b2e2dee7d800ff27658c3a69",slug:"gene-expression-and-regulation-in-mammalian-cells-transcription-toward-the-establishment-of-novel-therapeutics",bookSignature:"Fumiaki Uchiumi",coverURL:"https://cdn.intechopen.com/books/images_new/7204.jpg",editedByType:"Edited by",editors:[{id:"47235",title:"Dr.",name:"Fumiaki",middleName:null,surname:"Uchiumi",slug:"fumiaki-uchiumi",fullName:"Fumiaki Uchiumi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5784",title:"Antibody Engineering",subtitle:null,isOpenForSubmission:!1,hash:"2c8c3e133140fbc7f563918285e7c3c2",slug:"antibody-engineering",bookSignature:"Thomas Böldicke",coverURL:"https://cdn.intechopen.com/books/images_new/5784.jpg",editedByType:"Edited by",editors:[{id:"176804",title:"Dr.",name:"Thomas",middleName:null,surname:"Böldicke",slug:"thomas-boldicke",fullName:"Thomas Böldicke"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6435",title:"Gene Expression and Regulation in Mammalian Cells",subtitle:"Transcription From General Aspects",isOpenForSubmission:!1,hash:"8573c44c537def5c800a0f6d4ed844d6",slug:"gene-expression-and-regulation-in-mammalian-cells-transcription-from-general-aspects",bookSignature:"Fumiaki Uchiumi",coverURL:"https://cdn.intechopen.com/books/images_new/6435.jpg",editedByType:"Edited by",editors:[{id:"47235",title:"Dr.",name:"Fumiaki",middleName:null,surname:"Uchiumi",slug:"fumiaki-uchiumi",fullName:"Fumiaki Uchiumi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5986",title:"The Role of Matrix Metalloproteinase in Human Body Pathologies",subtitle:null,isOpenForSubmission:!1,hash:"ef3e8940d7f0b229028d6fb71b1e0927",slug:"the-role-of-matrix-metalloproteinase-in-human-body-pathologies",bookSignature:"Francesco Travascio",coverURL:"https://cdn.intechopen.com/books/images_new/5986.jpg",editedByType:"Edited by",editors:[{id:"172239",title:"Dr.",name:"Francesco",middleName:null,surname:"Travascio",slug:"francesco-travascio",fullName:"Francesco Travascio"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5817",title:"Embryo Cleavage",subtitle:null,isOpenForSubmission:!1,hash:"11de486fcf8fe42d4359c65e71a8f1da",slug:"embryo-cleavage",bookSignature:"Bin Wu",coverURL:"https://cdn.intechopen.com/books/images_new/5817.jpg",editedByType:"Edited by",editors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",slug:"bin-wu",fullName:"Bin Wu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4588",title:"New Discoveries in Embryology",subtitle:null,isOpenForSubmission:!1,hash:"2d40aace9724b9c451a8d8168acd0169",slug:"new-discoveries-in-embryology",bookSignature:"Bin Wu",coverURL:"https://cdn.intechopen.com/books/images_new/4588.jpg",editedByType:"Edited by",editors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",slug:"bin-wu",fullName:"Bin Wu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4594",title:"胚胎移植新进展",subtitle:"Advances in Embryo Transfer",isOpenForSubmission:!1,hash:"32b738c0d0cbce7a61a3ea63b5d43ed0",slug:"advances-in-embryo-transfer-translation-chinese",bookSignature:"Bin Wu",coverURL:"https://cdn.intechopen.com/books/images_new/4594.jpg",editedByType:"Edited by",editors:[{id:"108807",title:"Ph.D.",name:"Bin",middleName:null,surname:"Wu",slug:"bin-wu",fullName:"Bin Wu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1907",title:"Reviews on Selected Topics of Telomere Biology",subtitle:null,isOpenForSubmission:!1,hash:"5f4f25ba706645403bab2aa721a0809b",slug:"reviews-on-selected-topics-of-telomere-biology",bookSignature:"Bibo Li",coverURL:"https://cdn.intechopen.com/books/images_new/1907.jpg",editedByType:"Edited by",editors:[{id:"109879",title:"Dr.",name:"Bibo",middleName:null,surname:"Li",slug:"bibo-li",fullName:"Bibo Li"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2518",title:"Binding Protein",subtitle:null,isOpenForSubmission:!1,hash:"6e70c7a9b0007d8f78ae4f3effba9664",slug:"binding-protein",bookSignature:"Kotb Abdelmohsen",coverURL:"https://cdn.intechopen.com/books/images_new/2518.jpg",editedByType:"Edited by",editors:[{id:"144861",title:"Dr.",name:"Kotb",middleName:null,surname:"Abdelmohsen",slug:"kotb-abdelmohsen",fullName:"Kotb Abdelmohsen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:31,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"38236",doi:"10.5772/50129",title:"Extrinsic and Intrinsic Apoptosis Signal Pathway Review",slug:"extrinsic-and-intrinsic-apoptosis-signal-pathway-review",totalDownloads:11160,totalCrossrefCites:41,totalDimensionsCites:79,abstract:null,book:{id:"3141",slug:"apoptosis-and-medicine",title:"Apoptosis and Medicine",fullTitle:"Apoptosis and Medicine"},signatures:"Zhao Hongmei",authors:[{id:"146795",title:"Dr.",name:"Zhao",middleName:null,surname:"Hongmei",slug:"zhao-hongmei",fullName:"Zhao Hongmei"}]},{id:"35489",doi:"10.5772/37107",title:"MM-GB(PB)SA Calculations of Protein-Ligand Binding Free Energies",slug:"mm-gb-pb-sa-calculations-of-protein-ligand-binding-free-energies",totalDownloads:8562,totalCrossrefCites:11,totalDimensionsCites:60,abstract:null,book:{id:"2265",slug:"molecular-dynamics-studies-of-synthetic-and-biological-macromolecules",title:"Molecular Dynamics",fullTitle:"Molecular Dynamics - Studies of Synthetic and Biological Macromolecules"},signatures:"Joseph M. Hayes and Georgios Archontis",authors:[{id:"102666",title:"Dr.",name:"Joseph",middleName:"M.",surname:"Hayes",slug:"joseph-hayes",fullName:"Joseph Hayes"},{id:"111282",title:"Prof.",name:"Georgios",middleName:null,surname:"Archontis",slug:"georgios-archontis",fullName:"Georgios Archontis"}]},{id:"38806",doi:"10.5772/48277",title:"Bacterial Two-Component Systems: Structures and Signaling Mechanisms",slug:"bacterial-two-component-systems-structures-and-signaling-mechanisms",totalDownloads:5294,totalCrossrefCites:14,totalDimensionsCites:30,abstract:null,book:{id:"2569",slug:"protein-phosphorylation-in-human-health",title:"Protein Phosphorylation in Human Health",fullTitle:"Protein Phosphorylation in Human Health"},signatures:"Shuishu Wang",authors:[{id:"141519",title:"Dr.",name:"Shuishu",middleName:null,surname:"Wang",slug:"shuishu-wang",fullName:"Shuishu Wang"}]},{id:"30743",doi:"10.5772/35890",title:"Chromosomes as Tools for Discovering Biodiversity – The Case of Erythrinidae Fish Family",slug:"chromosomes-as-tools-for-discovering-biodiversity-the-case-of-erythrinidae-fish-family-",totalDownloads:2026,totalCrossrefCites:10,totalDimensionsCites:30,abstract:null,book:{id:"1721",slug:"recent-trends-in-cytogenetic-studies-methodologies-and-applications",title:"Recent Trends in Cytogenetic Studies",fullTitle:"Recent Trends in Cytogenetic Studies - Methodologies and Applications"},signatures:"Marcelo de Bello Cioffi, Wagner Franco Molina, Roberto Ferreira Artoni and Luiz Antonio Carlos Bertollo",authors:[{id:"92318",title:"Prof.",name:"Roberto",middleName:null,surname:"Artoni",slug:"roberto-artoni",fullName:"Roberto Artoni"},{id:"106252",title:"Dr.",name:"Luiz",middleName:"Antonio Carlos",surname:"Bertollo",slug:"luiz-bertollo",fullName:"Luiz Bertollo"},{id:"106412",title:"MSc.",name:"Marcelo",middleName:null,surname:"Cioffi",slug:"marcelo-cioffi",fullName:"Marcelo Cioffi"},{id:"134346",title:"Dr.",name:"Wagner",middleName:null,surname:"Molina",slug:"wagner-molina",fullName:"Wagner Molina"}]},{id:"16933",doi:"10.5772/24319",title:"Mutation Patterns Due to Converging Mitochondrial Replication and Transcription Increase Lifespan, and Cause Growth Rate-Longevity Tradeoffs",slug:"mutation-patterns-due-to-converging-mitochondrial-replication-and-transcription-increase-lifespan-an",totalDownloads:2411,totalCrossrefCites:11,totalDimensionsCites:28,abstract:null,book:{id:"267",slug:"dna-replication-current-advances",title:"DNA Replication",fullTitle:"DNA Replication - Current Advances"},signatures:"Hervé Seligmann",authors:[{id:"118814",title:"Dr.",name:"Herve",middleName:null,surname:"Seligmann",slug:"herve-seligmann",fullName:"Herve Seligmann"}]}],mostDownloadedChaptersLast30Days:[{id:"62578",title:"DNA Polymorphisms: DNA-Based Molecular Markers and Their Application in Medicine",slug:"dna-polymorphisms-dna-based-molecular-markers-and-their-application-in-medicine",totalDownloads:4440,totalCrossrefCites:6,totalDimensionsCites:11,abstract:"DNA polymorphisms are the different DNA sequences among individuals, groups, or populations. Polymorphism at the DNA level includes a wide range of variations from single base pair change, many base pairs, and repeated sequences. Genomic variability can be present in many forms, including single nucleotide polymorphisms (SNPs), variable number of tandem repeats (VNTRs, e.g., mini- and microsatellites), transposable elements (e.g., Alu repeats), structural alterations, and copy number variations. Different forms of DNA polymorphisms can be tracked using a variety of techniques; some of these techniques include restriction fragment length polymorphisms (RFLPs) with Southern blots, polymerase chain reactions (PCRs), hybridization techniques using DNA microarray chips, and genome sequencing. During the last years, the recent advance of molecular technologies revealed new discoveries of DNA polymorphisms. DNA polymorphisms are endless, and more discoveries continue at a rapid rate. Mapping the human genome requires a set of genetic markers. DNA polymorphism serves as a genetic marker for its own location in the chromosome; thus, they are convenient for analysis and are often used as in molecular genetic studies.",book:{id:"6719",slug:"genetic-diversity-and-disease-susceptibility",title:"Genetic Diversity and Disease Susceptibility",fullTitle:"Genetic Diversity and Disease Susceptibility"},signatures:"Salwa Teama",authors:[{id:"249329",title:"Dr.",name:"Salwa",middleName:null,surname:"Teama",slug:"salwa-teama",fullName:"Salwa Teama"}]},{id:"58467",title:"Generation of Antibody Diversity",slug:"generation-of-antibody-diversity",totalDownloads:3111,totalCrossrefCites:2,totalDimensionsCites:2,abstract:"Because of the huge diversity, the immunoglobulin repertoire cannot be encoded by static genes, which would explode the genomic capacity comprising about 20,000–25,000 human genes. The immunoglobulin repertoire is provided by the process of somatic germ line recombination, which is the only controlled alteration of the genomic DNA after meiosis. It takes place in mammalian B lymphocyte (B cells) precursors in the bone marrow. The genome germ line sequence of undeveloped B cells is organized in gene segments and compromise V (variable), D (diversity), and J (joining) gene segments constituting the variable domain of the heavy chain and only V and J genes for building up the variable domain of the light chain. The rearrangement of the variable region follows a strict order. The following processes that participate in the generation of antibody diversity were summarized—allelic, combinational, and junctional diversity, pairing of IgH and IgL, and receptor editing—which all together produce the primary antigen repertoire (pre-antigen stimulation). When a B cell encounters a foreign antigen, affinity maturation and class switch are induced. Thereby the antibody repertoire increases. The resulting secondary immunoglobulin repertoire reveals in humans at least 1011 specificities for different antigens.",book:{id:"5784",slug:"antibody-engineering",title:"Antibody Engineering",fullTitle:"Antibody Engineering"},signatures:"Oliver Backhaus",authors:[{id:"177685",title:"M.Sc.",name:"Oliver",middleName:null,surname:"Backhaus",slug:"oliver-backhaus",fullName:"Oliver Backhaus"}]},{id:"61204",title:"Polymorphisms",slug:"polymorphisms",totalDownloads:2005,totalCrossrefCites:2,totalDimensionsCites:5,abstract:"Polymorphism or variation in DNA sequence can affect individual phenotypes such as color of skin or eyes, susceptible to diseases, and respond to drug, vaccine, chemical, and pathogen. It occurs more often than mutations (frequency ≥ 1%). The common polymorphism is single nucleotide polymorphism (SNP) which is a single base change in a DNA sequence that occurs most commonly in the human genome. SNPs have been used as molecular markers in a wide range of studies. Genome-wide association studies (GWAS) searches for SNPs that occur more frequently in person with a particular disease than in person without the disease and pinpoint genes or regions that may contribute to a risk of disease. This topic describes about polymorphisms, SNPs, GWAS, linkage disequilibrium (LD), minor allele frequency, haplotype, method for SNP genotyping, and application of SNPs and genome-wide association study in human diseases and drug development.",book:{id:"6719",slug:"genetic-diversity-and-disease-susceptibility",title:"Genetic Diversity and Disease Susceptibility",fullTitle:"Genetic Diversity and Disease Susceptibility"},signatures:"Wasana Sukhumsirichart",authors:[{id:"238537",title:"Associate Prof.",name:"Wasana",middleName:null,surname:"Sukhumsirichart",slug:"wasana-sukhumsirichart",fullName:"Wasana Sukhumsirichart"}]},{id:"21711",title:"Screening of Bacterial Recombinants: Strategies and Preventing False Positives",slug:"screening-of-bacterial-recombinants-strategies-and-preventing-false-positives",totalDownloads:28414,totalCrossrefCites:1,totalDimensionsCites:5,abstract:null,book:{id:"375",slug:"molecular-cloning-selected-applications-in-medicine-and-biology",title:"Molecular Cloning",fullTitle:"Molecular Cloning - Selected Applications in Medicine and Biology"},signatures:"Sriram Padmanabhan, Sampali Banerjee and Naganath Mandi",authors:[{id:"46458",title:"Dr.",name:"Sriram",middleName:null,surname:"Padmanabhan",slug:"sriram-padmanabhan",fullName:"Sriram Padmanabhan"},{id:"136523",title:"Prof.",name:"Sampali",middleName:null,surname:"Banerjee",slug:"sampali-banerjee",fullName:"Sampali Banerjee"},{id:"136524",title:"Prof.",name:"Naganath",middleName:null,surname:"Mandi",slug:"naganath-mandi",fullName:"Naganath Mandi"}]},{id:"49200",title:"Human Embryology",slug:"human-embryology",totalDownloads:3523,totalCrossrefCites:5,totalDimensionsCites:7,abstract:"The study of human embryology has a very long history. Modern embryology owes its initial development to the key embryo collections that began in the 19th century. The first large collection was that of Carnegie, and this was followed later by the major 7 collections. The second role of the Carnegie collection was for researchers to establish a defined set of Carnegie stages based on embryo morphological features. Today, embryos are imaged three-dimensionally (3D) by a range of imaging modalities including, magnetic resonance microscopy (MRM), episcopic fluorescence image capture (EFIC), phase-contrast X-ray computed tomography (pCT), and optical projection tomography (OPT). Historically, embryo serial images were reconstructed using wax-plate and model techniques. The above new 3D imaging techniques now allow 3D computer reconstructions, analysis, and even 3D printing. This chapter will describe how the classical embryology collections and techniques have developed into today’s imaging and analysis techniques, giving new insights to human embryonic development.",book:{id:"4588",slug:"new-discoveries-in-embryology",title:"New Discoveries in Embryology",fullTitle:"New Discoveries in Embryology"},signatures:"Shigehito Yamada, Mark Hill and Tetsuya Takakuwa",authors:[{id:"49486",title:"Prof.",name:"Shigehito",middleName:null,surname:"Yamada",slug:"shigehito-yamada",fullName:"Shigehito Yamada"},{id:"90205",title:"Prof.",name:"Tetsuya",middleName:null,surname:"Takakuwa",slug:"tetsuya-takakuwa",fullName:"Tetsuya Takakuwa"},{id:"175453",title:"Dr.",name:"Mark",middleName:null,surname:"Hill",slug:"mark-hill",fullName:"Mark Hill"}]}],onlineFirstChaptersFilter:{topicId:"54",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:8,limit:8,total:0},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:8,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:286,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:105,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:9,numberOfPublishedChapters:101,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:11,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}},{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}}]},series:{item:{id:"22",title:"Business, Management and Economics",doi:"10.5772/intechopen.100359",issn:null,scope:"
\r\n\tThis series will provide a comprehensive overview of recent research trends in business and management, economics, and marketing. Topics will include asset liability management, financial consequences of the financial crisis and covid-19, financial accounting, mergers and acquisitions, management accounting, SMEs, financial markets, corporate finance and governance, managerial technology and innovation, resource management and sustainable development, social entrepreneurship, corporate responsibility, ethics and accountability, microeconomics, labour economics, macroeconomics, public economics, financial economics, econometrics, direct marketing, creative marketing, internet marketing, market planning and forecasting, brand management, market segmentation and targeting and other topics under business and management. This book series will focus on various aspects of business and management whose in-depth understanding is critical for business and company management to function effectively during this uncertain time of financial crisis, Covid-19 pandemic, and military activity in Europe.
",coverUrl:"https://cdn.intechopen.com/series/covers/22.jpg",latestPublicationDate:"May 11th, 2022",hasOnlineFirst:!1,numberOfPublishedBooks:1,editor:{id:"356540",title:"Prof.",name:"Taufiq",middleName:null,surname:"Choudhry",slug:"taufiq-choudhry",fullName:"Taufiq Choudhry",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000036X2hvQAC/Profile_Picture_2022-03-14T08:58:03.jpg",biography:"Prof. Choudhry holds a BSc degree in Economics from the University of Iowa, as well as a Masters and Ph.D. in Applied Economics from Clemson University, USA. In January 2006, he became a Professor of Finance at the University of Southampton Business School. He was previously a Professor of Finance at the University of Bradford Management School. He has over 80 articles published in international finance and economics journals. His research interests and specialties include financial econometrics, financial economics, international economics and finance, housing markets, financial markets, among others.",institutionString:null,institution:{name:"University of Southampton",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:5,paginationItems:[{id:"91",title:"Sustainable Economy and Fair Society",coverUrl:"https://cdn.intechopen.com/series_topics/covers/91.jpg",isOpenForSubmission:!0,annualVolume:11975,editor:{id:"181603",title:"Dr.",name:"Antonella",middleName:null,surname:"Petrillo",slug:"antonella-petrillo",fullName:"Antonella Petrillo",profilePictureURL:"https://mts.intechopen.com/storage/users/181603/images/system/181603.jpg",biography:"Antonella Petrillo is a Professor at the Department of Engineering of the University of Naples “Parthenope”, Italy. She received her Ph.D. in Mechanical Engineering from the University of Cassino. Her research interests include multi-criteria decision analysis, industrial plant, logistics, manufacturing and safety. She serves as an Associate Editor for the International Journal of the Analytic Hierarchy Process. She is a member of AHP Academy and a member of several editorial boards. She has over 160 Scientific Publications in International Journals and Conferences and she is the author of 5 books on Innovation and Decision Making in Industrial Applications and Engineering.",institutionString:null,institution:{name:"Parthenope University of Naples",institutionURL:null,country:{name:"Italy"}}},editorTwo:null,editorThree:null},{id:"92",title:"Health and Wellbeing",coverUrl:"https://cdn.intechopen.com/series_topics/covers/92.jpg",isOpenForSubmission:!0,annualVolume:11976,editor:{id:"348225",title:"Prof.",name:"Ann",middleName:null,surname:"Hemingway",slug:"ann-hemingway",fullName:"Ann Hemingway",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000035LZFoQAO/Profile_Picture_2022-04-11T14:55:40.jpg",biography:"Professor Hemingway is a public health researcher, Bournemouth University, undertaking international and UK research focused on reducing inequalities in health outcomes for marginalised and excluded populations and more recently focused on equine assisted interventions.",institutionString:null,institution:{name:"Bournemouth University",institutionURL:null,country:{name:"United Kingdom"}}},editorTwo:null,editorThree:null},{id:"93",title:"Inclusivity and Social Equity",coverUrl:"https://cdn.intechopen.com/series_topics/covers/93.jpg",isOpenForSubmission:!0,annualVolume:11977,editor:{id:"210060",title:"Prof. Dr.",name:"Ebba",middleName:null,surname:"Ossiannilsson",slug:"ebba-ossiannilsson",fullName:"Ebba Ossiannilsson",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6LkBQAU/Profile_Picture_2022-02-28T13:31:48.png",biography:'Professor Dr. Ebba Ossiannilsson is an independent researcher, expert, consultant, quality auditor and influencer in the fields of open, flexible online and distance learning (OFDL) and the "new normal". Her focus is on quality, innovation, leadership, and personalised learning. She works primarily at the strategic and policy levels, both nationally and internationally, and with key international organisations. She is committed to promoting and improving OFDL in the context of SDG4 and the future of education. Ossiannilsson has more than 20 years of experience in her current field, but more than 40 years in the education sector. She works as a reviewer and expert for the European Commission and collaborates with the Joint Research Centre for Quality in Open Education. Ossiannilsson also collaborates with ITCILO and ICoBC (International Council on Badges and Credentials). She is a member of the ICDE Board of Directors and has previously served on the boards of EDEN and EUCEN. Ossiannilsson is a quality expert and reviewer for ICDE, EDEN and the EADTU. She chairs the ICDE OER Advocacy Committee and is a member of the ICDE Quality Network. She is regularly invited as a keynote speaker at conferences. She is a guest editor for several special issues and a member of the editorial board of several scientific journals. She has published more than 200 articles and is currently working on book projects in the field of OFDL. Ossiannilsson is a visiting professor at several international universities and was recently appointed Professor and Research Fellow at Victoria University of Wellington, NZ. Ossiannilsson has been awarded the following fellowships: EDEN Fellows, EDEN Council of Fellows, and Open Education Europe. She is a ICDE OER Ambassador, Open Education Europe Ambassador, GIZ Ambassador for Quality in Digital Learning, and part of the Globe-Community of Digital Learning and Champion of SPARC Europe. On a national level, she is a quality developer at the Swedish Institute for Standards (SIS) and for ISO. She is a member of the Digital Skills and Jobs Coalition Sweden and Vice President of the Swedish Association for Distance Education. She is currently working on a government initiative on quality in distance education at the National Council for Higher Education. She holds a Ph.D. from the University of Oulu, Finland.',institutionString:"Swedish Association for Distance Education, Sweden",institution:null},editorTwo:null,editorThree:null},{id:"94",title:"Climate Change and Environmental Sustainability",coverUrl:"https://cdn.intechopen.com/series_topics/covers/94.jpg",isOpenForSubmission:!1,annualVolume:null,editor:null,editorTwo:null,editorThree:null},{id:"95",title:"Urban Planning and Environmental Management",coverUrl:"https://cdn.intechopen.com/series_topics/covers/95.jpg",isOpenForSubmission:!0,annualVolume:11979,editor:{id:"181079",title:"Dr.",name:"Christoph",middleName:null,surname:"Lüthi",slug:"christoph-luthi",fullName:"Christoph Lüthi",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRHSqQAO/Profile_Picture_2022-04-12T15:51:33.png",biography:"Dr. Christoph Lüthi is an urban infrastructure planner with over 25 years of experience in planning and design of urban infrastructure in middle and low-income countries. He holds a Master’s Degree in Urban Development Planning from the University College of London (UCL), and a Ph.D. in Urban Planning & Engineering from TU Berlin. He has conducted applied research on urban planning and infrastructure issues in over 20 countries in Africa and Asia. In 2005 he joined Eawag-Sandec as Leader of the Strategic Environmental Sanitation Planning Group. Since 2015 he heads the research department Sanitation, Water and Solid Waste for Development (Sandec) at the Swiss Federal Institute of Aquatic Research and Technology (Eawag).",institutionString:"Swiss Federal Institute of Aquatic Science and Technology, Switzerland",institution:null},editorTwo:{id:"290571",title:"Dr.",name:"Rui Alexandre",middleName:null,surname:"Castanho",slug:"rui-alexandre-castanho",fullName:"Rui Alexandre Castanho",profilePictureURL:"https://mts.intechopen.com/storage/users/290571/images/system/290571.jpg",biography:"Rui Alexandre Castanho has a master\\'s degree in Planning, Audit, and Control in Urban Green Spaces and an international Ph.D. in Sustainable Planning in Borderlands. Currently, he is a professor at WSB University, Poland, and a visiting professor at the University of Johannesburg, South Africa. Dr. Castanho is a post-doc researcher on the GREAT Project, University of Azores, Ponta Delgada, Portugal. He collaborates with the Environmental Resources Analysis Research Group (ARAM), University of Extremadura (UEx), Spain; VALORIZA - Research Center for the Enhancement of Endogenous Resources, Polytechnic Institute of Portalegre (IPP), Portugal; Centre for Tourism Research, Development and Innovation (CITUR), Madeira, Portugal; and AQUAGEO Research Group, University of Campinas (UNICAMP), Brazil.",institutionString:"University of Johannesburg, South Africa and WSB University, Poland",institution:{name:"University of Johannesburg",institutionURL:null,country:{name:"South Africa"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:2,paginationItems:[{id:"81644",title:"Perspective Chapter: Ethics of Using Placebo Controlled Trials for Covid-19 Vaccine Development in Vulnerable Populations",doi:"10.5772/intechopen.104776",signatures:"Lesley Burgess, Jurie Jordaan and Matthew Wilson",slug:"perspective-chapter-ethics-of-using-placebo-controlled-trials-for-covid-19-vaccine-development-in-vu",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"80546",title:"Streptococcal Skin and Skin-Structure Infections",doi:"10.5772/intechopen.102894",signatures:"Alwyn Rapose",slug:"streptococcal-skin-and-skin-structure-infections",totalDownloads:48,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Streptococcal Infections",coverURL:"https://cdn.intechopen.com/books/images_new/10828.jpg",subseries:{id:"3",title:"Bacterial Infectious Diseases"}}}]},overviewPagePublishedBooks:{paginationCount:13,paginationItems:[{type:"book",id:"6667",title:"Influenza",subtitle:"Therapeutics and Challenges",coverURL:"https://cdn.intechopen.com/books/images_new/6667.jpg",slug:"influenza-therapeutics-and-challenges",publishedDate:"September 19th 2018",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"105e347b2d5dbbe6b593aceffa051efa",volumeInSeries:1,fullTitle:"Influenza - Therapeutics and Challenges",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:null,institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}]},{type:"book",id:"7064",title:"Current Perspectives in Human Papillomavirus",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7064.jpg",slug:"current-perspectives-in-human-papillomavirus",publishedDate:"May 2nd 2019",editedByType:"Edited by",bookSignature:"Shailendra K. Saxena",hash:"d92a4085627bab25ddc7942fbf44cf05",volumeInSeries:2,fullTitle:"Current Perspectives in Human Papillomavirus",editors:[{id:"158026",title:"Prof.",name:"Shailendra K.",middleName:null,surname:"Saxena",slug:"shailendra-k.-saxena",fullName:"Shailendra K. Saxena",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRET3QAO/Profile_Picture_2022-05-10T10:10:26.jpeg",biography:"Professor Dr. Shailendra K. Saxena is a vice dean and professor at King George's Medical University, Lucknow, India. His research interests involve understanding the molecular mechanisms of host defense during human viral infections and developing new predictive, preventive, and therapeutic strategies for them using Japanese encephalitis virus (JEV), HIV, and emerging viruses as a model via stem cell and cell culture technologies. His research work has been published in various high-impact factor journals (Science, PNAS, Nature Medicine) with a high number of citations. He has received many awards and honors in India and abroad including various Young Scientist Awards, BBSRC India Partnering Award, and Dr. JC Bose National Award of Department of Biotechnology, Min. of Science and Technology, Govt. of India. Dr. Saxena is a fellow of various international societies/academies including the Royal College of Pathologists, United Kingdom; Royal Society of Medicine, London; Royal Society of Biology, United Kingdom; Royal Society of Chemistry, London; and Academy of Translational Medicine Professionals, Austria. He was named a Global Leader in Science by The Scientist. He is also an international opinion leader/expert in vaccination for Japanese encephalitis by IPIC (UK).",institutionString:null,institution:{name:"King George's Medical University",institutionURL:null,country:{name:"India"}}}]},{type:"book",id:"7123",title:"Current Topics in Neglected Tropical Diseases",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7123.jpg",slug:"current-topics-in-neglected-tropical-diseases",publishedDate:"December 4th 2019",editedByType:"Edited by",bookSignature:"Alfonso J. Rodriguez-Morales",hash:"61c627da05b2ace83056d11357bdf361",volumeInSeries:3,fullTitle:"Current Topics in Neglected Tropical Diseases",editors:[{id:"131400",title:"Prof.",name:"Alfonso J.",middleName:null,surname:"Rodriguez-Morales",slug:"alfonso-j.-rodriguez-morales",fullName:"Alfonso J. Rodriguez-Morales",profilePictureURL:"https://mts.intechopen.com/storage/users/131400/images/system/131400.png",biography:"Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly zoonotic and vector-borne diseases (especially arboviral diseases). He is the president of the Travel Medicine Committee of the Pan-American Infectious Diseases Association (API), as well as the president of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is a vice-president of the Latin American Society for Travel Medicine (SLAMVI) and a Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as a Senior Researcher, at the Ministry of Science of Colombia. He is a professor at the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Americas, in Pereira, Risaralda, Colombia. He is an External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also a professor at the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. In 2021 he has been awarded the “Raul Isturiz Award” Medal of the API. Also, in 2021, he was awarded with the “Jose Felix Patiño” Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions to COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 47 (Google Scholar H index, 68).",institutionString:"Institución Universitaria Visión de las Américas, Colombia",institution:null}]},{type:"book",id:"7839",title:"Malaria",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7839.jpg",slug:"malaria",publishedDate:"December 11th 2019",editedByType:"Edited by",bookSignature:"Fyson H. Kasenga",hash:"91cde4582ead884cb0f355a19b67cd56",volumeInSeries:4,fullTitle:"Malaria",editors:[{id:"86725",title:"Dr.",name:"Fyson",middleName:"Hanania",surname:"Kasenga",slug:"fyson-kasenga",fullName:"Fyson Kasenga",profilePictureURL:"https://mts.intechopen.com/storage/users/86725/images/system/86725.jpg",biography:"Dr. Kasenga is a graduate of Tumaini University, Kilimanjaro Christian Medical College, Moshi, Tanzania and Umeå University, Sweden. He obtained a Master’s degree in Public Health and PhD in Public Health and Epidemiology. He has a background in Clinical Medicine and has taken courses at higher diploma levels in public health from University of Transkei, Republic of South Africa, and African Medical and Research Foundation (AMREF) in Nairobi, Kenya. Dr. Kasenga worked in different places in and outside Malawi, and has held various positions, such as Licensed Medical Officer, HIV/AIDS Programme Officer, HIV/AIDS resource person in the International Department of Diakonhjemet College, Oslo, Norway. He also managed an Integrated HIV/AIDS Prevention programme for over 5 years. He is currently working as a Director for the Health Ministries Department of Malawi Union of the Seventh Day Adventist Church. Dr. Kasenga has published over 5 articles on HIV/AIDS issues focusing on Prevention of Mother to Child Transmission of HIV (PMTCT), including a book chapter on HIV testing counseling (currently in press). Dr. Kasenga is married to Grace and blessed with three children, a son and two daughters: Happy, Lettice and Sungani.",institutionString:"Malawi Adventist University",institution:{name:"Malawi Adventist University",institutionURL:null,country:{name:"Malawi"}}}]}]},openForSubmissionBooks:{paginationCount:7,paginationItems:[{id:"11476",title:"Globalization and Sustainability - Recent Advances, New Perspectives and Emerging Issues",coverURL:"https://cdn.intechopen.com/books/images_new/11476.jpg",hash:"8d41fa5f3a5da07469bbc121594bfd3e",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"March 24th 2022",isOpenForSubmission:!0,editors:[{id:"335401",title:"Prof.",name:"Margherita",surname:"Mori",slug:"margherita-mori",fullName:"Margherita Mori"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11460",title:"Pluralistic Approaches for Conservation and Sustainability in Biodiversity",coverURL:"https://cdn.intechopen.com/books/images_new/11460.jpg",hash:"ab014f8ed1669757335225786833e9a9",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"April 22nd 2022",isOpenForSubmission:!0,editors:[{id:"101105",title:"Dr.",name:"Gopal",surname:"Shukla",slug:"gopal-shukla",fullName:"Gopal Shukla"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11475",title:"Food Security Challenges and Approaches",coverURL:"https://cdn.intechopen.com/books/images_new/11475.jpg",hash:"090302a30e461cee643ec49675c811ec",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 5th 2022",isOpenForSubmission:!0,editors:[{id:"292145",title:"Dr.",name:"Muhammad",surname:"Haseeb Ahmad",slug:"muhammad-haseeb-ahmad",fullName:"Muhammad Haseeb Ahmad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11450",title:"Environmental Impacts of COVID-19 Pandemic on the World",coverURL:"https://cdn.intechopen.com/books/images_new/11450.jpg",hash:"a58c7b02d07903004be70f744f2e1835",secondStepPassed:!0,currentStepOfPublishingProcess:3,submissionDeadline:"May 10th 2022",isOpenForSubmission:!0,editors:[{id:"63465",title:"Prof.",name:"Mohamed Nageeb",surname:"Rashed",slug:"mohamed-nageeb-rashed",fullName:"Mohamed Nageeb Rashed"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11477",title:"Public Economics - New Perspectives and Uncertainty",coverURL:"https://cdn.intechopen.com/books/images_new/11477.jpg",hash:"a8e6c515dc924146fbd2712eb4e7d118",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"May 27th 2022",isOpenForSubmission:!0,editors:[{id:"414400",title:"Dr.",name:"Habtamu",surname:"Alem",slug:"habtamu-alem",fullName:"Habtamu Alem"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11457",title:"Forest Degradation Under Global Change",coverURL:"https://cdn.intechopen.com/books/images_new/11457.jpg",hash:"8df7150b01ae754024c65d1a62f190d9",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"June 1st 2022",isOpenForSubmission:!0,editors:[{id:"317087",title:"Dr.",name:"Pavel",surname:"Samec",slug:"pavel-samec",fullName:"Pavel Samec"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{id:"11474",title:"Quality of Life Interventions - Magnitude of Effect and Transferability",coverURL:"https://cdn.intechopen.com/books/images_new/11474.jpg",hash:"5a6bcdaf5ee144d043bcdab893ff9e1c",secondStepPassed:!1,currentStepOfPublishingProcess:2,submissionDeadline:"June 2nd 2022",isOpenForSubmission:!0,editors:[{id:"245319",title:"Ph.D.",name:"Sage",surname:"Arbor",slug:"sage-arbor",fullName:"Sage Arbor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},onlineFirstChapters:{paginationCount:2,paginationItems:[{id:"81644",title:"Perspective Chapter: Ethics of Using Placebo Controlled Trials for Covid-19 Vaccine Development in Vulnerable Populations",doi:"10.5772/intechopen.104776",signatures:"Lesley Burgess, Jurie Jordaan and Matthew Wilson",slug:"perspective-chapter-ethics-of-using-placebo-controlled-trials-for-covid-19-vaccine-development-in-vu",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"SARS-CoV-2 Variants - Two Years After",coverURL:"https://cdn.intechopen.com/books/images_new/11573.jpg",subseries:{id:"6",title:"Viral Infectious Diseases"}}},{id:"80546",title:"Streptococcal Skin and Skin-Structure Infections",doi:"10.5772/intechopen.102894",signatures:"Alwyn Rapose",slug:"streptococcal-skin-and-skin-structure-infections",totalDownloads:48,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Streptococcal Infections",coverURL:"https://cdn.intechopen.com/books/images_new/10828.jpg",subseries:{id:"3",title:"Bacterial Infectious Diseases"}}}]},subseriesFiltersForOFChapters:[{caption:"Bacterial Infectious Diseases",value:3,count:1,group:"subseries"},{caption:"Viral Infectious Diseases",value:6,count:1,group:"subseries"}],publishedBooks:{paginationCount:11,paginationItems:[{type:"book",id:"10795",title:"Plant Stress Physiology",subtitle:"Perspectives in Agriculture",coverURL:"https://cdn.intechopen.com/books/images_new/10795.jpg",slug:"plant-stress-physiology-perspectives-in-agriculture",publishedDate:"April 28th 2022",editedByType:"Edited by",bookSignature:"Mirza Hasanuzzaman and Kamran Nahar",hash:"c5a7932b74fe612b256bf95d0709756e",volumeInSeries:11,fullTitle:"Plant Stress Physiology - Perspectives in Agriculture",editors:[{id:"76477",title:"Prof.",name:"Mirza",middleName:null,surname:"Hasanuzzaman",slug:"mirza-hasanuzzaman",fullName:"Mirza Hasanuzzaman",profilePictureURL:"https://mts.intechopen.com/storage/users/76477/images/system/76477.png",institutionString:"Sher-e-Bangla Agricultural University",institution:{name:"Sher-e-Bangla Agricultural University",institutionURL:null,country:{name:"Bangladesh"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7999",title:"Free Radical Medicine and Biology",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7999.jpg",slug:"free-radical-medicine-and-biology",publishedDate:"July 15th 2020",editedByType:"Edited by",bookSignature:"Kusal Das, Swastika Das, Mallanagouda Shivanagouda Biradar, Varaprasad Bobbarala and S. Subba Tata",hash:"083e5d427097d368a3f8a02bd6c76bf8",volumeInSeries:10,fullTitle:"Free Radical Medicine and Biology",editors:[{id:"187859",title:"Prof.",name:"Kusal",middleName:"K.",surname:"Das",slug:"kusal-das",fullName:"Kusal Das",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSBDeQAO/Profile_Picture_1623411145568",institutionString:"BLDE (Deemed to be University), India",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8762",title:"Melatonin",subtitle:"The Hormone of Darkness and its Therapeutic Potential and Perspectives",coverURL:"https://cdn.intechopen.com/books/images_new/8762.jpg",slug:"melatonin-the-hormone-of-darkness-and-its-therapeutic-potential-and-perspectives",publishedDate:"June 24th 2020",editedByType:"Edited by",bookSignature:"Marilena Vlachou",hash:"bfbc5538173f11acb0f9549a85b70489",volumeInSeries:9,fullTitle:"Melatonin - The Hormone of Darkness and its Therapeutic Potential and Perspectives",editors:[{id:"246279",title:"Associate Prof.",name:"Marilena",middleName:null,surname:"Vlachou",slug:"marilena-vlachou",fullName:"Marilena Vlachou",profilePictureURL:"https://mts.intechopen.com/storage/users/246279/images/system/246279.jpg",institutionString:"National and Kapodistrian University of Athens",institution:{name:"National and Kapodistrian University of Athens",institutionURL:null,country:{name:"Greece"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8002",title:"Tumor Progression and Metastasis",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8002.jpg",slug:"tumor-progression-and-metastasis",publishedDate:"April 8th 2020",editedByType:"Edited by",bookSignature:"Ahmed Lasfar and Karine Cohen-Solal",hash:"db17b0fe0a9b6e80ff02b81a93bafa4e",volumeInSeries:8,fullTitle:"Tumor Progression and Metastasis",editors:[{id:"32546",title:"Dr.",name:"Ahmed",middleName:null,surname:"Lasfar",slug:"ahmed-lasfar",fullName:"Ahmed Lasfar",profilePictureURL:"https://mts.intechopen.com/storage/users/32546/images/system/32546.png",institutionString:"Rutgers, The State University of New Jersey",institution:{name:"Rutgers, The State University of New Jersey",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6897",title:"Biophysical Chemistry",subtitle:"Advance Applications",coverURL:"https://cdn.intechopen.com/books/images_new/6897.jpg",slug:"biophysical-chemistry-advance-applications",publishedDate:"February 19th 2020",editedByType:"Edited by",bookSignature:"Mohammed A. A. Khalid",hash:"0ad18ab382e2ffb9ff202d15282297eb",volumeInSeries:7,fullTitle:"Biophysical Chemistry - Advance Applications",editors:[{id:"137240",title:"Prof.",name:"Mohammed",middleName:null,surname:"Khalid",slug:"mohammed-khalid",fullName:"Mohammed Khalid",profilePictureURL:"https://mts.intechopen.com/storage/users/137240/images/system/137240.png",institutionString:"Taif University",institution:{name:"Taif University",institutionURL:null,country:{name:"Saudi Arabia"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8430",title:"Neurodevelopment and Neurodevelopmental Disorder",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8430.jpg",slug:"neurodevelopment-and-neurodevelopmental-disorder",publishedDate:"November 27th 2019",editedByType:"Edited by",bookSignature:"Michael Fitzgerald",hash:"696c96d038de473216e48b199613c111",volumeInSeries:6,fullTitle:"Neurodevelopment and Neurodevelopmental Disorder",editors:[{id:"205005",title:"Dr.",name:"Michael",middleName:null,surname:"Fitzgerald",slug:"michael-fitzgerald",fullName:"Michael Fitzgerald",profilePictureURL:"https://mts.intechopen.com/storage/users/205005/images/system/205005.jpg",institutionString:"Independant Researcher",institution:{name:"Trinity College Dublin",institutionURL:null,country:{name:"Ireland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8008",title:"Antioxidants",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/8008.jpg",slug:"antioxidants",publishedDate:"November 6th 2019",editedByType:"Edited by",bookSignature:"Emad Shalaby",hash:"76361b4061e830906267933c1c670027",volumeInSeries:5,fullTitle:"Antioxidants",editors:[{id:"63600",title:"Prof.",name:"Emad",middleName:null,surname:"Shalaby",slug:"emad-shalaby",fullName:"Emad Shalaby",profilePictureURL:"https://mts.intechopen.com/storage/users/63600/images/system/63600.png",institutionString:"Cairo University",institution:{name:"Cairo University",institutionURL:null,country:{name:"Egypt"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"8797",title:"Adipose Tissue",subtitle:"An Update",coverURL:"https://cdn.intechopen.com/books/images_new/8797.jpg",slug:"adipose-tissue-an-update",publishedDate:"November 6th 2019",editedByType:"Edited by",bookSignature:"Leszek Szablewski",hash:"34880b7b450ef96fa5063c867c028b02",volumeInSeries:4,fullTitle:"Adipose Tissue - An Update",editors:[{id:"49739",title:"Dr.",name:"Leszek",middleName:null,surname:"Szablewski",slug:"leszek-szablewski",fullName:"Leszek Szablewski",profilePictureURL:"https://mts.intechopen.com/storage/users/49739/images/system/49739.jpg",institutionString:"Medical University of Warsaw",institution:{name:"Medical University of Warsaw",institutionURL:null,country:{name:"Poland"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6924",title:"Adenosine Triphosphate in Health and Disease",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6924.jpg",slug:"adenosine-triphosphate-in-health-and-disease",publishedDate:"April 24th 2019",editedByType:"Edited by",bookSignature:"Gyula Mozsik",hash:"04106c232a3c68fec07ba7cf00d2522d",volumeInSeries:3,fullTitle:"Adenosine Triphosphate in Health and Disease",editors:[{id:"58390",title:"Dr.",name:"Gyula",middleName:null,surname:"Mozsik",slug:"gyula-mozsik",fullName:"Gyula Mozsik",profilePictureURL:"https://mts.intechopen.com/storage/users/58390/images/system/58390.png",institutionString:"University of Pécs",institution:{name:"University of Pecs",institutionURL:null,country:{name:"Hungary"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"6925",title:"Endoplasmic Reticulum",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6925.jpg",slug:"endoplasmic-reticulum",publishedDate:"April 17th 2019",editedByType:"Edited by",bookSignature:"Angel Català",hash:"a9e90d2dbdbc46128dfe7dac9f87c6b4",volumeInSeries:2,fullTitle:"Endoplasmic Reticulum",editors:[{id:"196544",title:"Prof.",name:"Angel",middleName:null,surname:"Catala",slug:"angel-catala",fullName:"Angel Catala",profilePictureURL:"https://mts.intechopen.com/storage/users/196544/images/system/196544.jpg",institutionString:"Universidad Nacional de La Plata",institution:{name:"National University of La Plata",institutionURL:null,country:{name:"Argentina"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7264",title:"Calcium and Signal Transduction",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7264.jpg",slug:"calcium-and-signal-transduction",publishedDate:"October 24th 2018",editedByType:"Edited by",bookSignature:"John N. Buchholz and Erik J. Behringer",hash:"e373a3d1123dbd45fddf75d90e3e7c38",volumeInSeries:1,fullTitle:"Calcium and Signal Transduction",editors:[{id:"89438",title:"Dr.",name:"John N.",middleName:null,surname:"Buchholz",slug:"john-n.-buchholz",fullName:"John N. Buchholz",profilePictureURL:"https://mts.intechopen.com/storage/users/89438/images/6463_n.jpg",institutionString:null,institution:{name:"Loma Linda University",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},subseriesFiltersForPublishedBooks:[{group:"subseries",caption:"Plant Physiology",value:13,count:1},{group:"subseries",caption:"Human Physiology",value:12,count:2},{group:"subseries",caption:"Cell Physiology",value:11,count:8}],publicationYearFilters:[{group:"publicationYear",caption:"2022",value:2022,count:1},{group:"publicationYear",caption:"2020",value:2020,count:4},{group:"publicationYear",caption:"2019",value:2019,count:5},{group:"publicationYear",caption:"2018",value:2018,count:1}],authors:{paginationCount:25,paginationItems:[{id:"429683",title:"Dr.",name:"Bilal",middleName:null,surname:"Khalid",slug:"bilal-khalid",fullName:"Bilal Khalid",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/429683/images/system/429683.png",biography:"Dr. Bilal Khalid received a Ph.D. in Industrial Business Administration from KMITL Business School, Bangkok, in 2021, and a master’s in International Business Management from Stamford International University, Bangkok, in 2017. Dr. Khalid\\'s research interests include leadership and negotiations, digital transformations, gamification, eLearning, blockchain, Big Data, and management of information technology. Dr. Bilal Khalid also serves as an academic editor at Education Research International and a reviewer for international journals.",institutionString:"KMITL Business School",institution:{name:"King Mongkut's Institute of Technology Ladkrabang",country:{name:"Thailand"}}},{id:"418514",title:"Dr.",name:"Muhammad",middleName:null,surname:"Mohiuddin",slug:"muhammad-mohiuddin",fullName:"Muhammad Mohiuddin",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000038UqSfQAK/Profile_Picture_2022-05-13T10:39:03.jpg",biography:"Dr. Muhammad Mohiuddin is an Associate Professor of International Business at Laval University, Canada. He has taught at Thompson Rivers University, Canada; University of Paris-Est, France; Osnabruck University of Applied Science, Germany; and Shanghai Institute of Technology and Tianjin University of Technology, China. He has published research in Research Policy, Applied Economics, Review of Economic Philosophy, Strategic Change, International Journal of Logistics, Sustainability, Journal of Environmental Management, Journal of Global Information Management, Journal of Cleaner Production, M@N@GEMENT, and more. He is a member of CEDIMES Institut (France), Academy of International Business (AIB), Strategic Management Society (SMS), Academy of Management (AOM), Administrative Science Association of Canada (ASAC), and Canadian council of small business and entrepreneurship (CCSBE). He is currently the director of the Research Group on Contemporary Asia (GERAC) at Laval University. He is also co-managing editor of Transnational Corporations Review and a guest editor for Electronic Commerce Research and Journal of Internet Technology.",institutionString:null,institution:{name:"Université Laval",country:{name:"Canada"}}},{id:"189147",title:"Dr.",name:"Hailan",middleName:null,surname:"Salamun",slug:"hailan-salamun",fullName:"Hailan Salamun",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/189147/images/19274_n.jpeg",biography:"Hailan Salamun, (Dr.) was born in Selangor, Malaysia and graduated from Tunku Ampuan Jamaah Religious High School at Shah Alam. Obtained a degree from the International Islamic University (UIA), Gombak in the field of Islamic Revealed Knowledge and Heritage. Next, I furthered my studies to the professional level to obtain a Diploma in Education at UIA. After serving for several years in school, I furthered my studies to the Master of Dakwah and Leadership at Universiti Kebangsaan Malaysia (UKM), Bangi. I graduated with a Doctor of Philosophy in Principalship Leadership from the University of Malaya (UM) in 2010. I am currently a senior lecturer in the Department of Nationalism and Civilization, Center for Basic and Continuing Education, Universiti Malaysia Terengganu. Prior to that, I had served in several educational institutions such as schools, the Institute of Teacher Education (IPG), and also the University of Malaya. I am also actively involved in paper presentation, writing and publishing. My research interests are focused on leadership, education, society and Islamic civilization. This area of research requires a detailed understanding of Islamic studies and research studies in leadership. Another research interest that I have explored recently is the politics of the Malay community and also the leadership of the mosque.",institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"442081",title:"Dr.",name:"Audrey",middleName:null,surname:"Addy",slug:"audrey-addy",fullName:"Audrey Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Kwame Nkrumah University of Science and Technology",country:{name:"Ghana"}}},{id:"437993",title:"Mr.",name:"Job",middleName:null,surname:"Jackson",slug:"job-jackson",fullName:"Job Jackson",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Management College of Southern Africa",country:{name:"South Africa"}}},{id:"428495",title:"Prof.",name:"Asyraf",middleName:null,surname:"Ab Rahman",slug:"asyraf-ab-rahman",fullName:"Asyraf Ab Rahman",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universiti Malaysia Terengganu",country:{name:"Malaysia"}}},{id:"429650",title:"Dr.",name:"Jacqueline",middleName:null,surname:"Kareem",slug:"jacqueline-kareem",fullName:"Jacqueline Kareem",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Christ University",country:{name:"India"}}},{id:"421041",title:"Dr.",name:"Sunil",middleName:null,surname:"Kumar Ramdas",slug:"sunil-kumar-ramdas",fullName:"Sunil Kumar Ramdas",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Jain University",country:{name:"India"}}},{id:"421833",title:"Mr.",name:"Eugene",middleName:null,surname:"Owusu-Acheampong",slug:"eugene-owusu-acheampong",fullName:"Eugene Owusu-Acheampong",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of Ghana",country:{name:"Ghana"}}},{id:"239876",title:"Ph.D.",name:"Luciana",middleName:null,surname:"Mourão",slug:"luciana-mourao",fullName:"Luciana Mourão",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Salgado de Oliveira",country:{name:"Brazil"}}},{id:"421735",title:"Dr.",name:"elizabeth",middleName:null,surname:"addy",slug:"elizabeth-addy",fullName:"elizabeth addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"442083",title:"Dr.",name:"James",middleName:null,surname:"Addy",slug:"james-addy",fullName:"James Addy",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437991",title:"Prof.",name:"Muhammad",middleName:null,surname:"Hoque",slug:"muhammad-hoque",fullName:"Muhammad Hoque",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421006",title:"Dr.",name:"Anna",middleName:null,surname:"Uster",slug:"anna-uster",fullName:"Anna Uster",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470243",title:"Dr.",name:"Md Samim",middleName:null,surname:"Al Azad",slug:"md-samim-al-azad",fullName:"Md Samim Al Azad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"470244",title:"Dr.",name:"Slimane",middleName:null,surname:"Ed-dafali",slug:"slimane-ed-dafali",fullName:"Slimane Ed-dafali",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421011",title:"Dr.",name:"Afatakpa",middleName:null,surname:"Fortune",slug:"afatakpa-fortune",fullName:"Afatakpa Fortune",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"446057",title:"Mr.",name:"Okedare",middleName:null,surname:"David Olubukunmi",slug:"okedare-david-olubukunmi",fullName:"Okedare David Olubukunmi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421778",title:"Dr.",name:"Fatimah",middleName:"Saeed",surname:"AlAhmari",slug:"fatimah-alahmari",fullName:"Fatimah AlAhmari",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421024",title:"Prof.",name:"Harold Andrew",middleName:null,surname:"Patrick",slug:"harold-andrew-patrick",fullName:"Harold Andrew Patrick",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421065",title:"Ms.",name:"Euzália",middleName:null,surname:"do Rosário Botelho Tomé",slug:"euzalia-do-rosario-botelho-tome",fullName:"Euzália do Rosário Botelho Tomé",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421053",title:"Associate Prof.",name:"Ken",middleName:null,surname:"Kalala Ndalamba",slug:"ken-kalala-ndalamba",fullName:"Ken Kalala Ndalamba",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"421826",title:"Dr.",name:"Inusah",middleName:null,surname:"Salifu",slug:"inusah-salifu",fullName:"Inusah Salifu",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"420823",title:"Prof.",name:"Gardênia da Silva",middleName:null,surname:"Abbad",slug:"gardenia-da-silva-abbad",fullName:"Gardênia da Silva Abbad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"437613",title:"MSc.",name:"Juliana",middleName:null,surname:"Legentil",slug:"juliana-legentil",fullName:"Juliana Legentil",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null}]}},subseries:{item:{id:"18",type:"subseries",title:"Proteomics",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",hasOnlineFirst:!0,hasPublishedBooks:!0,annualVolume:11414,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null,series:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983"},editorialBoard:[{id:"72288",title:"Dr.",name:"Arli Aditya",middleName:null,surname:"Parikesit",slug:"arli-aditya-parikesit",fullName:"Arli Aditya Parikesit",profilePictureURL:"https://mts.intechopen.com/storage/users/72288/images/system/72288.jpg",institutionString:null,institution:{name:"Indonesia International Institute for Life Sciences",institutionURL:null,country:{name:"Indonesia"}}},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",slug:"cesar-lopez-camarillo",fullName:"Cesar Lopez-Camarillo",profilePictureURL:"https://mts.intechopen.com/storage/users/40928/images/3884_n.png",institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",institutionURL:null,country:{name:"Mexico"}}},{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",slug:"shymaa-enany",fullName:"Shymaa Enany",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRqB9QAK/Profile_Picture_1626163237970",institutionString:null,institution:{name:"Suez Canal University",institutionURL:null,country:{name:"Egypt"}}}]},onlineFirstChapters:{paginationCount:8,paginationItems:[{id:"81799",title:"Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases",doi:"10.5772/intechopen.104978",signatures:"Richa Rai",slug:"cross-talk-of-purinergic-and-immune-signaling-implication-in-inflammatory-and-pathogenic-diseases",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81764",title:"Involvement of the Purinergic System in Cell Death in Models of Retinopathies",doi:"10.5772/intechopen.103935",signatures:"Douglas Penaforte Cruz, Marinna Garcia Repossi and Lucianne Fragel Madeira",slug:"involvement-of-the-purinergic-system-in-cell-death-in-models-of-retinopathies",totalDownloads:3,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81681",title:"Immunomodulatory Effects of a M2-Conditioned Medium (PRS® CK STORM): Theory on the Possible Complex Mechanism of Action through Anti-Inflammatory Modulation of the TLR System and the Purinergic System",doi:"10.5772/intechopen.104486",signatures:"Juan Pedro Lapuente",slug:"immunomodulatory-effects-of-a-m2-conditioned-medium-prs-ck-storm-theory-on-the-possible-complex-mech",totalDownloads:5,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81580",title:"Graft-Versus-Host Disease: Pathogenesis and Treatment",doi:"10.5772/intechopen.104450",signatures:"Shin Mukai",slug:"graft-versus-host-disease-pathogenesis-and-treatment",totalDownloads:14,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"80485",title:"Potential Marker for Diagnosis and Screening of Iron Deficiency Anemia in Children",doi:"10.5772/intechopen.102792",signatures:"Yulia Nadar Indrasari, Siti Nurul Hapsari and Muhamad Robiul Fuadi",slug:"potential-marker-for-diagnosis-and-screening-of-iron-deficiency-anemia-in-children",totalDownloads:42,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"79693",title:"Ferroptosis: Can Iron be the Last or Cure for a Cell?",doi:"10.5772/intechopen.101426",signatures:"Asuman Akkaya Fırat",slug:"ferroptosis-can-iron-be-the-last-or-cure-for-a-cell",totalDownloads:90,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"79616",title:"Dietary Iron",doi:"10.5772/intechopen.101265",signatures:"Kouser Firdose and Noor Firdose",slug:"dietary-iron",totalDownloads:142,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"78977",title:"FERALGINE™ a New Oral iron Compound",doi:"10.5772/intechopen.100445",signatures:"Valentina Talarico, Laura Giancotti, Giuseppe Antonio Mazza, Santina Marrazzo, Roberto Miniero and Marco Bertini",slug:"feralgine-a-new-oral-iron-compound",totalDownloads:128,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}}]},publishedBooks:{paginationCount:1,paginationItems:[{type:"book",id:"7437",title:"Nanomedicines",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7437.jpg",slug:"nanomedicines",publishedDate:"February 13th 2019",editedByType:"Edited by",bookSignature:"Muhammad Akhyar Farrukh",hash:"0e1f5f6258f074c533976c4f4d248568",volumeInSeries:5,fullTitle:"Nanomedicines",editors:[{id:"63182",title:"Dr.",name:"Muhammad Akhyar",middleName:null,surname:"Farrukh",slug:"muhammad-akhyar-farrukh",fullName:"Muhammad Akhyar Farrukh",profilePictureURL:"https://mts.intechopen.com/storage/users/63182/images/system/63182.png",institutionString:"Forman Christian College",institution:{name:"Forman Christian College",institutionURL:null,country:{name:"Pakistan"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}},{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.jpg",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}}]},submityourwork:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:8,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:286,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:105,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:9,numberOfPublishedChapters:101,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:11,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],subseriesList:[{id:"4",title:"Fungal Infectious Diseases",scope:"Fungi are ubiquitous and there are almost no non-pathogenic fungi. Fungal infectious illness prevalence and prognosis are determined by the exposure between fungi and host, host immunological state, fungal virulence, and early and accurate diagnosis and treatment. \r\nPatients with both congenital and acquired immunodeficiency are more likely to be infected with opportunistic mycosis. Fungal infectious disease outbreaks are common during the post- disaster rebuilding era, which is characterised by high population density, migration, and poor health and medical conditions.\r\nSystemic or local fungal infection is mainly associated with the fungi directly inhaled or inoculated in the environment during the disaster. The most common fungal infection pathways are human to human (anthropophilic), animal to human (zoophilic), and environment to human (soilophile). Diseases are common as a result of widespread exposure to pathogenic fungus dispersed into the environment. \r\nFungi that are both common and emerging are intertwined. In Southeast Asia, for example, Talaromyces marneffei is an important pathogenic thermally dimorphic fungus that causes systemic mycosis. Widespread fungal infections with complicated and variable clinical manifestations, such as Candida auris infection resistant to several antifungal medicines, Covid-19 associated with Trichoderma, and terbinafine resistant dermatophytosis in India, are among the most serious disorders. \r\nInappropriate local or systemic use of glucocorticoids, as well as their immunosuppressive effects, may lead to changes in fungal infection spectrum and clinical characteristics. Hematogenous candidiasis is a worrisome issue that affects people all over the world, particularly ICU patients. CARD9 deficiency and fungal infection have been major issues in recent years. Invasive aspergillosis is associated with a significant death rate. Special attention should be given to endemic fungal infections, identification of important clinical fungal infections advanced in yeasts, filamentous fungal infections, skin mycobiome and fungal genomes, and immunity to fungal infections.\r\nIn addition, endemic fungal diseases or uncommon fungal infections caused by Mucor irregularis, dermatophytosis, Malassezia, cryptococcosis, chromoblastomycosis, coccidiosis, blastomycosis, histoplasmosis, sporotrichosis, and other fungi, should be monitored. \r\nThis topic includes the research progress on the etiology and pathogenesis of fungal infections, new methods of isolation and identification, rapid detection, drug sensitivity testing, new antifungal drugs, schemes and case series reports. It will provide significant opportunities and support for scientists, clinical doctors, mycologists, antifungal drug researchers, public health practitioners, and epidemiologists from all over the world to share new research, ideas and solutions to promote the development and progress of medical mycology.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/4.jpg",keywords:"Emerging Fungal Pathogens, Invasive Infections, Epidemiology, Cell Membrane, Fungal Virulence, Diagnosis, Treatment"},{id:"5",title:"Parasitic Infectious Diseases",scope:"Parasitic diseases have evolved alongside their human hosts. In many cases, these diseases have adapted so well that they have developed efficient resilience methods in the human host and can live in the host for years. Others, particularly some blood parasites, can cause very acute diseases and are responsible for millions of deaths yearly. Many parasitic diseases are classified as neglected tropical diseases because they have received minimal funding over recent years and, in many cases, are under-reported despite the critical role they play in morbidity and mortality among human and animal hosts. The current topic, Parasitic Infectious Diseases, in the Infectious Diseases Series aims to publish studies on the systematics, epidemiology, molecular biology, genomics, pathogenesis, genetics, and clinical significance of parasitic diseases from blood borne to intestinal parasites as well as zoonotic parasites. We hope to cover all aspects of parasitic diseases to provide current and relevant research data on these very important diseases. In the current atmosphere of the Coronavirus pandemic, communities around the world, particularly those in different underdeveloped areas, are faced with the growing challenges of the high burden of parasitic diseases. At the same time, they are faced with the Covid-19 pandemic leading to what some authors have called potential syndemics that might worsen the outcome of such infections. Therefore, it is important to conduct studies that examine parasitic infections in the context of the coronavirus pandemic for the benefit of all communities to help foster more informed decisions for the betterment of human and animal health.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/5.jpg",keywords:"Blood Borne Parasites, Intestinal Parasites, Protozoa, Helminths, Arthropods, Water Born Parasites, Epidemiology, Molecular Biology, Systematics, Genomics, Proteomics, Ecology"},{id:"6",title:"Viral Infectious Diseases",scope:"The Viral Infectious Diseases Book Series aims to provide a comprehensive overview of recent research trends and discoveries in various viral infectious diseases emerging around the globe. The emergence of any viral disease is hard to anticipate, which often contributes to death. A viral disease can be defined as an infectious disease that has recently appeared within a population or exists in nature with the rapid expansion of incident or geographic range. This series will focus on various crucial factors related to emerging viral infectious diseases, including epidemiology, pathogenesis, host immune response, clinical manifestations, diagnosis, treatment, and clinical recommendations for managing viral infectious diseases, highlighting the recent issues with future directions for effective therapeutic strategies.",coverUrl:"https://cdn.intechopen.com/series_topics/covers/6.jpg",keywords:"Novel Viruses, Virus Transmission, Virus Evolution, Molecular Virology, Control and Prevention, Virus-host Interaction"}],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"May 15th, 2022",hasOnlineFirst:!0,numberOfOpenTopics:4,numberOfPublishedChapters:286,numberOfPublishedBooks:27,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},subseries:[{id:"14",title:"Cell and Molecular Biology",keywords:"Omics (Transcriptomics; Proteomics; Metabolomics), Molecular Biology, Cell Biology, Signal Transduction and Regulation, Cell Growth and Differentiation, Apoptosis, Necroptosis, Ferroptosis, Autophagy, Cell Cycle, Macromolecules and Complexes, Gene Expression",scope:"The Cell and Molecular Biology topic within the IntechOpen Biochemistry Series aims to rapidly publish contributions on all aspects of cell and molecular biology, including aspects related to biochemical and genetic research (not only in humans but all living beings). We encourage the submission of manuscripts that provide novel and mechanistic insights that report significant advances in the fields. Topics include, but are not limited to: Advanced techniques of cellular and molecular biology (Molecular methodologies, imaging techniques, and bioinformatics); Biological activities at the molecular level; Biological processes of cell functions, cell division, senescence, maintenance, and cell death; Biomolecules interactions; Cancer; Cell biology; Chemical biology; Computational biology; Cytochemistry; Developmental biology; Disease mechanisms and therapeutics; DNA, and RNA metabolism; Gene functions, genetics, and genomics; Genetics; Immunology; Medical microbiology; Molecular biology; Molecular genetics; Molecular processes of cell and organelle dynamics; Neuroscience; Protein biosynthesis, degradation, and functions; Regulation of molecular interactions in a cell; Signalling networks and system biology; Structural biology; Virology and microbiology.",annualVolume:11410,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"79367",title:"Dr.",name:"Ana Isabel",middleName:null,surname:"Flores",fullName:"Ana Isabel Flores",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRpIOQA0/Profile_Picture_1632418099564",institutionString:null,institution:{name:"Hospital Universitario 12 De Octubre",institutionURL:null,country:{name:"Spain"}}},{id:"328234",title:"Ph.D.",name:"Christian",middleName:null,surname:"Palavecino",fullName:"Christian Palavecino",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y000030DhEhQAK/Profile_Picture_1628835318625",institutionString:null,institution:{name:"Central University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"186585",title:"Dr.",name:"Francisco Javier",middleName:null,surname:"Martin-Romero",fullName:"Francisco Javier Martin-Romero",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSB3HQAW/Profile_Picture_1631258137641",institutionString:null,institution:{name:"University of Extremadura",institutionURL:null,country:{name:"Spain"}}}]},{id:"15",title:"Chemical Biology",keywords:"Phenolic Compounds, Essential Oils, Modification of Biomolecules, Glycobiology, Combinatorial Chemistry, Therapeutic peptides, Enzyme Inhibitors",scope:"Chemical biology spans the fields of chemistry and biology involving the application of biological and chemical molecules and techniques. In recent years, the application of chemistry to biological molecules has gained significant interest in medicinal and pharmacological studies. This topic will be devoted to understanding the interplay between biomolecules and chemical compounds, their structure and function, and their potential applications in related fields. Being a part of the biochemistry discipline, the ideas and concepts that have emerged from Chemical Biology have affected other related areas. This topic will closely deal with all emerging trends in this discipline.",annualVolume:11411,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null,editorialBoard:[{id:"241413",title:"Dr.",name:"Azhar",middleName:null,surname:"Rasul",fullName:"Azhar Rasul",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRT1oQAG/Profile_Picture_1635251978933",institutionString:null,institution:{name:"Government College University, Faisalabad",institutionURL:null,country:{name:"Pakistan"}}},{id:"178316",title:"Ph.D.",name:"Sergey",middleName:null,surname:"Sedykh",fullName:"Sergey Sedykh",profilePictureURL:"https://mts.intechopen.com/storage/users/178316/images/system/178316.jfif",institutionString:null,institution:{name:"Novosibirsk State University",institutionURL:null,country:{name:"Russia"}}}]},{id:"17",title:"Metabolism",keywords:"Biomolecules Metabolism, Energy Metabolism, Metabolic Pathways, Key Metabolic Enzymes, Metabolic Adaptation",scope:"Metabolism is frequently defined in biochemistry textbooks as the overall process that allows living systems to acquire and use the free energy they need for their vital functions or the chemical processes that occur within a living organism to maintain life. Behind these definitions are hidden all the aspects of normal and pathological functioning of all processes that the topic ‘Metabolism’ will cover within the Biochemistry Series. Thus all studies on metabolism will be considered for publication.",annualVolume:11413,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null,editorialBoard:[{id:"243049",title:"Dr.",name:"Anca",middleName:null,surname:"Pantea Stoian",fullName:"Anca Pantea Stoian",profilePictureURL:"https://mts.intechopen.com/storage/users/243049/images/system/243049.jpg",institutionString:null,institution:{name:"Carol Davila University of Medicine and Pharmacy",institutionURL:null,country:{name:"Romania"}}},{id:"203824",title:"Dr.",name:"Attilio",middleName:null,surname:"Rigotti",fullName:"Attilio Rigotti",profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institutionString:null,institution:{name:"Pontifical Catholic University of Chile",institutionURL:null,country:{name:"Chile"}}},{id:"300470",title:"Dr.",name:"Yanfei (Jacob)",middleName:null,surname:"Qi",fullName:"Yanfei (Jacob) Qi",profilePictureURL:"https://mts.intechopen.com/storage/users/300470/images/system/300470.jpg",institutionString:null,institution:{name:"Centenary Institute of Cancer Medicine and Cell Biology",institutionURL:null,country:{name:"Australia"}}}]},{id:"18",title:"Proteomics",keywords:"Mono- and Two-Dimensional Gel Electrophoresis (1-and 2-DE), Liquid Chromatography (LC), Mass Spectrometry/Tandem Mass Spectrometry (MS; MS/MS), Proteins",scope:"With the recognition that the human genome cannot provide answers to the etiology of a disorder, changes in the proteins expressed by a genome became a focus in research. Thus proteomics, an area of research that detects all protein forms expressed in an organism, including splice isoforms and post-translational modifications, is more suitable than genomics for a comprehensive understanding of the biochemical processes that govern life. The most common proteomics applications are currently in the clinical field for the identification, in a variety of biological matrices, of biomarkers for diagnosis and therapeutic intervention of disorders. From the comparison of proteomic profiles of control and disease or different physiological states, which may emerge, changes in protein expression can provide new insights into the roles played by some proteins in human pathologies. Understanding how proteins function and interact with each other is another goal of proteomics that makes this approach even more intriguing. Specialized technology and expertise are required to assess the proteome of any biological sample. Currently, proteomics relies mainly on mass spectrometry (MS) combined with electrophoretic (1 or 2-DE-MS) and/or chromatographic techniques (LC-MS/MS). MS is an excellent tool that has gained popularity in proteomics because of its ability to gather a complex body of information such as cataloging protein expression, identifying protein modification sites, and defining protein interactions. The Proteomics topic aims to attract contributions on all aspects of MS-based proteomics that, by pushing the boundaries of MS capabilities, may address biological problems that have not been resolved yet.",annualVolume:11414,isOpenForSubmission:!0,coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null,editorialBoard:[{id:"72288",title:"Dr.",name:"Arli Aditya",middleName:null,surname:"Parikesit",fullName:"Arli Aditya Parikesit",profilePictureURL:"https://mts.intechopen.com/storage/users/72288/images/system/72288.jpg",institutionString:null,institution:{name:"Indonesia International Institute for Life Sciences",institutionURL:null,country:{name:"Indonesia"}}},{id:"40928",title:"Dr.",name:"Cesar",middleName:null,surname:"Lopez-Camarillo",fullName:"Cesar Lopez-Camarillo",profilePictureURL:"https://mts.intechopen.com/storage/users/40928/images/3884_n.png",institutionString:null,institution:{name:"Universidad Autónoma de la Ciudad de México",institutionURL:null,country:{name:"Mexico"}}},{id:"81926",title:"Dr.",name:"Shymaa",middleName:null,surname:"Enany",fullName:"Shymaa Enany",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRqB9QAK/Profile_Picture_1626163237970",institutionString:null,institution:{name:"Suez Canal University",institutionURL:null,country:{name:"Egypt"}}}]}]}},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"profile.detail",path:"/profiles/189087",hash:"",query:{},params:{id:"189087"},fullPath:"/profiles/189087",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var t;(t=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(t)}()